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Building And Validating Next-Generation Neurodevices Using Novel Materials,
Fabrication, And Analytic Strategies
Abstract
Technologies that enable scientists to record and modulate neural activity across spatial scales are
advancing the way that neurological disorders are diagnosed and treated, and fueling breakthroughs in
our fundamental understanding of brain function. Despite the rapid pace of technology development,
significant challenges remain in realizing safe, stable, and functional interfaces between manmade
electronics and soft biological tissues. Additionally, technologies that employ multimodal methods to
interrogate brain function across temporal and spatial scales, from single cells to large networks, offer
insights beyond what is possible with electrical monitoring alone. However, the tools and methodologies
to enable these studies are still in their infancy. Recently, carbon nanomaterials have shown great
promise to improve performance and multimodal capabilities of bioelectronic interfaces through their
unique optical and electronic properties, flexibility, biocompatibility, and nanoscale topology.
Unfortunately, their translation beyond the lab has lagged due to a lack of scalable assembly methods for
incorporating such nanomaterials into functional devices. In this thesis, I leverage carbon nanomaterials
to address several key limitations in the field of bioelectronic interfaces and establish scalable fabrication
methods to enable their translation beyond the lab. First, I demonstrate the value of transparent, flexible
electronics by analyzing simultaneous optical and electrical recordings of brain activity at the microscale
using custom-fabricated graphene electronics. Second, I leverage a recently discovered 2D nanomaterial,
Ti3C2 MXene, to improve the capabilities and performance of neural microelectronic devices. Third, I
fabricate and validate human-scale Ti3C2 MXene epidermal electrode arrays in clinical applications.
Leveraging the unique solution-processability of Ti3C2 MXene, I establish novel fabrication methods for
both high-resolution microelectrode arrays and macroscale epidermal electrode arrays that are scalable
and sufficiently cost-effective to allow translation of MXene bioelectronics beyond the lab and into clinical
use. Thetechnologies and methodologies developed in this thesis advance bioelectronic technology for
both research and clinical applications, with the goal of improving patient quality of life and illuminating
complex brain dynamics across spatial scales.
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ABSTRACT
BUILDING AND VALIDATING NEXT-GENERATION NEURODEVICES
USING NOVEL MATERIALS, FABRICATION, AND ANALYTIC
STRATEGIES
Nicolette Driscoll
Flavia Vitale
Brian Litt

Technologies that enable scientists to record and modulate neural activity across
spatial scales are advancing the way that neurological disorders are diagnosed and treated,
and fueling breakthroughs in our fundamental understanding of brain function. Despite the
rapid pace of technology development, significant challenges remain in realizing safe, stable,
and functional interfaces between manmade electronics and soft biological tissues.
Additionally, technologies that employ multimodal methods to interrogate brain function
across temporal and spatial scales, from single cells to large networks, offer insights beyond
what is possible with electrical monitoring alone. However, the tools and methodologies to
enable these studies are still in their infancy. Recently, carbon nanomaterials have shown
great promise to improve performance and multimodal capabilities of bioelectronic
interfaces through their unique optical and electronic properties, flexibility, biocompatibility,
and nanoscale topology. Unfortunately, their translation beyond the lab has lagged due to a
lack of scalable assembly methods for incorporating such nanomaterials into functional
devices. In this thesis, I leverage carbon nanomaterials to address several key limitations in
the field of bioelectronic interfaces and establish scalable fabrication methods to enable their
translation beyond the lab. First, I demonstrate the value of transparent, flexible electronics
by analyzing simultaneous optical and electrical recordings of brain activity at the microscale
using custom-fabricated graphene electronics. Second, I leverage a recently discovered 2D
nanomaterial, Ti3C2 MXene, to improve the capabilities and performance of neural
microelectronic devices. Third, I fabricate and validate human-scale Ti3C2 MXene epidermal
v

electrode arrays in clinical applications. Leveraging the unique solution-processability of
Ti3C2 MXene, I establish novel fabrication methods for both high-resolution microelectrode
arrays and macroscale epidermal electrode arrays that are scalable and sufficiently costeffective to allow translation of MXene bioelectronics beyond the lab and into clinical use. The
technologies and methodologies developed in this thesis advance bioelectronic technology
for both research and clinical applications, with the goal of improving patient quality of life
and illuminating complex brain dynamics across spatial scales.
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Chapter 1: Introduction
Since the first evidence of electrical activity in the nervous system was observed by
Luigi Galvani in the 1790s, a host of technologies have evolved to enable recording and
modulating electrical activity in excitable tissues. These technologies have enabled
breakthroughs in our understanding of brain function and neuropathologies, have provided
diagnostic and therapeutic tools for diseases such as epilepsy and Parkinson’s disease, and
have even enabled locked-in patients to control external effectors through brain computer
interfaces (BCIs) to regain some independence.
Today, neurotechnologies are shedding new light on the fundamental mechanisms
governing the structure and function of neural circuits, which is essential to advance
diagnostics and therapies for debilitating neurological diseases and disorders. In epilepsy, for
example, targeted therapies such as surgical resection, thermal ablation, or responsive
neurostimulation rely on precise localization of seizure onset regions to be effective.
Currently, these seizure onset regions are identified by a combination of electrophysiological
recordings from mm-scale implanted electrodes, non-invasive imaging techniques such as
magnetic resonance imaging (MRI) and positron emission tomography (PET), and through
observing seizure semiology. These techniques offer limited spatial resolution, however, and
a growing body of literature suggests that seizure activity may begin at the scale of neural
microcircuits, which current clinical technologies cannot observe [1]–[3]. Thus, there is great
interest in observing the cell and microcircuit level dynamics of seizure initiation and linking
these to the macroscale, brain-wide activity observed with current clinical technologies. This
notion of recording neural activity across spatial scales is critical for improving our
understanding and targeting of therapies not only for epilepsy, but for many neurological
diseases and disorders, and it was one of the primary motivations for the BRAIN Initiative
launched in 2013.
There remain significant technological hurdles to achieving this goal, many of which
stem from challenges associated with interfacing manmade electronics with soft biological
tissues such as the brain. Recently, carbon nanomaterials such as graphene and carbon
nanotubes have shown significant promise for improving the electrical properties, flexibility,
biocompatibility, and multimodal capabilities of tissue-interfacing electrodes. Despite their
promise, a lack of scalable assembly methods for producing devices using nanomaterials has
1
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so far been a significant barrier to their translation and widespread adoption. The goal of this
thesis is to develop new technologies for mapping and modulating neural and neuromuscular
activity across spatial scales by leveraging the unique properties of carbon nanomaterials and
by establishing scalable fabrication methods that will enable translating these technologies
beyond the lab and into clinical and consumer use.
At one end of the spatial scale, tools and techniques have been evolving to observe
brain activity at the cellular level. In particular, the rise of optogenetics has enabled optical
imaging and modulation of targeted cell types in the brain to discern the functions of different
cell assemblies [4]. Optical imaging techniques, such as calcium imaging, enable observing
activity with high spatial resolution, however their temporal resolution is limited by the
kinetics of the fluorescent reporter molecules and it remains challenging to image at high
resolution across a broad field of view [5]. Electrophysiology with microelectrodes offers a
complimentary approach, with high temporal resolution but sparse spatial sampling.
Combining these two recording modalities presents a unique opportunity to harness the
spatial resolution of optical imaging along with the temporal resolution of electrophysiology,
however this requires imaging and recording simultaneously in the same location. This is not
possible using conventional microelectrode arrays utilizing opaque materials, as these block
optical access and suffer from photoelectric artifacts. Recently, progress in transparent
microelectrode array technology, predominantly utilizing graphene, has enabled such
multimodal studies [6]–[9]. However, innovation is still needed in experimental and
analytical methods to fully realize their potential. So far, these multimodal studies have
mainly focused on 2-photon imaging either from brain slices or from the cortical surface of
anesthetized animals. This approach offers a limited field of view that may fall beneath only
one or a small number of the transparent electrodes. Thus, there is a need to establish new
experimental methods enabling broader area coverage to observe brain dynamics across
spatial scales relevant in epilepsy. Additionally, new analytical approaches are needed to link
the spatial and temporal information contained in the two modalities. In Chapter 3 of this
thesis, I build upon previous work to improve the performance of transparent graphene
electronics, I establish new experimental techniques for multimodal recording across a mmscale area of cortex, and I develop a framework for combining data features from optical and
2
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electrical domains. Taken together, these advances offer the ability to study neural circuits
with unprecedented spatiotemporal resolution, making it possible to link cell-level behavior
to broader network oscillations.
While graphene offers excellent optical transparency for multimodal studies, these
electrodes cannot be scaled down to cellular dimensions to record individual neuron spiking
activity because they are hindered by high impedance. Thus, it has not yet been possible to
record one-to-one optical and electrical spiking activity of individual cells except through the
use of cumbersome patch pipettes. This highlights one of the main challenges in achieving
high density neural recording from microelectrodes, even setting aside optical transparency
requirements. Microelectrodes suffer from a trade-off between geometric surface area and
interface impedance: as electrodes are scaled down to cellular dimensions, a concurrent rise
in their impedance causes a degradation in recorded signal quality [10]. This challenge is
often addressed by increasing the effective surface area over which ionic species can interact
with the electrode without increasing the geometric area. This can be achieved through
nanopatterning [11], surface roughening [12], or electroplating with porous additives [13]
and has led to significant interest in the use of nanomaterials to achieve nanoscale topology
[14]–[16]. Though nanomaterials have shown great promise for improving microelectrode
performance, due to their intrinsically high specific surface areas and their favorable
electronic properties, incorporating these materials into flexible substrates has proven
challenging. For example, graphene and carbon nanotubes must be synthesized through hightemperature chemical vapor deposition processes which are incompatible with flexible
polymeric substrates, and thus require tedious manual steps to transfer and pattern films
after their growth [17].
Recently, a newly discovered family of 2D nanomaterials, MXenes, have attracted
interest for applications in energy storage [18], electromagnetic interface shielding [19], and
supercapacitors [20] owing to their exceptional electronic, thermal, and mechanical
properties. Of the dozens of MXenes that have been discovered, Ti 3C2 has been the most
extensively characterized and optimized, and it exhibits remarkably high electronic
conductivity (~15,000 S/cm) [21] and volumetric capacitance (1500 F/cm 3) [22]. Ti3C2 also
contains abundant surface-terminating functional groups, such as hydroxyl (–OH), oxygen
3

Chapter 1: Introduction

(–O), and fluorine (–F), which endow it with a hydrophilic nature and allow for flexible
surface modification and functionalization. These unique properties make Ti 3C2 an appealing
candidate for improving neural microelectrode performance, while also enabling the use of
simple and scalable solution processing methods which are more practical than those
required to use other carbon nanomaterials. In Chapter 4 of this thesis, I develop a fabrication
method to produce microelectrodes of Ti3C2 MXene, and I demonstrate their effectiveness for
high-resolution neural recording, the first-ever demonstration of any MXene for in vivo
electrophysiology. I show that Ti3C2 microelectrodes possess exceptionally low
electrochemical impedance and improved signal quality compared to gold electrodes, thus
identifying Ti3C2 as a promising new bioelectronic material.
While Chapters 3 and 4 of this thesis focus on microscale interrogation within the
brain, macroscale electrodes deployed across the body can offer a broader view of activity
and key capabilities for medical therapeutics, healthcare monitoring, and wearable devices.
For example, non-invasive epidermal electronics can offer important insights into the
function of the heart (via electrocardiography; ECG), muscles (via electromyography; EMG),
nerves (via nerve-conduction studies), and brain (through electroencephalography; EEG).
Additionally, active bioelectronic devices capable of delivering targeted electrical stimulation
can be used to treat a number of conditions, including neurological diseases [23], [24], heart
arrythmias [25], [26], and inflammatory disorders [27], [28]. The promise of such devices has
fueled a revolution in “bioelectronic medicine”, where electrical modulation of neural
circuitry is used in place of pharmacotherapy [29].
In both passive recording and active stimulation devices, conventional materials and
fabrication processes still remain inadequate for producing high-density multielectrode
arrays that can map and modulate activity in excitable tissues at high spatiotemporal
resolution and over broad areas. For example, in epidermal electronics achieving low
electrode-skin interface impedance has proven a key challenge that has limited the spatial
resolution of epidermal interfaces. Typically, these interfaces require a conductive gel to
reduce the impedance, and these gels are problematic on many fronts: they can be irritating
to the skin [30], they leave unwanted residues in the hair, they can short neighboring
electrodes and thus limit high density recording, and they dry out over time, causing changing
4
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electrode impedances and preventing practical long-term monitoring. New materials may
hold the key for overcoming this and other crucial challenges.
In Chapter 5, I develop a highly scalable method for producing large-area, highdensity Ti3C2 MXene multielectrode arrays − which we name MXtrodes − of arbitrary size and
geometry for varied bioelectronic applications. I perform a comprehensive evaluation of the
electrochemical properties of the MXtrodes relevant for recording and stimulation of
excitable tissues, and I show that they are comparable, and in many aspects superior to,
conventional bioelectronic materials, especially in the context of delivering charge for safe
and effective electrical stimulation. I demonstrate MXtrodes of different scales and
geometries for mapping and modulating excitable networks in different applications,
including

scalp

electroencephalography

(EEG),

electromyography

(EMG),

electrocardiography (ECG), electrocorticography (ECoG), and neural stimulation. Notably, I
show that mm-scale MXtrodes achieve low electrode-skin interface impedance without any
conductive gel, enabling high-density epidermal electronics. Finally, I characterize the
compatibility of MXtrodes with clinical imaging modalities and demonstrate artifact-free
high-field magnetic resonance and computed tomography imaging. MXtrodes represent a
new class of flexible, multichannel, high-density bioelectronic interfaces which leverage the
exceptional properties of Ti3C2 MXene to enable human-scale, clinically-translatable
neurodevices that show great promise for numerous applications in healthcare, research, and
wearable electronics.

5

Chapter 2: Background
2.1 The promise of bioelectronics
Devices which can record and modulate electrical activity in the brain and other
excitable tissues are a mainstay for medical diagnostics and monitoring and increasingly for
therapeutic interventions. They are key tools in neuroscience research, allowing scientists to
decipher the neural basis of movements, behaviors, and even abstract thoughts. They are
enabling a revolution in at-home health and activity monitoring via wearable devices and
have allowed the development of brain-computer interfaces to restore lost functions. In
recent years, there has also been growing interest in the use of neuromodulation as a
treatment option for a number of chronic diseases as a complementary approach to
traditional pharmacotherapy, a concept known as bioelectronic medicine [29].
In the field of medical diagnostics and monitoring, the use of electrodes to monitor
electrical activity in the body is not new. The first ECG was recorded by Willem Einthoven in
1902 [31], and the first EEG recordings were performed by Hans Berger in 1924 [32]. Since
that time, both techniques have become mainstays of clinical care. In addition to these
noninvasive recording methods, techniques in which electrical activity is recorded directly
from brain tissue have become essential for informing resection surgeries for brain tumors
and epilepsy treatment. Intraoperative recordings can help a surgeon distinguish between
healthy and pathologic tissue during a tumor resection surgery, and long-term recordings
from implanted electrocorticography electrodes in epilepsy patients can help identify seizure
foci to target resection surgery. These are just a few examples of the numerous ways in which
electrophysiologic recording is used in clinical medicine.
In addition to passive recording, modulating activity through electrical stimulation
has also become a key therapeutic approach. The first demonstration of this notion was the
invention of the cardiac pacemaker in 1952, with the earliest implants in human beings
carried out between 1958 and 1960 [33]. Since then, stimulation devices have been
developed for the brain and peripheral nerves to treat a variety of diseases. Deep brain
stimulation (DBS), which delivers consistent electrical stimulation to focal areas within the
brain, was approved in the U.S. in 2002, and it has been heralded as providing “a new life for
people with Parkinson’s disease” as it can effectively eliminate debilitating tremor and other
6
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motor symptoms [34]. While the exact mechanisms for how DBS achieves its effects are still
not fully understood, this approach has shown so much promise that it is currently being
evaluated for treating a number of additional disorders, including dystonia, depression,
multiple sclerosis, and obsessive compulsive disorder. Stimulation of nerves can achieve
similar effects, and one such example is vagus nerve stimulation (VNS), which was approved
in the U.S. in 1997 for the treatment of medically refractory partial-onset seizures. Like DBS,
VNS has also gained attention as a potential treatment option for numerous disorders beyond
its initial indication, including depression, mood disorders, migraines, and inflammatory
disorders such as rheumatoid arthritis, diabetes, and cardiovascular disease [35]. More
recently, closed-loop neuromodulation systems have emerged which are capable of
monitoring activity and delivering electrical stimulation only when needed, rather than
constantly stimulating. These devices, which are likened to “pacemakers for the brain”, have
shown great promise for the treatment of medically refractory epilepsy by sensing the onset
of abnormal brain activity and stimulating to inhibit seizure initiation [36].
In recent years, bioelectronics have also enabled the development of brain-computer
interfaces (BCIs) which can restore lost sensory or motor functions. For example, cochlear
implants have proven effective for restoring partial hearing to the deaf [37], and retinal
prostheses have been developed for restoring limited vision to the blind [38]. These devices
relay signals from external sensors to small, implanted electrodes which stimulate the
sensory cells in the cochlea and retina, respectively. For patients suffering from paralysis or
locked-in syndrome, motor BCIs capable of decoding movement intention from electrodes
placed in motor areas of the brain and translating this into the movement of an external
effector, such as a computer cursor or a robotic arm, offer great promise for restoring some
independence and greatly enhancing quality of life [39].
Beyond their uses in clinical medicine, bioelectronics are increasingly finding their
way into consumer use in the form of wearable devices. While many of these devices sense
signals other than the biopotentials which are the main focus of this work, including
temperature, motion, and metabolites in sweat, there are growing applications where
monitoring of electrophysiologic signatures is useful. For example, heart rate monitors have
been used by athletes for decades but sensors that now collect the full ECG waveform are
7
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increasingly being incorporated into smartwatches to check for abnormal heart rhythms.
There has also been increasing interest in consumer-grade EEG headsets for monitoring
stress and attention, for enabling “brain training” with neurofeedback, for tracking sleep and
meditation, and even for brain-controlled videogaming [40], [41]. Wearable EMG sensors
have also gained attention for monitoring muscle activity during exercise to tune sports
performance [42].
Finally, it is difficult to overstate the importance of devices for recording and
modulating the activity of excitable tissues in neuroscience research. Such devices have
contributed in profound ways to our understanding of the nervous system and other
excitable tissues, from the level of individual cell behavior up to large scale network activity.
To choose just one notable example, the development of microelectrodes in the 1950s
allowed “micromapping”: precisely mapping regions of the cortical surface that
corresponded to particular sensory and motor areas on the body. Through a series of
micromapping experiments in monkeys, Michael Merzenich showed that the cortical maps
corresponding to individual fingers were plastic and would rearrange in response to the
amputation of a finger [43]. These and other experiments using microelectrodes eventually
gave rise to the concept of neuroplasticity, overturning the longstanding belief that the adult
brain was static and leading to revolutionary new therapies for deficits in speech, language,
memory, and reading which had been believed to be untreatable.
The numerous examples of bioelectronic interfaces outlined in this section highlight
the tremendous potential of these technologies for applications across healthcare, research,
and consumer electronics. At their core, such technologies all rely on an interface between
manmade electronics and biological tissues. Improving the properties of this interface is one
of the core themes of this thesis work.

8
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2.2 Methods for neural recording and modulation
“There are only a handful of tools at the neuroscientist’s disposal to monitor
brain activity without seriously interfering with it. Can we finish the job with
these tools alone? Maybe not, but for now, we have to live with them and
believe that we will not fail or falter. Each of the existing methods is a
compromise between spatial and temporal resolution. The desired temporal
resolution is the operation speed of neurons, that is, the millisecond scale. The
desired spatial resolution depends on the goal of the investigation and
expands from the global scale of the brain down to the spines of individual
neurons. No current method is capable of continuously zooming from the
decimeter to the micrometer scale, which is why several methods are being
used, often in combination.”
−

Gyorgy Buzsaki [44]

There are numerous methods for recording and modulating the activity of the brain
and other excitable tissues, and as Gyorgy Buzsaki so nicely stated, they each offer a specific
range of temporal and spatial resolution. These methods span multiple modalities, including
electrical, optical, magnetic, acoustic, and chemical. The work of this thesis focuses on the
electrical and optical domains, however in this section I will provide a brief overview of the
numerous approaches for neural recording and modulation. I will focus on methods primarily
applied to the study of the brain, however many of these approaches can be extended to the
study of the peripheral nervous system. A useful schematic depicting the spatiotemporal
resolution of some of these methods is shown in Figure 2.1.
2.2.1 Electrical
The origin of extracellular fields and currents
Activity within the nervous system is a complex interplay of electronic and chemical
signaling. The primary information-encoding cells in the nervous system are neurons, though
glial cells also play important roles. Neurons communicate with each other by firing action
9
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Figure 2.1 The spatiotemporal domain of neuroscience methods. Each colored region represents
the useful domain of spatial and temporal resolution for one method available for the study of the
brain. Open regions represent measurement techniques; filled regions represent perturbation
techniques. Inset, a cartoon rendering of the methods available in 1988, notable for the large gaps
where no useful method existed. Regions allocated to each domain are somewhat arbitrary and
represent estimates. From [375].

potentials (APs), also called “units” or “spikes”, which result in the release of chemical
neurotransmitters at synapses, which in turn influence the behavior of other neurons. During
an action potential, voltage-gated ion channels embedded in the cell membrane facilitate a
coordinated pattern of Na+ ion influx into the cell, followed by K+ ion outflux, resulting in a
large amplitude voltage spike ~1 ms in duration which is largest in amplitude near the soma
(Figure 2.2). Even when neurons are not firing APs, smaller ionic currents at the postsynaptic
membrane, called excitatory or inhibitory postsynaptic potentials, affect the neuron’s
membrane potential, causing it to deviate from its resting state of approximately -70 mV.
These voltage fluctuations are much smaller than those of APs, but they last for 10s of
milliseconds and contribute significantly to the extracellular field.
10
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Figure 2.2 Extracellular contribution of an action potential (“spike”) to the LFP. The peak-topeak voltage range is indicated b the color of the traces. Note that the spike amplitude decreases
rapidly with distance from the soma. Note the widening of the spike with distance from the soma,
owing to greater contributions from dendritic currents and intrinsic filtering of high-frequency
currents by the cell membrane. From [45].

At any point in the extracellular space, the measured potential V e is the superposition
of all ionic processes, from fast action potentials, to synaptic currents and Ca2+-mediated
spikes, to even slow fluctuations in glia. This potential is often referred to as the local field
potential (LFP) when recorded on the cortical surface. The voltage arising from any
transmembrane current, assuming a current dipole, decays as 1/r2, where r is the distance
between the recording electrode and the source current [45]. Another consistent feature of
extracellular potential is that the magnitude of the power (or the square of the Fourier
amplitude), is inversely related to temporal frequency f. This 1/f power scaling relation is
attributed in part to the low-pass frequency filtering properties of dendrites [46], as well as
to broader network mechanisms: in a brief time window only a limited number of neurons
can be recruited in a given volume, whereas in a longer time window the activity of many
more neurons can contribute to the LFP, generating a larger amplitude LFP at slower
frequencies [45].
11
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In measuring extracellular potentials, it is important to keep these relations in mind
as both the size of the electrode and its distance from the active neurons will affect the signal
content. Importantly, the Ve that is measured by an electrode reflects a spatial average of the
activity near the electrode. Thus, electrodes record a “spatiotemporally smoothed” version of
the extracellular potential integrated over their surface, and a larger electrode will record
less high frequency signal content corresponding to individual neuron activity. A summary of
the various scales of neural recording and their frequency content is shown in Figure 2.3.
Macroscale recording: Scalp EEG
Scalp electroencephalography is one of the oldest and most widely used methods for
investigating the electric activity of the brain. EEG electrodes are typically ~10 mm in
diameter, and the signals they detect represent only the largest, most synchronous neural
signals since they must travel through the brain, cerebrospinal fluid, skull, and scalp before
reaching the electrode. The skull and scalp act as low-pass filters, thus the EEG typically
retains little high frequency content and little relationship to the firing patterns of the

Figure 2.3 Methods for brain recording at different scales. Several types of brain signals can be
recorded from noninvasive and invasive electrodes: EEG signals are recorded from the scalp, ECoG
from the brain surface, and spikes from brain-penetrating electrodes. From [376].
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contributing individual neurons [47]. The spatial resolution of EEG is inherently quite poor,
however computational methods for source localization can give theoretical approximations
for the areas of cortex responsible for the activity recorded on the scalp [48], [49].
Mesoscale recording: Intracranial EEG
When EEG recordings are obtained with intracranial electrodes, it is referred to as
intracranial EEG (iEEG). This can be in the form of electrocorticography (ECoG) using grids
and strips of electrodes placed subdurally onto the surface of the brain, or stereotaxic EEG
(sEEG) using thin penetrating electrodes placed into deeper targets within the brain. These
techniques are used in patients with drug-resistant epilepsy, for whom surgical resection of
seizure foci may offer seizure freedom. Typically, these patients are implanted with a number
of ECoG and sEEG electrodes, then weaned off of their antiepileptic medications and
continuously monitored in the hospital with the goal of recording seizures or abnormal
interictal activity that can help to localize the patient’s seizure foci. iEEG recordings offer
much higher resolution than EEG and they can resolve a wider range of frequency content
due to their placement directly on the surface (ECoG) or within (sEEG) the brain. ECoG
electrodes are typically Pt or stainless steel flat electrodes 2.3 mm in diameter with a 10 mm
pitch between contacts, while sEEG electrodes are typically cylindrical contacts ~2mm in
length spaced along a probe ~1 mm in diameter [50]. Using known estimates of the number
of neurons per cortical area along with the size of these electrodes, it can be assumed that
there are ~500,000 cells beneath or surrounding one of these electrodes [51]. Still, iEEG
signals typically contain information in frequency bands ranging from delta (1-3 Hz) all the
way up to high-gamma activity (60-250 Hz), which is a correlate of averaged neuronal spiking
activity [52].
Microscale recording: Microelectrodes
In the electrical domain, microelectrodes offer the highest spatial and temporal
resolution for recording and stimulating neural activity. They are typically <100 µm in
dimension and can resolve the spiking activity of individual neurons. Microelectrodes were
originally developed as research tools for academic investigation into the neural mechanisms
13
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that regulate attention, movement, and behavior. They fall into three general categories: (1)
microwire arrays, (2) microfabricated planar arrays, and (3) micromachined arrays (Figure
2.4). Microwire electrodes are typically conductive core wires, with an insulation layer such
as glass, parylene, or polyimide coating the wire except at the very tip, where the recording
contact is located. Multiple microwires can be arranged into an array, typically requiring
manual assembly [53] (Figure 2.4a).
Planar microelectrode arrays (Figure 2.4b) are typically produced using
microfabrication techniques drawn from the well-established methods of the semiconductor
industry, and these include both surface micro-ECoG (µECoG) arrays and penetrating shank
arrays. µECoG arrays typically consist of thin metal films patterned through photolithography
on polymer substrates. Achieving high electrode density on a surface µECoG array to
maximize spatial resolution has been quite challenging due to the need to wire out the signals
from each individual electrode, however recent advances allowing the incorporation of active
multiplexing electronics onto such arrays have pushed the limits of µECoG resolution [54]
(Figure 2.5a). Additionally, surface µECoG arrays typically cannot resolve individual neuron
APs because the neuronal cell bodies that generate them are located ~100s of micrometers
deep in the cortex, however recent work has shown that unit activity can be recorded from

Figure 2.4 Classes of implantable microelectrodes. (a) 50 µm polyimide-insulated tungsten
microwires with chiseled tips (Tucker-Davis Technologies). (b) Microfabricated silicon planar
Michigan array with iridium electrode sites (NeuroNexus Technologies). Scale bar: 100 µm. (c)
Micromachined boron-doped silicon array (Blackrock Microsystems). Scale bar: 400 µm. From [377].
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Figure 2.5 Advanced µECoG array technologies. (a) Actively multiplexed high-density µECoG array.
Active transistors within the array allow for sampling from 360 electrodes with just 40 wires. From
[54]. (b-c) NeuroGrid high-density µECoG array. 10 µm2 electrodes are arranged in 2x2 tetrode
arrangement for isolation of individual neuronal spikes from the cortical surface. Scale bars: (b) 1 mm,
(c) 1 mm, (d) 20 µm. From [378].

the cortical surface with electrodes that are sufficiently small (~10 µm2 in size) and low in
impedance [55] (Figure 2.5b-d). The other class of planar microelectrode arrays are
penetrating shank arrays. These are typically fabricated on rigid silicon substrates, with
multiple electrode contacts along the length of the shank. This enables recording neural
activity at multiple depths spanning the cortex or other brain areas with just a single probe
inserted. Recently, the use of complementary metal-oxide-semiconductor (CMOS) processing
has enabled pushing the bounds of electrode density on these planar depth electrodes to
unprecedented new limits. The Neuropixels probe unveiled in 2017 offers 384 recording
channels, programmably addressable from a selection of 960 possible recording sites along
a 10 mm-long, 70 x 20 µm cross-section shank, the highest density electrode array reported
to date [56].
The final main class of microelectrodes are micromachined arrays. These are similar
to microwire arrays in that each “probe” contains a single electrode contact located at its tip,
however they are produced by micromachining a block of silicon into an array of needle-like
probes. This “bed of nails” type electrode array was introduced in the late 1990s and became
known as the Utah array [57]. Today’s version of the Utah array offers 100 penetrating
electrode contacts within a 2 x 2 mm area, and it is the only microelectrode array that has
been approved for human use in the U.S. This had made the Utah array central in human BCI
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research [58], despite the fact that its rigid needle-like architecture presents significant
challenges for long-term recording reliability [59].
Electrical stimulation
While recording electrodes provide insight into the activity within the nervous
system, they do not allow for control over its dynamics. Electrical stimulation is one way to
perturb neural activity, both for research purposes (i.e. to see how the system responds to a
change in stimuli) and also for therapeutic purposes (i.e. to inhibit or alter pathologic
activity). As mentioned in section 2.1, electrical stimulation in the brain and peripheral
nervous system has proven an effective therapy for Parkinson’s disease, depression, and
many other conditions. Electrical stimulation is non-selective, meaning that any excitable
cells within the vicinity of the stimulation delivery will be affected. The amount of charge that
can be safely delivered for electrical stimulation depends largely a quantity known as charge
injection capacity (CIC), which depends on innate electrochemical properties of the electrode
material, as well as the geometry and surface roughness of the electrode [60]. CIC will be
discussed further in Section 2.4. Common materials for stimulation electrodes include
platinum and platinum-iridium, though coatings of iridium oxide and titanium nitride are
often used to improve the CIC of electrodes [61].
2.2.2 Optical
Calcium imaging
Calcium imaging is a sensitive method for monitoring neuronal activity because most
depolarizing electrical signals are associated with Ca2+ influx attributable to the activation of
one or more of the numerous types of voltage-gated Ca2+ channels abundantly expressed in
the nervous system [62]. These signals are often further amplified by Ca 2+ release from
intracellular Ca2+ stores. Fluctuations in intracellular Ca2+ concentration in response to cell
activity can be observed using fluorescent indicators that exhibit altered fluorescent
properties when bound with free Ca2+ ions. There are two general classes of Ca2+ indicators:
genetically encoded fluorescent proteins and chemically engineered fluorophores [63].
Chemical Ca2+ indicator dyes, such as Orgeon Green BAPTA provide large signal-to-noise
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ratios, but they can be difficult to load into cells in intact tissue, they can compartmentalize
into cellular organelles, and they leak out of cells over longer recording periods, making
chronic imaging infeasible [64]. Genetically encoded Ca2+ indicators (GECIs), such as the
GCaMP family, have the advantage of genetic targeting so that imaging can be performed with
only specific cell types containing the Ca2+ indicator. They also do not suffer from the
challenges that prevent chronic imaging with synthetic dyes. There have been many types of
Ca2+ indicators developed over the years, and they each have slightly different Ca 2+ binding
affinity, excitation/emission wavelengths, and signal-to-noise ratios [62]. A few key
limitations of calcium imaging techniques include: (i) their temporal resolution is limited by
the kinetics of Ca2+ binding and unbinding from the fluorescent indicators, as well as by the
speed of the imaging instrumentation such that neuronal action potentials cannot be clearly
resolved [5], (ii) it is challenging to image at high resolution across a broad field of view [65],
(iii) due to light scattering in tissue, it is difficult to image deep structures, although new
implantable GRIN lens scopes have improved these capabilities [66], and (iv) calcium
transients are an indirect measure of neuronal activity.
Voltage imaging
Another technique for observing neural activity is the use of voltage-sensitive
fluorescent indicators. These enable direct imaging of voltage, which is an attractive method
for studying neural circuits [67]. Small molecule voltage-sensitive fluorescent indicators
generally fall into two classes: electrochromic-type dyes which posses fast response speeds
sufficient to track action potentials but with low sensitivity, and oxonols, which have larger
fluorescent responses to voltage but respond too slowly to visualize discrete action potentials
[68]. Voltage imaging offers a direct measure of neural activity, in contrast to the indirect
measure of calcium transients in Ca2+ imaging, and it is capable of resolving the fast dynamics
of individual action potentials. However, voltage imaging has several inherent challenges
which have limited its widespread adoption. First, to resolve action potentials the speed of
image acquisition must be fast, on the order of 1000 Hz to accurately sample action potentials,
while acquisition speeds for Ca2+ imaging can be in the range of 1-10 Hz [68]. This means that
voltage indicators have less time to deliver photons to the imaging detector, making each
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measurement inherently noisier. Achieving fast acquisition speeds while maintaining a large
field of view is also a significant challenge for imaging instrumentation. Also, voltage
indicators must localize to the plasma membrane to properly sense voltage, in contrast to
Ca2+ indicators which are localized to the cytosol. This makes it challenging to segment
adjacent cells in the image processing to resolve activity from individual cells [68]. Finally,
voltage imaging is hindered by background autofluorescence and signal decay by
photobleaching [69]. A comparison of voltage imaging to Ca2+ imaging is shown in Figure 2.6.

Figure 2.6 Comparison of voltage and Ca2+ imaging in neurons. (a) Ca2+ (green) and voltage
(magenta) responses to single, spontaneous action potentials in the same rat hippocampal neuron, as
recorded by GCaMP6s (green) and the voltage-sensitive dye RhoVR 1 (magenta). Panels (b) and (c)
depict the neuron (white star) analyzed in panel (a). Scale bar: 20 µm. Adapted from [379].

Optogenetics
Optogenetics is a powerful technique that enables modulating the activity of
genetically-targeted cell types with light. It involves manipulating neurons so that they
express genes taken from algae that encode light-sensitive ion channels and pumps, called
opsins. In the first key demonstration in 2005, the gene encoding channelrhodopsin-2 (ChR2)
was delivered to neurons via a lentivirus vector, and subsequently these neurons could be
induced to fire action potentials upon delivery of millisecond-timescale pulses of blue light
[70]. Since that initial demonstration, the optogenetics toolkit has been expanded to include
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opsins that mediate neural activation with green and red light, and light-sensitive chloride
pumps that act as inhibitory opsins, among others [71]. Optogenetics has made it possible to
causally probe the contributions of specific cell types to neural circuits, since activation and
silencing of those specific cells can reveal the impact they have on the generation of behaviors
and pathologies. The ability to selectively perturb the activity of specific cell types is a key
advantage for optogenetics over electrical stimulation, which is nonspecific.
One of the primary challenges in optogenetics is that the visible light needed for opsin
activation is scattered and absorbed by neural tissue. The mean scattering length for visible
light in biological tissues is on the order of 100s of micrometers, though it is slightly higher
for infrared light [72]. Thus, methods of light delivery to the brain have become a key research
area. Approaches include implantable optical fibers [73], implantable probes with integrated
optical waveguides [74] or micro-LEDs [75], and more exotic methods such as ultrasonic
guiding of light [76]. Even more recently, methods have been evolving for finely directing
light stimulation using spatial light modulation to enable studies with single-cell targeting
precision [77].
Optogenetics has proven a powerful technique in neuroscience research, and it is still
in the early years of its adoption. An open question that remains is how optogenetic tools
might someday be used clinically. It is still too early to know whether the opsin genes will be
well tolerated in the human body, especially over long timescales. Even so, one promising
candidate for optogenetics-based treatment in humans is retinitis pigmentosa, which is
attractive because the retina is both immune-privileged and allows simple light delivery
through the eye [78].
2.2.3 Magnetic
Imaging
Magnetic fields are perhaps the only modality that can access arbitrarily deep tissues
with little signal attenuation, due to the low magnetic susceptibility of biological tissues [79].
Functional magnetic resonance imaging (fMRI) exploits the differences between the magnetic
properties of oxygenated and deoxygenated hemoglobin to measure local increases in blood
flow that accompanies neural activity [80]. It is a noninvasive method that allows whole-brain
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imaging, however it has limited spatial and temporal resolution and it an indirect metabolic
correlate of neural activity. The spatial resolution is primarily defined by the voxel size, which
is on the order of ~1 mm3 or larger, and the signal-to-noise ratio of the acquired data [81].
The temporal resolution is on the order of ~1 s, and it is limited both by the image sampling
rate and the inherently slow hemodynamic response time [82]. Despite its relatively poor
spatiotemporal resolution, fMRI has enabled many insights into the functions of specific
regions in the human brain and their contributions to different cognitive processes.
Modulation
In addition to enabling non-invasive, whole brain imaging, magnetic fields can be
leveraged to modulate activity in the brain. Transcranial magnetic stimulation (TMS) is a
technique in which magnetic fields with frequencies <1 kHz and amplitudes >1 T can
inductively evoke ionic currents it order to non-invasively modulate brain activity through
the skull [83]. TMS pulses are produced by sending a brief, high-current pulse through a coil
of wire, which produces a transient magnetic field with lines of flux passing perpendicularly
to the plane of the coil. This magnetic field in turn induces an electric field in the tissue,
perpendicular to the magnetic field, which can excite neurons and induce currents [83].
Different coil geometries have been engineered to target the TMS stimulation area, however
the spatial resolution is still limited to ~1 cm. TMS is most frequently used as a research tool
to probe brain physiology, however it has also shown potential as a therapeutic option for
treating depression and other psychiatric disorders [84].
Another method for exploiting magnetic fields to achieve neuromodulation is the use
of magnetic nanoparticles (MNPs) as transducers. There are two primary mechanisms by
which MNPs can transduce magnetic fields into neural activation: magnetothermal and
magnetomechanical. In the first, MNPs exposed to an alternating magnetic field generate heat
through hysteresis, which in turn activates heat-sensitive cation channels in neurons to
trigger action potentials [85]. In the second, iron-containing MNPs tethered to the cell
membrane produce a torque on the membrane in the presence of magnetic fields, which
triggers mechanosensitive cation channels in neurons to achieve neuromodulation [86]. In
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contrast to neuromodulation using DBS or TMS, the use of these magnetic transducers allows
modulation on the microscale, as well as cell-type specific targeting.
2.2.4 Acoustic
Ultrasound (US) is a form of acoustic energy that easily penetrates soft tissues at
wavelengths on the order of ~100 µm. This allows US-based methods to deliver focused
energy several centimeters deep into tissue, and with spatial precision corresponding to the
wavelength [87]. Furthermore, sound waves propagate at speeds of ~1.5 km/s in soft tissue,
which allows US to operate with temporal precision below 1 ms. These properties have made
US a widely used technology in clinical medicine, and more recently have drawn attention in
the neuroscience research community.
Imaging
US has long been used as a tool for imaging soft tissues throughout the body. US
imaging is a pulse-echo technique involving the transmission of brief pulses of US into tissue
and recording the backscattered echoes from objects and interfaces in the tissue [87].
Scattering arises from materials with different density or compressibility relative to the
surrounding medium, including tissue interfaces and blood cells. Although US is strongly
attenuated by bone, brain imaging is possible through the intact skull in mice, and through
cranial windows in other species. Recently, methods using ultrafast US have been
demonstrated for visualizing hemodynamic correlates of neural activity in behaving animals
with brain-wide coverage. The technique, known as functional US imaging (fUSI) can image
cerebral blood flow with greatly enhanced temporal resolution compared to fMRI, and it has
the added advantage that it can be used to image awake, behaving subjects (including during
locomotion) by fixing a miniaturized US probe onto the skull [88].
Modulation
The same properties that make US attractive for neural imaging also make it
appealing for neuromodulation, including the ability of sound waves to penetrate deep into
tissues and achieve high spatiotemporal precision. For neuromodulation, US waves only need
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to travel in one direction (backscattering is no longer important), which allows lower
frequencies to be used which more easily travel through the intact skull, including the human
skull [87]. In awake nonhuman primates and humans, focused ultrasound (FUS) applied to
the brain has been shown to modify perception, behavior, and other neurophysiological
responses [89]. The exact mechanisms by which FUS achieves its neuromodulatory effects
are not fully understood, but it is believed to act through mechanical force on neurons,
transduced by mechanosensitive ion channels [90]. More work is needed to explore the safety
and efficacy of FUS for neuromodulation, but it offers great promise as a non-invasive method
that can target cm-deep brain areas with higher spatial precision that TMS.

The list of neural recording and modulation methods outlined in this section is by no
means exhaustive, but it gives an overview of some of the primary modalities for interacting
with the nervous system, as well as their pros and cons, in order to provide context for the
methods explored in this thesis.

2.3 Challenges for bio-interfacing electrodes
The design and fabrication of bioelectronic interfaces are guided by some universal
principles, including low interfacial impedance and intimate integration with soft and
curvilinear tissues. The inherent mismatch between biological tissues and manmade
electronics cannot be ignored, it and has required significant innovation to realize electronics
which can intimately and safely interact with tissues. At epidermal interfaces, human skin is
both stretchable and breathable, but electronics are typically non-stretchable and require
impermeable encapsulation for prolonged lifetimes. At implanted interfaces, tissues are soft
and ionically conductive while conventional electronics are rigid and electronically
conductive. These and other inherent mismatches between tissues and electronics pose
significant challenges.
2.3.1 Implantable interfaces
Electrodes that are implanted inside the body face the challenge of long-term
exposure to a warm, aqueous, saline environment and must contend with the body’s innate
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immune response. Decades of investigations into the long-term performance of implanted
neural electrodes have established that the quality of signals transduced across this interface
considerably decays over time [91], [92]. One of the primary factors that limits the functional
lifespan of implanted bioelectronics is the mismatch in mechanical properties between the
materials composing the device and the surrounding soft tissues. Numerous studies have
shown that chronic implantation of stiff, penetrating microelectrode probes into brain tissue
triggers a cascade of biological responses that are detrimental to the recording performance
of the electrode [93], [94]. There is an acute wound-healing response triggered by the initial
probe insertion, characterized by the migration of activated microglia, reactive astrocytes,
and blood-borne macrophages to the cite as well as the secretion of inflammatory cytokines,
reactive oxygen species, and other neurotoxic factors [95], [96]. If the probe remains in the
tissue, this acute response transforms into a chronic foreign body response. This response is
characterized by the formation of an insulating glial scar around the implant, composed of
fibroblasts, reactive astrocytes, and activated microglia, as well as the formation of a
neurodegenerative zone around the implant where neurons die or migrate away from the
site [92], [97]. The acute and chronic phases of the biological response to a stiff implant are
shown in Figure 2.7. The glial scar limits ionic exchange between the electrode and
surrounding tissue, effectively insulating it from the neural signals, and the death and
migration of neurons away from the implant means that there are fewer signals to record.
Several strategies have proven effective for minimizing the biological response to
implanted electrodes. For instance, the addition of coatings which elute anti-inflammatory
drugs can significantly reduce the inflammatory response [98]. The most effective
approaches for improving the long-term performance of implanted electrodes, however,
center on making electrodes smaller and softer. Neural tissues are soft (<10 kPa), compliant,
and constantly undergoing micro and macroscopic motions caused by pulsatile blood flow
and motions of the human body [99]. Conventional electronic materials, notably noble metals
and silicon, have Young’s moduli orders of magnitudes higher than that of the neural tissue
(~100 GPa), which means that rigid electronics in these tissues are constantly undergoing
micromotions with respect to the surrounding tissue, exacerbating the inflammatory
response. To combat this challenge, new ultrasoft and flexible probes have been developed,
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Figure 2.7 Biological response to implantation of a stiff probe. Illustration of the (A) acute, and (B)
chronic phases of the biological response to stiff microelectrodes implanted into brain tissue. (C)
Legend of symbols used in (A) and (B).

which can move with the tissue and have been shown to elicit a significantly reduced
biological response [100]. In addition to using soft, compliant materials, reducing the size of
the electronics can also reduce the inflammatory response by reducing the tissue
compression forces and damage to capillaries and vasculature during insertion [101].
This poses another significant challenge for implantable electrodes: while making
them ultra-compliant and reducing their dimensions can greatly improve their long-term
recording functionality, implanting such devices into neural tissues becomes challenging
because they may be too compliant to bear the necessary insertion forces to enter the tissue,
and instead buckle. Numerous strategies have emerged for implanting soft probes into neural
tissue, including the use of temporary rigid insertion shuttles [100], dissolvable coatings
[102], shape memory polymers [103], and microfluidic actuation [104], among others [105].
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Another key challenge for implantable interfaces is the durability of the electrode and
insulation materials in the warm, wet, oxidizing environment of the body. The electrode
material must be corrosion-resistant over the planned life of the implant, which is one reason
noble metals, such as Pt and its alloys, have been widely used in clinical devices such ECoG
and sEEG. If the electrode will be used to deliver electrical stimulation, avoiding
electrochemical corrosion during charge injection cycles also becomes an important
consideration. The insulation materials must also withstand cracking and delamination, as
this leads to current leakage and potential shorts, parasitic capacitances, fluctuations in
electrode impedance, and accelerated degradation of the underlying conductive layers [106].
Finally, minimizing electrode impedance is an important consideration for any
implantable interface, and it becomes a significant challenge when electrodes are
miniaturized to achieve high spatial resolution recording or microstimulation. Electrode
impedance will be discussed in more detail in Section 2.4, however a key relation is that
impedance rises as the size of an electrode is reduced. Achieving a low interface impedance
is key for recording high-fidelity signals, as well as for safely and efficiently delivering charge
for stimulation. Thus, choosing electrode materials that effectively minimize impedance is a
primary consideration for implantable interfaces.
2.3.2 Epidermal interfaces
Epidermal electrode interfaces face a different set of challenges compared to
implantable devices, however there are many areas of overlap. Like implantable interfaces,
mismatch in mechanical properties between electronics and the soft, flexible skin is one
important challenge. Human skin has a Young’s modulus of ~20-100 kPa, and can sustain up
to 15% tensile strain during normal motions [107], [108]. Thus, achieving compliant and
conformal contact between an epidermal sensor and the skin requires using soft, flexible, and
even stretchable materials. Insulating elastomeric substrates can meet these requirements,
however this is a more challenging problem for the conductive materials used for the
electrodes and interconnects. One common strategy for enabling deformable electronics is to
pattern thin metallic films into serpentine or fractal mesh geometries to minimize local
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strains [108], however other strategies incorporating stretchable hydrogels [109], liquid
metals [110], and carbon nanotube composites [111] have been demonstrated.
In epidermal interfaces, the electrode-tissue interface impedance is an even bigger
challenge than it is for implantable interfaces. The epidermis is essentially an “information
barrier”, insulting external electronics from the signals coming from deeper muscle or nerve
tissues [112]. The topmost layer, the stratum corneum, consists of dead skin cells and
intercellular lipids and it is electrically insulating, with a resistance that is significantly higher
than that of the underlying layers of the epidermis [112]. This layer dominates the electrodeskin interface impedance, which can be variable depending on skin hydration.
There are two main classes of epidermal interfaces: “wet” electrodes that use a
conductive hydrogel at the interface, and “dry” electrodes which do not have a hydrogel. Wet
electrodes typically achieve lower impedance because they hydrate the stratum corneum and
facilitate ionic exchange, and they are the preferred type for clinical ECG and EEG monitoring.
The hydrogels employed in these wet interfaces can pose significant problems for long-term
use, however, including skin irritation, and impedance variability as the gels dry out [113],
[114]. For scenarios where long-term wear, repeated placement and removal of the device,
or easy at-home use are desired, a dry electrode format may be more suitable. Achieving low
electrode-skin interface impedance is even more challenging for dry interfaces: they do not
offer direct skin-hydrating effects, and the roughness of the skin may introduce air pockets
between the skin and sensor, causing increased resistance [112]. Artifacts induced by motion
of the electrode relative to the skin are also typically more pronounced in dry electrodes
[115]. To overcome these challenges, new dry electrode technologies have focused on ultrathin, ultra-conformable architectures in order to ensure robust, gap-free contact [116] and
some have utilized microneedles capable of penetrating through the stratum corneum layer
[117].
Another important challenge for epidermal electronics, particularly in long-term
wear applications, is that most plastics and elastomers have poor gas permeability which
blocks perspiration and can induce skin irritation and inflammation [118]. Strategies to
address this challenge include using breathable textile-based electronics [119] and
engineering pores into soft silicone substrates [120]. These strategies must ensure
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appropriate insulation of conductive components while still allowing gas and moisture to
escape from the skin surface.

2.4 Properties at the electrode-tissue interface
2.4.1 Electrode impedance
One of the most important properties of the interface between an electrode, whether
intended for sensing or for stimulation, and a biological tissue is the electrochemical
impedance. Electrochemical impedance spectroscopy (EIS) measures the response of an
electrode to a small sinusoidal input signal, usually between 10 and 100 mV in amplitude. By
comparing the amplitude and phase of the input signal with the recorded output signal, the
electrochemical impedance, Z, can be deduced. Impedance is frequency-dependent, so the
measurement is typically repeated over a range of frequencies to result in a spectrum. It is
often plotted in two separate parts: the magnitude of Z in logarithmic scale,
|𝑍| =

𝑅𝑒{𝑍} + 𝐼𝑚{𝑍}

(1)

and the phase shift of Z,
𝜑 = arctan (𝐼𝑚{𝑍}/𝑅𝑒{𝑍})

(2)

in linear scale at each frequency tested. This representation is known as the Bode plot, and it
represents the ‘transfer function’ of the electrode interface, or how well signal content at
various frequencies is transferred over the electrode-electrolyte boundary. EIS is typically
measured in a phosphate buffered saline (PBS) solution approximating the ionic liquid
environment of the body, however it can also be measured on the skin.
A typical Bode plot for a metal electrode in PBS shows high-pass filtering behavior,
with high frequency signal content being authentically transferred while low-frequency
signal content is attenuated (Figure 2.8a) [121]. The mechanisms underlying this behavior
can be understood by modeling the electrode interface with an equivalent circuit model,
which describes the physical processes contributing to charge transfer (Figure 2.8b). The
ionic medium separating the working electrode and the counter electrode contributes a
frequency-independent attenuation, the access resistance, RA. At the boundary between the
working electrode and the ionic medium, the behavior is more complex and several
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Figure 2.8 EIS at the electrode-tissue interface. (a) Example Bode plot for a smooth metal electrode
in PBS. The top plot shows the magnitude and the bottom plot shows the phase of the impedance. The
colored zones indicate typical behavior in low (green), intermediate (yellow), and high (blue)
frequency ranges. (b) An equivalent circuit model outlining the different contributors to the overall
impedance between two electrodes. Here µE is referring to a microelectrode as the working electrode,
and CE refers to the counter electrode. At the interfaces, each electrode contributes a double-layer
capacitance, C, in parallel to an impedance, Z, representing all additional charge transfer mechanisms
available at the surface. The electrolyte between the two comprises the resistive contribution, RA. (c)
The double-layer capacitance at the electrode-electrolyte interface. Adapted from [121].

mechanisms acting in parallel contribute, which strongly depend on the material
characteristics of the surface. One mechanism that contributes is the double-layer
capacitance, or Helmholtz capacitance, that forms at the interface between a solid electrode
and surrounding electrolyte medium. Two layers of charge with opposing polarity form, one
at the surface of the electrode in the form of electrons, and one in the electrolyte consisting
of solubilized ions which self-organize into a layer (Figure 2.8c). This capacitance
contributes more at low frequencies, introducing a phase shift and attenuating the signal
[121].
The effect of the double-layer capacitance is directly proportional to the contact area
of the electrode with the electrolyte solution. This is one reason why rough or porous
electrode interfaces have lower interface impedance: the full three-dimensional contact area
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of the electrode surface can contribute to charge transfer, enhancing the capacitance of the
surface (Figure 2.9).

Figure 2.9 Impedance in relation to electrode size. (a) Impedance comparison between smooth Pt
electrodes and nano-roughened Pt electrodes at 1 kHz for different electrode diameters. (b) Increased
electrode roughness leads to a reduction in cutoff frequency in addition to the reduction in overall
impedance. (c) Impedance magnitude for different electrode diameters. The high-frequency
impedance is dominated by the access resistance, RA. From [121].

EIS is used broadly for benchmarking the performance of recording and stimulating
electrodes. For neural electrodes, it is common to report the impedance magnitude at 1 kHz,
as this is around the frequency where the information content in an action potential occurs.
It is important to note, however, that in many bioelectronic applications the primary
biosignals have much lower frequency content. EEG, for example, typically contains useful
information only below 100 Hz. In many epidermal sensing applications, therefore, it has
become more common to report the impedance magnitude at 10 Hz, although there is not yet
standardization across the field.
One reason the electrochemical impedance is used so broadly as a performance
measure is that it is believed to correlate with signal-to-noise ratio (SNR). The theoretical
basis for this notion is that Johnson or thermal noise, vn, scales with impedance according to
equation (3), where k is the Boltzmann constant, T is the temperature, and Δf is the bandwidth
of the amplifier:
𝑣 =

4𝑘𝑇𝛥𝑓𝑅𝑒{𝑍}

(3)

Because of this relation, a lower impedance electrode is expected to collect less thermal noise
and thus provide a higher SNR. Thus, signal losses at the interface will be smaller when lowimpedance electrodes are used [121].
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2.4.2 Charge injection capacity
Stimulating electrodes allow current to be driven over the solid-liquid boundary by
exchanging electronic charge carriers in the solid state to ionic charge carriers in the
biological medium. For bio-stimulating electrodes, it is important that this process does not
induce irreversible reactions that alter the electrode material. This means that the charge
injection mechanisms should allow for equal charge transfer in the opposite direction to
restore the original state of the electrode. In most bio-stimulation paradigms, charge is
delivered in the form of biphasic, charge-balanced pulses, meaning that the current injected
in the first half-phase is immediately compensated for by reversing the polarity over the
second half-phase such that the net charge transfer over the interface is zero.
There are several mechanisms which can contribute to charge injection. Capacitive
charging and discharging over the Helmholtz double-layer often contributes significantly, a
non-faradaic process in which no species are exchanged. Electrochemical reactions at the
electrode surface may also contribute to charge injection, such as the formation of an oxide
at the surface of a metal electrode when metal atoms react with oxygen in the electrolyte.
Here electrons are exchanged to ions in a faradaic reaction, which changes the chemical
composition of the electrode and the surrounding electrolyte. Over time, faradaic reactions
at the electrode interface can corrode or degrade the electrode, however this is not always
the case. Reactions where the products remain bound to the surface have a high degree of
reversibility, and these can be important contributors to charge injection. While capacitive
charge injection is preferable for safe and stable stimulation electrodes, in practice most
electrodes have mixed charge injection.
One irreversible faradaic reaction that can be generated by any electrode, regardless
of its material properties, is the electrolysis of water:
2H2O + 2e− → H2 + 2OH− (reduction)

(4)

2H2O → O2 + 4H+ + 4e− (oxidation)

(5)

This reaction results in the formation of oxygen or hydrogen gas and local pH changes, which
may damage the electrode and are harmful to the surrounding tissue. Thus, stimulation
electrodes are often characterized by their ‘water window’, or the outer voltage boundaries
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which are safe to apply to the electrode and will not induce electrolysis. These voltage
boundaries are material-dependent. Using these limits, stimulation electrodes are then
further characterized by their ‘maximally safe charge injection capacity’, CIC, which is defined
as the maximum charge per pulse that can be injected before water splitting occurs under
either the cathodic or anodic phase. In bio-stimulation, it is more common to lead with the
cathodic pulse to depolarize cell membranes, so the CIC in the cathodic phase, CICC, is often
the value reported for performance benchmarking.
To measure the CIC experimentally, biphasic, charge-balanced current pulses are
delivered through the working electrode in PBS while the voltage at the electrode interface
is monitored (Figure 2.10). Several key parameters can then be deduced from the observed
voltage excursion, or ‘voltage transient’. The access voltage, Va, is the instantaneous voltage
change when the current pulse is applied or removed, and it is related to the interface
impedance. The maximum cathodic voltage or excursion potential, Emc, is measured at the
termination of the access voltage in the cathodic phase, where the transient potential begins
to decay asymptotically towards the open circuit voltage. The CICC is then defined as the total
injected charge (current × pulse width) at which Emc reaches the reduction potential for
water, or the water window limit.

Figure 2.10 Schematic of a biphasic voltage transient potential. The metrics used in assessing the
charge injection limit include Va, the access voltage, and Emc, the maximum cathodic voltage, found at
the termination of Va. From [122].

The voltage produced across an electrode for a particular charge density is inversely
proportional to the surface area, meaning that in general larger electrodes are able to inject
more charge before exceeding the electrochemically safe limits [122]. However, this
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relationship is complicated by the fact that higher field and current densities are typically
reached at edges or corners, which means that reactions may be inhomogeneously
distributed over the surface. Thus, increasing the surface roughness of an electrode is one
way to improve the CIC because this increases the charge transfer area [123].
In addition to the CIC, another empirical relation has been established for
determining the safe limit of stimulation charge density: the Shannon limit. The limit derives
from histological evaluation of electrical stimulation-induced tissue damage observed in the
brains of animal models, and it is a useful relation for determining the boundary between
damaging and non-damaging levels of stimulation [124]. Shannon described the boundary
between tissue damaging and non-damaging levels of stimulation on a log charge density (D)
versus log charge per phase (Q) plot as a line with the equation:
log(𝐷) = 𝑘 − log (𝑄)

(6)

where the adjustable parameter k is typically chosen between 1.5 and 2.0, with a more
conservative estimate of damage thresholds using a lower k. While this empirical relation is
useful, studies have shown that it is less accurate for microelectrodes and that the limit for
damage also varies significantly with both pulse width and pulse frequency [125].
2.4.3 Charge storage capacity
Another useful characterization of stimulation electrodes is the charge storage
capacity, CSC, which is evaluated using slow-scan-rate cyclic voltammetry (CV) in PBS over a
potential range that is just within the water electrolysis window for the given electrode. CSC
is a measure of the total charge available from an electrode for delivering stimulation. It has
become common practice to characterize stimulation electrodes by their cathodic CSC, CSC C,
which is the time integral of the cathodic current during the CV scan (Figure 2.11). It is
important to note, however, that only a fraction of the charge enclosed by the CV is typically
available in practice for injection during a short pulse. Thus, while some electrode materials
can offer enhanced CSC due to internal pseudocapacitance, it is misleading to interpret this
as if the full internal surface area of the electrode is available for stimulation. In practice, only
the most superficial layers of the electrode will be actively involved in charge transfer during
a short stimulation pulses, and the CSC therefore overestimates the charge available [121].
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Figure 2.11 CV of activated iridium oxide film (AIROF). The cathodic CIC is shown by the blue area
of the voltammogram. From [60].

2.5 Carbon nanomaterials for bioelectronics
In recent years, a variety of carbon-based nanomaterials have emerged as promising
candidates for addressing some of the primary challenges of bioelectronic interfaces. These
nanocarbons exhibit a wide variety of structures, morphologies, and physical and chemical
properties which can be leveraged for different applications (Figure 2.12). They offer a
combination of mechanical flexibility, nanoscale topology, oxidation stability, and
biocompatibility which are advantageous for bioelectronics. Furthermore, their electrical,
physical, and chemical properties can be tuned through covalent or non-covalent
functionalization. In this thesis work, I leverage some of these key properties to build new
bioelectronic technologies based on graphene, and Ti3C2 MXene. To provide context for the
work in this thesis, in this section I will briefly summarize the current state of research into
using carbon nanomaterials for bioelectronics.
2.5.1 Carbon nanotubes
Carbon nanotubes (CNTs) are cylindrical nanostructures of carbon, structured as
seamlessly rolled-up sheets of graphene, which is an atomic layer of two-dimensional (2D)
sp2-hybridized carbon lattice. CNTs can be single-walled (SWCNTs), composed of one layer
of carbon lattice, or they can consist of multiple nested single-walled CNTs to form multi33
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Figure 2.12 Various carbon nanomaterials and their key advantages in bioelectronic interfaces.
Materials are shown in black boxes across the top, and their properties are shown in purple ovals
across the bottom. Modified from [380].

walled CNTs (MWCNTs). CNTs have been explored in bioelectronics due to their high intrinsic
surface area, conductivity, mechanical flexibility, and wide electrochemical water window
which contributes to a high charge injection capacity.
In neural recording applications, both CNT coatings on metallic microelectrodes and
electrodes entirely composed of vertically-aligned CNTs have shown significantly reduced
interface impedance and improved SNR compared to metallic controls of the same geometric
area [126], [127]. These improvements are attributed to their high specific surface area and
high conductivity. In stimulation applications, CNTs and CNT-coated surfaces have also been
shown to exhibit increased capacitance, and a wide water window [128]. Together with their
low interface impedance, these properties contribute to enhanced charge injection capacity,
and they have been demonstrated in several studies for effective neural stimulation [129].
CNT films are also quite mechanically flexible, and this property has been used to generate
flexible and even stretchable electrode arrays with all-carbon circuitry [14], [130]. The
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unique properties of CNTs on the nanoscale have also been harnessed at the macroscale by
combining aligned CNTs to form carbon nanotube fibers (CNTfs) through a wet-spinning
process [131], [132]. These CNTfs have been used for chronic neural recording and
stimulation in vivo, and their advantages include mechanical flexibility, low impedance, high
SNR, and resistance to biofouling [133].
In terms of biocompatibility, the safety of CNTs is a topic of some debate. Pristine
CNTs are highly hydrophobic, and thus they tend to aggregate in physiologic medium. When
freely circulating in the body, CNTs can aggregate in tissues and cause toxicity in the kidney,
liver, and spleen [134]. When CNTs are bound to an electrode interface, however, a more
important consideration is their cytotoxicity to the cell types with which the electrode will
directly interface. Several studies have demonstrated that neurons cultured on CNT
substrates actually exhibit increased neurite outgrowth, synapse formation, and activity
compared to neurons cultured on planar conductive controls [135], [136]. It is believed that
the nanoscale topology and positive surface charge of CNTs promote neuronal adhesion and
encourage growth [137].
2.5.2 Nanocrystalline diamond
Nanocrystalline diamond (NCD) refers to diamond films with grains smaller than 100
nm. NCD has been gaining interest for bio-interfacing microelectrodes due to its chemical
stability, biocompatibility, wide water potential window, optical transparency, and tunable
electrical conductivity [138]–[140]. When doped with boron, NCD can exhibit high
conductivity and excellent stability in physiologic medium, in addition to tunable optical
transparency [138]. The optical transparency can be utilized for combining optical imaging
and electrophysiological recording, however as the boron doping concentration increases to
improve conductivity, the optical transparency decreases [141]. NCD has been used as a
coating on microelectrodes and has shown promise for neural recording, though it has not
been as widely studied as CNTs and graphene derivatives.
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2.5.3 Graphene
Graphene is a one-atom thick 2D lattice structure of sp2-hybridized carbon. Graphene
and its derivatives have gained attention for bioelectronics due to their exceptional physical
and chemical properties, including high electrical conductivity, mechanical strength and
flexibility, high surface area, high chemical stability, and high optical transparency. Beyond
these properties, a number of studies have demonstrated a favorable biocompatibility profile
of graphene, though the material preparation (i.e. the synthesis and subsequent processing)
can influence its purity and surface chemistry to negatively affect biocompatibility [142]. In
this section, I will discuss three different forms of graphene that have gained attention: 2D
planar graphene, porous graphene, and out-of-plane/fuzzy graphene.
2D planar graphene
Planar monolayer graphene has attracted attention for enabling transparent
bioelectronics that allow studies combining electrophysiology with optical methods such as
optogenetics, Ca2+ imaging, optical coherence tomography imaging, or monitoring
biochemical activity of cells using fluorescent dyes. Similar transparent electronic platforms
have been demonstrated using indium tin oxide (ITO), however its brittle nature has made
integrating the electronics with soft tissues challenging. Thus graphene, with its high optical
transparency and conductivity along with its excellent mechanical flexibility, has largely
dominated this space and has enabled fabrication on flexible polymeric substrates. A number
of studies have demonstrated successful neural recording with graphene microelectrodes,
and several have also combined optical methods [6], [7], [143], [144]. Transparent graphene
microelectrodes have high impedance, though chemical doping methods have been shown to
reduce the impedance somewhat [6]. Planar graphene has also been shown to exhibit good
corrosion resistance, and thus it has also been explored as a coating material on metallic
electrodes to improve stability [145].
Porous graphene
3D porous graphene structures can be synthesized by various methods, including
hydrothermal treatment of graphene oxide nanosheet suspensions [146], template-directed
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CVD synthesis on Ni foam [147], and by laser pyrolysis of polymer substrates [16]. The high
accessible surface area of porous graphene has made it an attractive material for
electrochemical biosensing platforms and for bioelectronic devices. In one notable
demonstration, porous graphene microelectrodes were fabricated by laser pyrolysis of
polyimide films and used for neural recording and cortical microstimulation. The electrode
arrays showed good mechanical flexibility, low impedance, high charge storage and charge
injection capacity, and good long-term stability in a PBS environment [16].
Out-of-plane graphene
An alternative approach to forming 3D graphene structures is to perform out-of-plane
or vertical growth of graphene on a 3D Si nanowire mesh template, an approach which was
developed just in the past few years [148]. This produces so-called “fuzzy graphene” with a
different morphology and an even larger surface-to-volume ratio than the porous graphene
forms discussed above. The exceptionally high surface area of fuzzy graphene makes it an
attractive candidate for bioelectronics platforms. While this form of graphene is still quite
new, one study reported recordings of neuronal activity for neurons cultured on a fuzzy
graphene microelectrode array with high SNR [149]. The electrodes also showed significantly
reduced impedance and enhanced charge storage capacity compared to size-matched gold
electrodes [149].
Carbon nanomaterials show excellent promise for bioelectronic interfaces due to their
unique properties, and new devices incorporating various forms of nanocarbons may soon
gain more widespread adoption.
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graphene electronics
Neurological disorders such as epilepsy arise from disrupted brain networks. Our
capacity to treat these disorders is limited by our inability to map these networks at sufficient
temporal and spatial scales to target interventions. Current best techniques either sample
broad areas at low temporal resolution (e.g. calcium imaging) or record from discrete regions
at high temporal resolution (e.g. electrophysiology). This limitation hampers our ability to
understand and intervene in aberrations of network dynamics. In this chapter, I develop
transparent graphene microelectrode arrays, and establish experimental techniques to map
the onset and spatiotemporal spread of acute epileptic seizures in vivo by simultaneously
recording high bandwidth microelectrocorticography and calcium fluorescence. I then
integrate dynamic data features from both modalities using non-negative matrix
factorization to identify sequential spatiotemporal patterns of seizure onset and evolution,
revealing how the temporal progression of ictal electrophysiology is linked to the spatial
evolution of the recruited seizure core. This integrated analysis of multimodal data reveals
otherwise hidden state transitions in the spatial and temporal progression of acute seizures.
The techniques demonstrated here may enable future targeted therapeutic interventions and
novel spatially embedded models of local circuit dynamics during seizure onset and
evolution.

3.1 Introduction
Understanding the dynamics underlying seizure generation and spread at the scale of
neural microcircuits is critical for improving epilepsy therapies and enabling more efficient
seizure control. For example, targeted epilepsy treatments such as surgical resection, thermal
ablation, or responsive neurostimulation rely on precisely localizing seizure onset regions to
be effective. Currently, clinicians localize these regions by observing seizure semiology,
identifying electrophysiological signatures from millimeter-scale implanted electrodes, and
combining these features with non-invasive imaging techniques such as magnetic resonance
imaging (MRI) and positron emission tomography (PET). Unfortunately, the spatial and
temporal resolution of these techniques is limited to collective, region-wide network
oscillations, which hampers the development of precision therapy approaches. A growing
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body of literature indicates that seizures, in fact, begin at the scale of neural microcircuits,
which current clinical technologies cannot observe [1], [3], [150], [151]. Thus, there is great
interest in observing cellular and microcircuit level dynamics as seizures begin and spread,
and in linking these to the macroscale, brain-wide activity recorded by current clinical
technologies.
Recently, microelectrode array recordings in humans have opened a window into
complex, microscale ictal dynamics within the cortical area usually covered by a single
clinical electrocorticography (ECoG) electrode. Similarly, microarray and microwire studies
have revealed spatially distinct territories near the seizure onset zone [152], characterized
by heterogeneous firing of single cells [153] and associated with different states of excitationinhibition balance [154]. Observing seizures at this new scale has led to the idea that the
cortical areas involved can be divided into a core territory of recruited neurons (the ‘ictal
core’), surrounded by areas that receive intense synaptic input but do not show
hypersynchrony and pathologically high firing rates (the ‘ictal penumbra’). Observations at
the microscale have also revealed previously unobserved temporal phenomena at play
during epileptic seizures: individual ictal and interictal epileptiform discharges observed on
intracranial EEG (iEEG) can spread near-synchronously across macroscopic brain areas
[155], [156]. In contrast, microscale neurophysiological markers of the so-called ‘ictal
wavefront’ spread locally at much slower speeds, typically not exceeding ~5 mm/s [157]. It
has now become apparent that macroscale signatures of these microscale dynamics are
present in particular frequency bands of clinical iEEG, but were only identified with the
benefit of concurrent microelectrode recordings [158], [159].
Although microelectrode array recordings are significantly advancing our
understanding of microscale epileptic dynamics, these electrode arrays still cannot offer a
complete picture of neural circuits due to their limited spatial sampling. Recordings with the
Utah array (96 electrodes in a 4 x 4 mm area), for example, typically detect the activity from
several dozen up to ~180 neurons, at most, from patches of cortex that are just a few
millimeters across, and which contain hundreds of thousands of neurons [153]. Evolving
alongside implantable microelectrode technologies, optical tools and techniques enable
investigators to observe neural activity at cellular and even sub-cellular spatial scales [65],
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[160], [161]. Optogenetics gives these techniques tremendous power to image and modulate
the function of specific, genetically-targeted cell types in the brain to discern the roles of
different cell assemblies [4]. Calcium fluorescence imaging has provided insights into the role
of inhibitory interneurons in seizure initiation and spread [162], and in the microstructure
of synchronous neuronal assemblies in epileptic networks [163]–[165]. However, such
imaging studies typically suffer from low temporal resolution limited by the kinetics of the
fluorescent reporter molecules as well as the speed of currently available imaging systems
[5], [160], [166].
Combining electrophysiological and optical recording modalities presents a unique
opportunity to harness the spatial resolution of optical imaging along with the temporal
resolution of electrophysiology. However, such a combination requires imaging and
recording simultaneously in the same location, which is not possible with conventional
microelectrode arrays composed of opaque metallic materials, as these block optical access
and suffer from photoelectric artifacts [167]. Recently, progress in transparent
microelectrode array technology, predominantly utilizing graphene, has enabled such
multimodal studies [6]–[9]. However, innovation is still needed in experimental and
analytical methods to fully realize the potential of these multimodal mapping techniques.
Notably, there is currently a lack of analytical methods to combine high density optical and
neurophysiology datasets, while accounting for their differences in temporal and spatial
sampling.
In this work, we demonstrate a novel experimental and methodological paradigm
which combines mapping of microscale local network dynamics at high spatiotemporal
resolution with a quantitative analysis framework to distill the dynamics underlying seizure
generation and evolution in vivo. Specifically, we utilize custom-made, transparent graphene
microelectrode arrays to simultaneously record electrophysiology and optical signals of
microscale brain activity in a rodent model of acutely induced epileptic seizures. We combine
dynamic data features from both modalities in a sparsity-constrained non-negative matrix
factorization (NMF) approach in order to identify spatiotemporal patterns across these
acquisition modalities. NMF is used for dimensionality reduction, similar to principal
component analysis, but yields sparser and potentially more interpretable factors due to the
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non-negativity constraints on both the original feature matrix and the resultant factors. Such
an approach has previously been used to decompose dynamic functional connectivity into
sets of variably expressed subnetworks and track their temporal evolution in human
neuroimaging [168]–[170].
This analysis reveals how the temporal progression of ictal electrophysiology is
linked to the spatial evolution of the recruited seizure core. We show that locally synchronous
increases in broadband micro-ECoG (µECoG) power are associated with a progressive
expansion of the ictal core at seizure onset, and that state transitions occur during an
established seizure that are accompanied by subtle changes in ictal discharge morphology.
These microscale spatiotemporal dynamics are not apparent from electrophysiology alone,
and highlight the unique advantages of multimodal recording enabled by transparent
electronics. The analytical framework presented here serves as a proof of concept for future
studies combining data from multiple modalities, with the potential to illuminate
mechanisms underlying seizure initiation, spread, and microscale network interactions that
may characterize other types of brain disorders.

3.2 Development of transparent graphene microelectrode array
technology
3.2.1 Prior work
The first demonstrations of transparent graphene electronics for multimodal neural
recording were published simultaneously in 2014 by two separate groups. Dong-Wook Park
et al. developed a transparent array of 250 µm-diameter graphene electrodes encapsulated
in a flexible parylene C substrate and demonstrated the ability to optogenetically stimulate
neurons through the array while simultaneously recording local field potentials (LFPs), as
well as to image cortical vasculature through the array (Figure 3.1a) [7]. In that work, the
graphene arrays were fabricated by stacking 4 layers of CVD-grown graphene by coating each
graphene layer with PMMA, chemically etching the copper foil substrate, transferring the
PMMA/graphene to the wafer substrate, and subsequently dissolving the PMMA. This
transfer process is known to induce cracking defects in the graphene monolayers as well as
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Figure 3.1 Early demonstrations of transparent graphene microelectrodes. (a) CLEAR graphene
device from Dong-Wook Park et al. in parylene C substrate. Scale bar 500 µm. (b) Graphene electrode
array from Duygu Kuzum et al. in polyimide substrate. (c) Optical transmission of the device in (b),
showing reduced optical transparency within the OGB-1 emission range. (a) from [7], (b) and (c) from
[6].

to leave PMMA and Cu residues on the graphene film [171]. Thus, while Park et al. showed
functional devices, the 1 kHz impedance of their graphene electrodes was quite high at 244 ±
6 kΩ for 250 µm-diameter electrodes, likely due to defects and residues present on the
graphene films.
The second group, led by Duygu Kuzum, developed an array of 50x50 µm 2 graphene
electrodes encapsulated in a polyimide (PI) substrate, and demonstrated simultaneous twophoton calcium fluorescence imaging and low-noise electrophysiology (Figure 3.1b) [6]. The
recordings were performed in brain slices ex vivo. Kuzum et al. achieved superior impedance
performance compared to Park et al. by utilizing a cleaner graphene transfer method which
eliminated the copper etching step, and subsequently using nitric acid chemical doping to
reduce electrode impedance (541 kΩ for 50x50 µm2 electrodes). However, the choice of PI
substrate resulted in electrode arrays with inferior optical transparency. While parylene C is
highly transparent across the visible spectrum, PI absorbs light at wavelengths below 550
nm, which is within the emission range of common optical reporter molecules such as Oregon
Green BAPTA-1 (OGB-1) (Figure 3.1c).
Since these initial demonstrations, some progress has been made toward improving
transparent electrode technology. Kuzum’s group showed that electrodepositing Pt
nanoparticles onto graphene electrodes could significantly lower the impedance, however
this approach sacrifices optical transparency [144]. Another group took a different approach,
developing a transparent electrode array based on a nanomesh of Au coated with PEDOT:PSS,
rather than using graphene [9]. These Au nanomesh electrodes achieved far lower impedance
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than their graphene counterparts, however they had reduced optical transparency and were
more prone to light-induced artifacts than graphene electrodes are.
Here, we sought to build upon this foundational work, and to further optimize the
fabrication of transparent graphene microelectrodes to offer an improved combination of
high optical transparency and low electrochemical impedance. By optimizing the properties
of the graphene microelectrode array, we can improve the quality of data which can be
obtained during in vivo multimodal recording.
3.2.2 Fabrication optimization
To fabricate transparent graphene devices, we began with the protocol outlined by
Park et al. and made several important modifications to improve the graphene quality and
reduce electrode impedance [172]. We initially designed a µECoG array of nine 50 x 50 µm 2
electrodes in a parylene C substrate and used this device design to test and optimize the
graphene processing conditions.
As the first modification, we used a bubble transfer method similar to that described
by Gao et. al. [173] to transfer monolayers of graphene grown on copper foils via chemical
vapor deposition (CVD) to the wafer substrate. While conventional graphene transfer
methods rely on complete etching of metal substrates (typically copper) in suitable etchants,
which causes damage to the graphene and leaves metal residues, bubble transfer using
electrolysis of water enables transferring large-area graphene films with high purity and
without inducing cracking or damage. Using this improved transfer method, we sought to
determine an optimal number of stacked monolayers of graphene. We fabricated devices with
either one or two stacked monolayers of graphene and assessed the relationship between
number of graphene layers and electrochemical impedance (Figure 3.2a). While we found
that adding a second layer of graphene reduced the impedance (2.16 ± 0.23 MΩ for 2-layer
vs. 2.75 ± 0.26 MΩ for 1-layer graphene at 1 kHz), we sought to reduce the impedance further
without adding additional graphene layers, as these would reduce the optical transparency
of our devices and also add significant time to the fabrication process, as each graphene
transfer is performed sequentially. To this end, we next explored chemical doping methods
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Figure 3.2 Optimization of graphene processing. (a) Electrochemical impedance spectra for 50 µm
x 50 µm graphene µECoG electrodes of three preparations: 1-layer graphene, 2-layer graphene, and
HNO3-doped 2-layer graphene. Impedance magnitude significantly decreased with doping,
particularly at frequencies below 1 kHz. Noise in the low-frequency range for the un-doped graphene
samples is attributed to the high impedance modulus. Shaded bounds represent standard deviations.
(b) Impedance magnitude at 1 kHz for the three device preparations. Horizontal black bars indicate
means. (c) Impedance magnitude at 100 Hz for the three device preparations. Horizontal bars indicate
means. (d) Cyclic voltammograms showing superior CSCC in an HNO3-doped 2-layer graphene
electrode, as compared to an un-doped 2-layer graphene electrode (CSCC is 22.4 µC/cm2 and 15.9
µC/cm2, respectively). The scan rate was 500 mV/s.

for enhancing the out-of-plane conductivity of graphene, similar to those described by Kuzum
et al [6].
Exposing graphene to nitric acid (HNO3) results in the adsorption of electropositive
NO3– groups onto the graphene surface. Specifically, the HNO 3 molecule physisorbs onto the
graphene sheet, without breaking any C-C bonds, and then dissociates into three groups: two
radicals NO20 and NO30, and a water molecule: 2HNO3 = NO20 + NO30 + H2O. The two radicals
have a singly occupied state below the Fermi energy of the graphene layer, which allows two
electrons to transfer from graphene into these states, creating two holes and causing p-type
doping [174]. This p-type or hole doping has been shown to reduce electrochemical
impedance and improve the noise characteristics of graphene electrodes [174]–[176].
44

Chapter 3: Multimodal seizure mapping with transparent graphene electronics

Additionally, layer-by-layer doping has been shown to produce doped graphene sheets with
reduced and more stable sheet resistance values compared to doping after stacking of
graphene monolayers, where only the topmost layer experiences doping [175], [177]. We
optimized a process for HNO3 doping of graphene and performed this doping layer-by-layer
after the transfer of each graphene sheet to the wafer substrate. We tested various HNO 3
exposure times and temperatures, and found that exposing the graphene to 75% HNO 3 for 15
minutes at room temperature produced the largest and most stable impedance reduction. We
used these doping conditions for all subsequent device fabrication.
A summary of the results of these optimization procedures is shown in Figure 3.2, in
which we compare impedance values both at the commonly-used 1 kHz reference frequency,
and at the lower frequency of 100 Hz (Figure 3.2b,c). We show the values at 100 Hz because
many physiologic signals of interest in the brain are of lower frequency content than the
typical 1 kHz reference frequency. We find that the impedance relationships between 1-layer,
2-layer, and doped 2-layer graphene devices are similar at 1 kHz and 100 Hz, with the
advantage of chemical doping being more pronounced at lower frequencies: the 100 Hz
impedance of 1-layer devices is 25.6 ± 11 MΩ, 2-layer devices is 15.9 ± 5.5 MΩ, and HNO 3doped devices is 2.07 ± 0.65 MΩ. The significant spread of 100 Hz impedance values for the
un-doped device preparations can be attributed to their high impedance in this lower
frequency range, which limits the accuracy of the EIS measurement. As a low electrode

Figure 3.3 Raman spectroscopy. (a) Raman spectra of monolayer un-doped (red), bilayer un-doped
(green), and bilayer HNO3-doped (blue) graphene on Si wafer. The spectrum for the Si wafer substrate
(black) is included as a reference. (b) Raman spectrum of doped bilayer graphene between parylene C
layers in a completed device.
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Table 3.1 Raman spectroscopy analysis. Summary of results from Raman analysis of
graphene preparations on Si wafer

impedance is essential for obtaining recordings with high signal-to-noise ratio (SNR) [10],
[126], these results indicate that HNO3 doping is a useful approach for improving the
performance of graphene microelectrodes, especially at lower frequencies where most
physiologic signals of interest occur. In addition to EIS measurements, cyclic voltammetry
(CV) measurements were taken to assess the effect of HNO3 doping on the charge storage
capacity of graphene electrodes. Doping with nitric acid increased the charge storage capacity
from 22.87 µC/cm2 to 64.44 µC/cm2, indicating that this method of doping may also improve
the performance of graphene electrodes for neural stimulation applications (Figure 3.2d).
In addition to electrochemical characterization, we also performed Raman
spectroscopy to assess the quality of the graphene films and confirm successful p-type doping
after exposure to HNO3 (Figure 3.3a). First, Raman spectra for monolayer un-doped, bilayer
un-doped, and bilayer doped graphene films on an Si wafer substrate were evaluated.
Monolayer un-doped graphene exhibited a D peak at 1309.3 cm -1, a G peak at 1583.1 cm-1,
and a 2D peak at 2673.2 cm-1. The average ID/IG ratio, which is an indicator of defect
concentration, was 0.65. The fact that this ratio is less than unity indicates that our graphene
films are of high crystalline quality [178]. The addition of a second layer of un-doped
graphene resulted in a narrowing of the G peak, a broadening of the 2D peak, and an upshift
in position of the 2D peak, which agrees with previously reported results [178], [179]. In the
doped bilayer preparation, further broadening and upshift of the 2D peak was observed, and
the I2D/IG ratio was decreased significantly. These results indicate successful p-type doping
of our graphene films after HNO3 exposure [178], [180]. Values for FWHM(G), FWHM(2D),
Pos(2D), I2D/IG, and ID/IG for each of the three graphene preparations can be found in Table
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3.1. Next, Raman spectra for a doped graphene electrode in a fully-fabricated µECoG array
was evaluated to confirm that the doped graphene remained of high quality following device
fabrication (Figure 3.3b). The G and 2D peaks retained similar intensity and width as those
seen in the doped graphene on Si preparation, indicating that device fabrication does not
significantly alter the graphene properties. The peaks at 1210, 1340, 1440, and 1610 cm -1 are
attributed to parylene-C, and the graphene D peak is obscured by the parylene peak at 1340.
Using the optimal graphene processing conditions determined here, we proceeded
with device fabrication for in vivo testing. A schematic of the electrode fabrication process is
shown in Figure 3.4, and a detailed description of the process is provided in the methods at
the end of this chapter.

Figure 3.4 Fabrication of transparent graphene µECoG devices. Details of the fabrication are given
in the Methods section. Briefly, parylene C is deposited onto a Si wafer and Ti/Au traces are patterned
on the parylene C. CVD-grown graphene is transferred to this substrate using a bubble transfer
method. An SiO2 layer is deposited to protect the graphene during later processing steps, then the
graphene and SiO2 layers are patterned and etched. A top layer of parylene C is deposited to
encapsulate the device, then VIAs are etched to open the graphene electrode contacts as well as open
the Ti/Au bonding pads at the back end of the device. Finally, the SiO2 covering the graphene electrode
contacts is chemically etched away and the devices are removed from the wafer.

3.2.3 Electrode characterization
For in vivo experiments, we designed an µECoG electrode array consisting of a 4 x 4
grid of 50 µm x 50 µm square electrode contacts with 500 µm pitch (total recording area of
1.55 mm x 1.55 mm and total array footprint 2.75 mm x 2.75 mm). In each device, graphene
forms the electrodes and conductive traces in the distal end of the array, and overlaps with
Ti/Au conductive traces outside of the array, such that the entire recording area of the device
is fully-transparent (Figure 3.5a). The graphene electrodes and Ti/Au traces were patterned
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on a 4 µm-thick bottom parylene C substrate and encapsulated by another 4 µm-thick

Figure 3.5 Optically transparent graphene µECoG arrays. (a) Schematic of graphene µECoG device:
A fully transparent array of graphene microelectrodes and traces connects to gold traces in a flexible
cable which can be interfaced with a data acquisition system through a ZIF connector. (b) A graphene
µECoG device wrapped around a pipette tip to demonstrate its flexibility. Scale bar: 2 mm. (c) Images
of the graphene electrode array overlaid on the Penn logo to demonstrate optical transparency. Scale
bars, left to right: 1 mm, 250 μm, 100 μm. (d) Optical transmission spectra for different locations in the
graphene µECoG array. Overall, the device is > 90% transparent across the visible to near infrared
spectrum. The ringing behavior in the spectra is attributed to parylene C. Scale bar: 50 µm. (d) Mapping
of optical transmittance at 550 nm for the locations shown in (d). (e) 1 kHz impedance magnitude for
each 50 μm x 50 μm transparent graphene electrode in the array, averaged over 4 devices. Values are
overlaid in the corresponding electrode locations on a light microscopy image of a single device. For
clarity, electrodes are not shown to scale.
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parylene C layer to yield devices with a total thickness of 8 µm. The combination of the thin
profile of the device, the low Young’s modulus of parylene C and the extreme broadband
optical transmittance of both parylene-C and graphene endow the device with high flexibility
(Figure 3.5b) and optical transparency (Figure 3.5c). We found that the devices showed on
average >90% optical transparency across the visible spectrum (Figure 3.5d,e). The average
impedance over 4 such devices (n=64 channels) was 908 ± 488 kΩ at the 1 kHz reference
frequency (Figure 3.5f), which corresponds to an area-normalized impedance of 22.7 ± 12.2
Ω·cm2.

3.3 Acute, multimodal recording of pharmacologically-induced
seizures on the cortex
3.3.1 Experimental overview
We utilized our transparent graphene arrays to perform simultaneous calcium
epifluorescence imaging of neurons and electrophysiology recording in vivo in an acute
murine model of epilepsy. GCaMP6-expressing mice were anesthetized, and the graphene
µECoG arrays were placed on the cortical surface following craniotomy. Electrode arrays
were connected to a NeuroNexus amplifier/digitizer through a custom interface connector
for electrophysiological recording, and wide-field epifluorescence microscopy was used to
simultaneously capture GCaMP6 activity at low magnification at a frame acquisition rate of
10 Hz. Several previous studies combining electrophysiology and neuroimaging with
transparent microelectrodes have utilized two-photon imaging [181], [182], which offers
high spatial resolution but a limited field of view, thus providing detailed information for only
a small population of cells lying beneath one or a small number of individual electrodes. For
this study, we instead used wide-field epifluorescence imaging to observe the calcium
dynamics across the entire millimeter-scale cortical region covered by the array in order to
maximally leverage data features from each modality. This choice also allowed us to observe
the spatial dynamics of seizure spread across a millimeter-scale cortical area. The flexible
electrode arrays readily conformed to the cortical surface and their high broad-band optical
transparency allowed penetration of the excitation light (470 nm) and fluorescence emission
49

Chapter 3: Multimodal seizure mapping with transparent graphene electronics

Figure 3.6 Multimodal recording setup. (a) Schematic of the in vivo recording and imaging setup.
(b) Image of the graphene electrode array placed over barrel cortex, with baseline calcium
epifluorescence visible in green, and array outlined in white to show locations of the electrodes. Scale
bar: 300 μm.

light (500-550 nm). A potassium channel blocker, 4-aminopyridine (4-AP), was bath-applied
to induce epileptiform activity. A schematic of the recording and imaging setup is shown in
Figure 3.6a, and an image of the graphene electrode array on the cortex, outlined in white to
show the locations of the transparent electrodes is shown in Figure 3.6b. Seizure events
were recorded on the graphene array and were visible in epifluorescence imaging through
the electrodes as changes in normalized fluorescence, where each imaging pixel was
normalized by the amplitude and standard deviation of fluorescence changes observed in the
baseline, pre-seizure condition.
3.3.2 Multimodal data
The advantages of our experimental setup are underscored in Figure 3.7. With the
high-density graphene µECoG arrays, we obtained high temporal resolution recordings of
seizure activity, including the fast dynamics of seizure onset as well as discrete high
frequency oscillations (HFOs). HFOs are of particular interest because of their potential role
in ictogenesis and their use as a biomarker to identify seizure onset regions [183]–[185].
Throughout our study, we observed 200-300 Hz “fast-ripple” HFOs consistent with a
pathologic, seizure-prone state as determined by a clinician trained in EEG marking (Figure
3.7a). These oscillations are too brief and high frequency to be observed with calcium
imaging alone.
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While electrophysiological recordings offer the high temporal resolution necessary
to observe fast activity such as pathologic HFOs, the spatial resolution of these recordings is
limited by the minimum size and spacing achievable for microelectrodes in an array. Despite
recent advances in the development of ultra-high-density microelectrode arrays [54],
imaging modalities still offer superior spatial resolution for observing the spatial spreading
dynamics of neural activity, albeit with limited temporal resolution. Using calcium
fluorescence imaging, we observed complex, non-stereotyped spatial patterns of seizure

Figure 3.7 Simultaneous electrophysiology and calcium imaging of 4-AP-induced seizure
activity in an anesthetized mouse. (a) Examples of two clinician-validated high frequency
oscillations (HFOs) recorded on graphene electrodes. Raw, wideband signal from 3 adjacent electrodes
highlights the localized nature of the HFOs. Below these, the 80-600 Hz bandpass-filtered signal and
the spectrogram, which reveals 200-300 Hz power consistent with fast ripple HFOs, are shown for the
bottom-most wideband signal trace. (b) Two representative examples of ictal wavefront onset and
propagation patterns observed in the calcium epifluorescence imaging for different seizure events,
showing complex non-stereotyped spatial patterns of activation and spread. Ictal wavefront
progression is overlaid on images of baseline fluorescence. Scale bars: 500 μm.
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initiation and spread, which we illustrate by plotting the putative ictal wavefront evolution
over time for two different seizure events (Figure 3.7b).
It is important to note that our transparent graphene electrodes recorded seizure
activity with high signal-to-noise ratio (SNR). Despite some variability in electrode
impedance across the array during in vivo recordings, we found that all electrodes had SNR
>5, and that SNR was not in fact correlated with electrode impedance (Figure 3.8a,b).
Instead, the SNR values across the electrode array mapped more closely to the seizure onset
pattern, with electrodes closer to the seizure focus showing larger amplitude ictal spikes and
thus higher SNR (Figure 3.8c). While higher impedance electrodes do pick up more 60 Hz
noise interference, this artifact is removed in the data filtering step such that electrode
impedance does not affect the results of our analysis.

Figure 3.8 SNR vs. electrode impedance. (a) SNR vs. 1 kHz impedance magnitude for each electrode
during the in vivo recording analyzed in this work. No correlation between SNR and impedance was
found, as evidenced by the poor linear fit shown. Note that while the impedance magnitudes measured
in vivo are significantly higher than those measured in saline, these electrodes still achieve high SNR
>5. (b) Map of in vivo electrode impedances across the 16 ch graphene array. (c) Map of SNR values
across the 16 ch graphene array.

We performed our analysis on the data recorded during the first acute seizure onset
in one animal. While the animal experienced multiple seizure events following the drug
application, we were primarily interested in the dynamics at play during the brain’s initial
transition into the ictal state. Because it was not clear that the brain returned to a normal
baseline state in between seizures, we chose to focus solely on the initial seizure onset. The
multimodal data recorded during this seizure onset are shown in Figure 3.9. The locations
of the graphene electrodes on the cortex, and their position relative to the 4-AP application
site, are shown in Figure 3.9a. Upon visual inspection of the ECoG time series, we determined
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Figure 3.9 Concurrent multimodal data obtained during a single seizure onset. (a) Relative
positions of the graphene contacts on the cortex (individual electrodes not shown to scale) and the
location of 4-AP drug application. Electrodes labeled e, f, g, and h are highlighted and shown as example
data. (b) Fluorescence intensity (normalized to baseline mean and variance) beneath each individual
electrode and simultaneous µECoG recordings from the graphene array. The period of acute seizure
onset is magnified in the bottom panel. (c) Series of image frames corresponding to the seizure onset
shown in panel b. (d) Ictal wavefront evolution over time for the seizure shown in b. Note particularly
the early recruitment of channel e and the comparatively late recruitment of channel h. (e) Density
plot indicating the significant relationship between µECoG broadband power and local calcium
fluorescence averages. The colormap indicates the density, or normalized observed frequency of
values distributed along the two dimensions (µECoG broadband power, calcium fluorescence).
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the time of ictal onset by identifying changes in rhythmic background activity that evolve in
time and space; the determination was validated by a board certified epileptologist. In the
recording event shown here, µECoG traces first show an increasing frequency of epileptiform
discharges which appear near-synchronously across the whole electrode array, followed by
a higher frequency, evolving rhythm that changes in amplitude and frequency for the
duration of the seizure (Figure 3.9b).
Associated with these changes in the electrophysiological activity, we observe an
increase in high amplitude calcium transients, followed by a transition of the global calciumfluorescence to a higher overall amplitude. When fluorescence is instead measured at the
location of individual µECoG contacts, we further see a separation in the temporal dynamics
of this progression of seizure-associated calcium activity. While individual calcium transients
beneath each electrode appear to be timed nearly synchronously, channels to the left of the
array (nearer the location of chemoconvulsant drug application) show an earlier and higher
amplitude transition into the seizure state overall. This spatial evolution of the seizure is
apparent in the sequence of normalized calcium images (Figure 3.9c), where high amplitude
calcium fluorescence indicates that ictal activity evolves slowly from the bottom left corner
of the image to reach maximum amplitude near the end of the recorded segment shown here.
High amplitude fluorescence corresponds to temporal summation of very fast neuronal firing,
indicative of recruitment into the seizure. This intense, hypersynchronous activity in the
recruited ‘ictal core’ stands in stark contrast to the less synchronous and lower frequency
firing behavior of surrounding cortical areas, commonly referred to as the ‘ictal penumbra’.
The distinct neuronal dynamics of these areas are separated by a slowly traveling ‘ictal
wavefront’ that gradually expands throughout the recording to ultimately engulf nearly the
entire field of view (Figure 3.9c,d). Features of this core-penumbra organization of epileptic
activity have previously been described both in human microelectrode recordings in chronic
epilepsy, and in vitro using optical imaging of acutely induced seizures in cortical slices,
where these dynamics unfold across temporal and spatial scales comparable to the ones
reported here [154]. Similar to previous reports [154], [186], individual ictal discharges may
spread near-synchronously across the whole µECoG recording array, while calcium
fluorescence, and to some extent signal amplitude on the µECoG array, expands slowly across
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the recorded surface. We treat this slow spatial evolution of the seizure as a traveling wave
phenomenon [156], where we consider the boundary between significantly increased
calcium fluorescence and activity nearer the resting state background level to be the edge of
the ictal core (Figure 3.9d).
Despite the apparently synchronous onset of ictal features across individual channels
in the µECoG, there is a clear relationship between the spatial distribution of the calcium
signal, and local features of the electrophysiological recording. Specifically, we observe a
correlation between normalized µECoG broadband power (Pearson’s correlation coefficient
r = 0.71, p < 0.001 for linear fit), and local average normalized calcium fluorescence (Figure
3.9e). While less obvious in the µECoG signal alone, this observation indicates that both
calcium imaging and electrophysiology capture related, local spatiotemporal phenomena of
ictal onset.

3.4 Non-negative matrix factorization identifies sequences of state
transitions during seizure onset and evolution
3.4.1 Low dimensional representation of seizure dynamics
We next aim to describe the spatiotemporal profile of ictal onset across multimodal
data in a lower dimensional representation. We make the assumption that the high
dimensional dynamics of seizure onset and early ictal evolution can be well captured through
time varying expression of latent spatial factors and subnetworks, whose individual makeup
does not change with time, but fluctuates in its relative expression. First, we calculate features
previously identified as dynamic markers of ictal territories [152] using temporal windows
matching the calcium imaging frame acquisition speed: phase locked high gamma, high
gamma power, and local network synchrony. This choice enables us to downsample the
µECoG data while preserving the information afforded by its high temporal resolution, and
align in time with the calcium fluorescence images. To detect latent spatial factors and
subnetworks that best explain the temporal variation in key data features, we use a sparsity
constrained non-negative matrix factorization (NMF) [187], [188] with the number of factors
chosen to optimize the variance explained per factor for a limited total number of factors used
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Figure 3.10 Variance explained by number of factors. Residuals for NMF fits after optimization for
preset factor numbers ranging from 1 to 25. The final number of factors (k = 6) was selected as a tradeoff between maintaining a low number of factors and achieving a low residual variance.

for dimensionality reduction (Figure 3.10). This method yields interpretable and sparse
individual factors while remaining computationally tractable (Figure 3.11a). With this
approach, we are able to integrate insights across different recording modalities, and to
include many data features to trace latent dynamics that might not otherwise be easily
discernible from single data features alone [189].
The spatial evolution of the ictal core is apparent both in the calcium imaging- and
electrophysiology-derived components of the factors obtained with NMF. For example, as we
move from factor 1 to factor 6, we observe an increase in both µECoG broadband power and
calcium fluorescence amplitude (Figure 3.11b), which at the time of seizure onset is maximal
at the bottom left corner of the array, closest to the drug application site. Similar to these
univariate measures, NMF also yields µECoG-derived pairwise dynamic functional
connectivity factors, or ‘subgraphs’ (Figure 3.11c). These are modules of functional
connectivity whose variable expression over time approximates the full scale original
dynamic connectivity matrix in linear supposition [190]. Their temporal progression also
tracks transition into the seizure, and further evolution. For example, high gamma
connectivity is lowest for factors expressed during seizure onset; and higher for factors
expressed in the established seizure, when the ictal core occupies the majority of the
electrode grid (Figure 3.11c).
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Figure 3.11 Non-negative matrix factorization (NMF) of time varying feature matrix. (a) The
feature matrices supplied to the NMF (V matrix), and the resultant factorized matrices (H matrix
showing temporal expression of six factors; W matrix showing factor weights for six factors). The ictal
onset transition can be seen in most of the feature matrices, and occurs around the time factor 2 is
expressed most highly. (b) Example factor weights are illustrated for LFP raw power, and calcium
fluorescence in the sequence in which they are most highly expressed. Both show sequential increases
in combined overall weights, with a maximum in the bottom left quadrant of the matrix, corresponding
to the contact nearest the drug application site. (c) Factorized edge-weights can be used to reconstruct
frequency-band specific subnetworks of which the high gamma derived subnetworks are shown here.
These show a decoupling at seizure onset, with subsequent increases in coupling.
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The time varying expression of the six factors further identifies a sequence of state
transitions: periods that are characterized by expression of just a single factor alternate with
periods characterized by mixed expression of multiple factors, indicating a gradual transition
between states (Figure 3.11a). Thus, the factor loadings allow us to track transitions through
a reduced dimensionality feature space, and to identify key transitions between transiently
expressed states. It is of interest to determine whether these state transitions could be
identified without the calcium imaging data, which captures a clearer spatial evolution of
activity at slower time scales than the electrophysiology. To address this question, we
perform the same analysis separately with calcium imaging features, or with
electrophysiological data features alone. We observe that the state transitions are not
detectable in the electrophysiology-only analysis. The timing of state changes appears to be
preserved in the calcium-only analysis, although the dynamics of individual factor expression
differs from the combined analysis (Figure 3.12). These findings indicate that identifying the
sequential latent factors reported here requires the inclusion of calcium imaging data.
Using NMF, we derive a low-dimensional state space representing ictal onset. We
depict this state space as a 3-D plot for the three factors that are predominantly expressed

Figure 3.12 Factor loadings (i.e. H-matrix) derived from non-negative matrix factorization. (a)
Results derived from matrices containing electrophysiology-derived data features only show
transition into seizure and some progressive changes, but no clear sequential states. (b) Factor
loadings derived from calcium imaging features only shows sequential states similar to those of the
combined analysis.
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Figure 3.13 Spatiotemporal trajectories during induced epileptic seizure. (a) Weighting along
three factors showing high loadings early during the seizure, with each point colored by the cortical
surface area recruited to the size of the ictal core estimated from the number of suprathreshold pixels
on calcium imaging. Seizure onset is associated with a smooth trajectory through this state space. (b)
Three time points are sampled based on the extrema of the state-space trajectory, showing normalized
calcium fluorescence, raw electrophysiology, and dynamic subnetwork configuration. (c) Analogous to
the seizure onset, this plot illustrates the transition through state space based on three factors with
maximum activation late in the seizure. (d) Data for three time points late in the seizure are shown,
and are associated with gradual µECoG desynchronization along with continuing spatial increase of
the seizure core on calcium imaging.
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early in the seizure (Figure 3.13a,b). Next, we depict the 3-D state space of three factors that
are predominantly expressed later during the established seizure (Figure 3.13c,d).
Throughout the recording, transitions between factors are accompanied by smooth slow
increases in the spatial extent of the recruited seizure core as defined by imaging features. In
Figure 3.13b,d we show data segments that most closely correspond to each factor, by
selecting time windows around the maximum expression of a given factor. These segments
show distinctive patterns of specific dynamic features: a gradual increase in the spatial
distribution of the calcium signal, changes in ictal discharge morphology and frequency, and
strong initial synchronization with subsequent desynchronization in the between-channel
functional network.
3.4.2 State transitions are associated with changes in ictal discharge electrophysiology
Next, we explore whether features which are in principle measurable in clinical ECoG
recordings change quantitatively between seizure states identified from the multimodal NMF
analysis. The most prominent features of abnormal cortical dynamics observed in clinical
seizure recordings are often ictal epileptiform discharges, which are present in our µECoG
recordings (Figure 3.14a). For this analysis, we were interested in quantifiable features of
ictal discharges that (i) do not depend on the spatial resolution afforded by µECoG (e.g.
excluding between-electrode correlation measures), and (ii) were not already included in the
NMF analysis (e.g. excluding discharge amplitude). We identify two features that fulfil these
criteria, which we hypothesize could act as indicators for ictal state transitions: ictal
discharge frequency and ictal discharge stereotypy. We evaluate both features in 3s nonoverlapping sliding time windows that are labelled according to the factors maximally
expressed during that time window. We then compare median values of discharge frequency
and between-discharge correlation, as a measure of discharge stereotypy, for temporally
adjacent states (Figure 3.14b,c).
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This analysis reveals contrasting changes in discharge frequency and discharge
stereotypy. Discharge frequency monotonically increases from ictal onset, with increasing
frequency at each state transition, and reaches a maximum at the end of the recording.
However, discharges are most stereotyped early in the seizure, and become most variable in
the established seizure around the time windows characterized by high expression of factor
5, before returning to a more stereotyped state towards the end of the recording.

Figure 3.14 Electrophysiological changes associated with ictal state transitions. (a) Peakcentered averages of ictal discharges are shown for all discharges detected in a 10 s time window
around the peak expression of each of the six sequential factors derived from NMF. Note that for
visualization purposes we show averages at a lower detection threshold, meaning that some
fluctuations in the baseline are shown for comparison. For subsequent panels, thresholds were
selected to not include baseline fluctuations in the detected discharges. (b) Ictal discharge frequency
was estimated for non-overlapping 3s sliding windows labelled according to the factor that was
maximally expressed during the time window. This shows progressive increases in ictal discharge
frequency for the duration of the seizure. (c) Stereotypy of ictal discharges was measured by
calculating for each channel the between-discharge correlation for all discharges identified within a 3s
sliding window. This shows that discharges are very stereotyped early in the seizure and become most
heterogeneous around the expression of factor 5.
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3.5 Discussion
3.5.1 Transparent graphene electrode arrays enable multimodal seizure mapping
To truly harness the combined advantages of electrophysiology and optical imaging,
it is necessary to record and image in the same locations simultaneously. While insights have
been gained by utilizing single micropipette local field potential (LFP) recordings in locations
proximal to the imaging region [162], these studies do not offer spatial information about the
propagation of high frequency ictal activity, which requires the use of multi-electrode arrays.
In recent years, marked progress has been made in realizing transparent microelectrode
array technology, initially using graphene and more recently utilizing other materials [9]. One
of the key challenges in developing transparent microelectrodes has been a trade-off between
optical transparency and electrode impedance. For example, the impedance of graphene
electrodes, which are subject to graphene’s fundamental quantum capacitance limit [144],
can be reduced by electrodeposition of platinum nanoparticles on the surface [191], although
at the expense of optical transparency. In this study, we have optimized the process for
fabricating transparent graphene microelectrodes by utilizing a bubble transfer method to
deposit clean and defect-free graphene layers [171], a layer-by-layer HNO 3 doping procedure
[192], and sequentially stacked layers of graphene [193]. This optimization resulted in
electrodes with a combination of high optical transparency and low impedance which is the
best reported so far for graphene-based transparent electrodes of this size.
Electrophysiological signals detected with µECoG are extracellular in origin, and this
allows mixing of signals from different spatial origins and cell types through volume
conduction. Thus, even with the most advanced high-density surface µECoG arrays, the
effective spatial resolution is limited not only by the electrode spacing, but also by the
contributions of volume conduction and the unknown cellular origins of the recorded signal.
In contrast, calcium imaging relies on intracellular changes in calcium concentrations which
can be more precisely localized to their cellular origins. Furthermore, calcium indicators can
be genetically targeted to provide access to precisely isolated signals from specific neuronal
subpopulations in a way that is not currently achievable by electrophysiology [194], [195].
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Here, we used widefield calcium epifluorescence imaging to offer a broad field of view
encompassing the entire area covered by the 16-channel graphene array. Widefield imaging
combined with somatically expressed calcium indicators is more sensitive to dendritic
synaptic currents than individual action potentials, giving a readout of population activity
rather than individual neuronal firing. For epileptic seizures, which emerge at the population
level, this resolution is an appropriate spatial scale for subsequent analysis. However, some
phenomena that characterize seizure activity (e.g. HFOs) cannot be captured with calciumbased methods at all, given the slow dynamics of both calcium transients and the fluorescent
calcium indicators. Therefore, our approach allowed us to analyze the complex spatial
patterns of ictal wavefront progression over a millimeter-scale cortical area in combination
with spatially distributed measures of electrophysiology. In contrast to previous multimodal
studies which have utilized cellular resolution multiphoton imaging, our approach also offers
a much larger field of view.
To observe the contributions of excitatory neurons to ictal dynamics, in this study we
utilized an animal model expressing GCaMP6s in excitatory pyramidal neurons. In the future,
our approach can be extended to study the contributions of inhibitory interneurons. This
direction would be particularly valuable for shedding light on the delicate balance between
excitation and inhibition, and its role in seizure propagation, which is currently a subject of
much debate [152], [154].
3.5.2 Ictal dynamics unfold on multiple temporal scales
Seizures are characterized by abnormalities in neuronal dynamics spanning across
spatial and temporal scales. There is an extensive body of literature mapping these
phenomena using a variety of recording setups in a range of different model systems [152],
[196]. Convergent evidence from these studies suggests that at the onset of a focal seizure,
the cortical sheet organizes into distinct territories characterized by particular dynamics
signatures [156]. The recruited, intensely active ictal core is separated by an ictal wavefront
from the surrounding cortex (the ictal penumbra) that may be propagating ictal discharges
but lacks intense single neuron firing [1], [154]. These distinct seizure territories are best
characterized by microelectrode arrays that can record invasively from electrodes piercing
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pial layers and recording within cortical lamina, but evidence has also arisen from imaging
acute seizure-like events in vitro [154].
In our analysis, we quantitatively combine surface µECoG recording of ictal onset
with more spatially resolved calcium mesoscopic imaging, and find that we can identify
signatures of these distinct seizure territories in our acute in vivo model of epileptic seizures.
We further replicate previous observations of ictal dynamics unfolding on multiple temporal
scales: we observe fast spread of individual ictal discharges in both calcium imaging and
electrophysiology, as well as the slow, wave-like recruitment of the cortical surface into an
ictal core. Similar findings have previously been described based on a variety of
electrophysiological features (including multi-unit activity [197]), as well as demonstrated in
neural field models of cortical physiology [198].
While previous studies have demonstrated simultaneous electrophysiology and
imaging, none has so far addressed the challenges that arise in combining and interpreting
quantitative features from multiple modalities that operate on different spatial and temporal
scales. Dimensionality reduction techniques, such as NMF, are frequently applied to
neurophysiological data to extract low-dimensional information from high-dimensional
signals, and are thus relevant for the multimodal data on which we report in this study [189].
NMF provides linear representations of non-negative data, and the algorithm applied here
contains a sparsity constraint, allowing us to identify low-dimensional factorizations of the
data that contain only a limited number of active contributors to each factor [199]. To apply
NMF to multimodal data, modality-specific data matrices are concatenated into a single
matrix and aligned in time. This procedure allows us to utilize the high temporal resolution
of electrophysiological data by calculating key quantitative features that have been
associated with distinct ictal territories – such as phase-locked high gamma. Such features,
while requiring high temporal resolution to detect, evolve slowly enough in time to be related
to the slower dynamics identified from calcium imaging. The NMF analysis then provides us
with temporal loadings on sparse factors that span multiple imaging and electrophysiological
features, fully leveraging the strengths of both recording modalities.
Using this approach, we demonstrate that the ictal onset transition – defined by
changes in the ongoing oscillatory dynamics of electrophysiological recordings – can be
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factorized using a data-driven approach into a sequence of states that evolve on the time scale
of minutes. Identification of these spatiotemporal patterns is made possible by the
combination of recent advances in both transparent electrode fabrication and analytical
techniques for processing neuronal data. The framework demonstrated here, enabled by our
transparent graphene array technology, allows characterization of ictal phenomena observed
with multimodal experimental setups, and helps quantitatively integrate information from
concurrent calcium imaging and µECoG recordings.
3.5.3 Data driven multimodal analysis can identify new hypotheses for clinical
translation
Recording seizures with multimodal combined µECoG and calcium imaging will not
be achievable in human patients in the near future. However, there is already evidence that
experimental high-resolution recordings can aid in the identification of novel biomarkers
with translational potential. For example, microelectrode mapping of seizure territories has
led to the identification of phase-locked high gamma as a potential biomarker for the ictal
core and the seizure onset zone, even on intracranial macro-electrodes [152], [200].
In our analysis, we similarly illustrate how high-resolution mapping only achievable
in experimental settings might be used to provide new hypotheses that could be testable in
clinically achievable recordings. We show that calcium imaging provides data features that
separate distinct states within a single seizure, even where aggregate electrophysiological
features suggest only a monotonic, gradual change. We harness information on the putative
timing of state-changes identified as changes in expression of NMF factors. We achieve this
by exploring complementary features in the electrophysiological recordings, through which
we can identify putative electrophysiological correlates of ictal state changes. One example
of such a putative correlate is a gradual loss of local synchrony with progressive enlargement
of the seizure core, which can be seen in the changes to the dynamic subnetwork graphs
moving from factor 2 to factor 6 (Figure 3.13b,d). Similarly, the increasing variability of ictal
discharges during the established seizure (Figure 3.14c) may be a marker of a specific ictal
state which is potentially measurable with macroscopic clinical ECoG electrodes.

65

Chapter 3: Multimodal seizure mapping with transparent graphene electronics

Such changes may be quantitatively subtle, but informative with regard to the
underlying dynamical system generating ictal dynamics. If seizures are considered a
pathological stable oscillation around a limit cycle [201]–[203], reductions in stereotypy of
discharges may indicate that the system is approaching points of instability where closedloop interventions may be most successful. These neurophysiological changes, while
important, may not themselves be quantitatively sufficient to allow separation into states
from dimensionality reduction approaches as presented here in neurophysiological data
alone. However, as demonstrated through our analysis, they may be identifiable from
combined analysis with modalities that are more sensitive to dynamics of distinct seizure
territories, such as calcium imaging.
Characterizing individual seizures in such detail is important for several reasons:
markers associated with distinct spatial territories may guide resective epilepsy surgery and
identifying dynamically distinct states within a seizure may enable effective targeting of
stimulation for seizure abatement, harnessing novel closed-loop stimulation approaches for
the treatment of seizures. Thus, deriving candidate biomarkers from experimental animal
studies is an essential step in identifying novel treatment strategies for currently untreatable
epilepsies.
3.5.4 Methodological considerations and limitations
While the graphene electrode technology presented here enables recording of fast
ictal dynamics, we were not able to resolve multi-unit activity (MUA) in this study due both
to the size of the electrodes (50 µm x 50 µm) and their placement on the cortical surface
(relatively distant from the cell bodies which lie in deeper cortical layers). Previous studies
have reported successful recording of MUA from the cortical surface [55], when the
electrodes are scaled down to cellular dimensions (i.e. ≤ 30 µm in diameter), however the
high impedance of current transparent microelectrodes has largely prevented the realization
of functional electrodes at these cellular spatial dimensions. Further progress in transparent
electrode technology may enable high-fidelity recording from electrodes at this scale in the
future. Such progress may be achievable by exploring other materials systems which have
shown promise for optoelectronics and may offer higher conductivity than graphene, such as
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MXenes [21], [204]. Access to MUA activity can also be achieved by considering alternative
implantation strategies that place the graphene electrodes closer to cell bodies. Such
strategies could include brain slice studies or approaches where the array is implanted over
deep brain structures, such as the hippocampus, utilizing an implanted cranial window [205].
The seizure model used in this study is a bath-application of 4-AP, which offers
experimental control and the ability to reliably induce acute seizures for validating our
methodology and analytical methods. Yet, the model also has some limitations that are worth
noting. In particular, it is challenging to discern the effects of drug diffusion on the spatial
propagation of ictal activity, and the pharmacologically-induced seizure model may not
replicate ictal dynamics that occur in spontaneous seizures. While offering less experimental
control, a chronic seizure model in which mice experience spontaneous seizures following
drug-induced status epilepticus may offer a more naturalistic view of ictal dynamics [206].
In terms of analysis, the methodological choices make certain assumptions. Applying
dimensionality reduction techniques (such as NMF) to high-dimensional neuronal data
assumes that key information is contained in large signal changes affecting a high proportion
of recording channels. The representational accuracy of the low-dimensional approximation
of the full dataset can be arbitrarily increased by increasing the number of factors or
components, and a trade-off between accuracy and interpretability must be made.
Furthermore, NMF assumes that the dynamics emerge from variable expression of spatially
invariant factors, rather than changes in the spatial factors themselves. Other conceptual
approaches or interpretations may prove more useful for specific cases.
3.5.4 Conclusion
Novel recording and analysis methods such as the ones introduced here improve our
ability to quantify and ultimately understand the dynamics of epileptic activity in local
microcircuits, and brain-wide epileptogenic networks. Concurrently recorded multimodal
data may be used to address novel biological questions that are not tractable with a single
method approach. For example, genetically-targeted calcium imaging of inhibitory neuron
activity during concurrent measurement of the µECoG may enable separating the
contributions of excitatory and inhibitory cell types to the ECoG signal. Combining µECoG
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with imaging of cortical vasculature using injected fluorescent probes may also enable linking
neural activity patterns to changes in blood flow, offering a direct proxy for fMRI studies
[207].
Increasingly, through resective epilepsy surgery and laser ablation for example,
patients are being offered interventions that aim to disrupt epileptogenic networks in order
to reduce or stop their seizures. These therapies are currently driven by a crude
understanding of cortical dynamics at the scale of ECoG signals. This understanding is based
on coarse physical models, such as mesoscale neural masses representing large
homogeneous populations of different neuronal subtypes [208] and equivalent current
dipoles representing the electromagnetic spread of single source signals [209]. The sequence
of spatiotemporal patterns constituting distinct states in the ictal onset reported here all
occur at a spatial scale that would classically be regarded as a single source in most ECoG
models. We now have the technological ability to acquire data at unprecedented temporal
and spatial resolutions, and have the computing power and analysis methods at hand to
identify from these complex data the key features that capture the dynamics at play. Through
high fidelity recordings in experimental systems we will be able to inform the development
of new hypotheses and models that may more accurately explain the phenomena observed
in clinical recordings in human patients.
There is an urgent unmet need for novel therapies for patients who cannot currently
benefit from resective surgery or antiepileptic medication. Novel treatment approaches such
as responsive neuromodulation using electrically stimulating devices [210], [211], or novel
optogenetic closed-loop control strategies [212] are currently already in clinical use or in
development. Yet such modulation-based treatments require a detailed characterization of
state transitions in local epileptogenic circuits as well as models of how interventions may
disrupt these transitions. The integrated recording and analysis approach presented here is
one strategy to quantify these state transitions utilizing optical and electrophysiological
measurements. As such, we provide essential tools for epilepsy research to explore novel
treatments in experimental systems.
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3.6 Materials and methods
Graphene device fabrication
Three inch silicon wafers were coated with 4 µm parylene-C using a CVD process (SCS
Labcoter 2 Parylene Deposition System). Following photolithography, 10 nm titanium (Ti)
and 100 nm gold (Au) were evaporated onto the wafer using an electron-beam deposition
process, and lift-off techniques were used to pattern the metal to form traces and connection
pads. Monolayer graphene was transferred from a copper foil to the wafer using a wet bubbletransfer method consisting of the following steps: spin-coat 950 PMMA A4 on
graphene/copper foil; bake at 100°C for 2 min; apply 20V potential between tweezers
gripping copper foil and stainless steel counter electrode placed in 1 mM NaOH solution, and
grip copper foil in tweezers while slowly submerging into NaOH, releasing graphene/PMMA
from foil; transfer graphene/PMMA to three water baths for cleaning; transfer
graphene/PMMA onto wafer substrate and let air dry for 2 hrs; bake wafer at 150°C for 2 min,
then remove PMMA with acetone, IPA (soak for 20 min), and deionized (DI) water rinse.
Following each graphene transfer to the wafer, the graphene was doped by soaking the wafer
in 75% HNO3 in DI water at room temperature for 15 minutes and subsequently dried with
an N2 gun. SiO2 (30 nm) was then deposited onto the wafer using e-beam deposition to protect
the graphene from damage during subsequent reactive ion etching (RIE) steps. The SiO 2 and
graphene were patterned using photolithography and RIE to form the electrode array and
traces, such that graphene traces overlapped Ti/Au traces. A second 4 µm layer of paryleneC was deposited through CVD and subsequently patterned through photolithography and RIE
to form the outline of the device and to open the graphene electrode sites and Ti/Au contact
pads. The protective SiO2 layer was removed from the graphene electrode contacts by
immersing the wafer in 1:6 buffered oxide etchant (BOE) for 30 s. Devices were released from
the wafer and Kapton tape was applied to the back of the Ti/Au bond pad region to ensure
proper thickness and stiffness for insertion into a zero insertion force (ZIF) connector and
connection to the recording amplifier.

69

Chapter 3: Multimodal seizure mapping with transparent graphene electronics

Electrochemical characterization
Electrochemical impedance spectroscopy (EIS) measurements were made using a Gamry
Reference 600 potentiostat/galvanostat/ZRA in standard three-electrode configuration in 10
mM phosphate buffered saline (PBS) solution (pH 7.4). A graphitic carbon rod was used as
the counter electrode, and an aqueous (3 M KCl) Ag/AgCl electrode was used as the reference.
EIS measurements were taken between 1 Hz and 1 MHz using a 20 mV rms AC voltage. Cyclic
voltammetry measurements were also taken using the Gamry Reference 600 from -0.8 to 0.8
V, with scan rates of 200, 300, 400, and 500 mV/s and a potential step of 5 mV. The cathodal
charge storage capacity (CSCC) was calculated by integrating the area under the average CV
curve and dividing by the sweep rate (50 mV/s).
Ultraviolet-visible spectroscopy
Transmission mode UV-vis spectroscopy was obtained using a Perkin-Elmer Lambda-950
spectrophotometer over wavelengths from 300 to 1000 nm. Spectra were taken for the interelectrode space (consisting of top and bottom parylene-C layers only), for a graphene
electrode contact (consisting of the bottom layer parylene-C and the graphene layer), and for
a graphene trace (consisting of top and bottom parylene-C layers and graphene layer).
In vivo imaging and electrophysiological recording
All experiments were performed under a protocol approved by the Children’s Hospital of
Philadelphia Institutional Animal Care and Use Committee. Briefly, 6 to 8-week-old Thy1GCaMP6 (Jax #025776, Jackson Laboratory) mice were anesthetized with isoflurane (0.5%1.5%) in oxygen. Using a micro-drill, a hole was made for inserting a stainless steel skull
screw with a silver- ground wire. A metal headplate with 6x6 mm 2 square imaging well
(Narishige USA) was fixed to the skull overlying the somatosensory cortex with dental acrylic
(Ortho-Jet). A rectangular craniotomy was drilled (right hemisphere, center at 2 mm
posterior and 2 mm lateral of bregma). The exposed cortical surface was kept wet by ACSF
containing the following (in mM): 155 NaCl, 3 KCl, 1 MgCl2, 3 CaCl2, and 10 HEPES. After the
craniotomy surgery, aesthetic was switched to ketamine/xylazine (100/10 mg /kg) and the
headplate was attached to a small imaging platform (Narishige USA) and mounted on an x,y70
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translational stage of an upright microscope (Olympus BX-61). The graphene electrode array,
a custom-connector, and the headstage (SmartLink16, NeuroNexus) were attached to a
stainless steel bar, which was then attached to a micro-manipulator. The graphene electrode
array was gently placed on the cortical surface. Signals from the graphene electrode array
were sampled at 5 kHz via the headstage and the controller (SmartBox, Neuronexus), and the
data was saved to a PC. The microscope was equipped with blue LED (470nm, Thorlabs), a
filter cube (49002, Chroma) and sCMOS camera (Orca Flash 4 V2, Hamamatsu). The imaging
data was captured in TIF format on another PC, and timing of electrophysiological recording
and imaging was synched by a TTL signal. For epifluorescence imaging, excitation light was
continuously illuminated and fluorescence images were captured at a constant acquisition
rate of 10 Hz. Baseline activity was recorded for 20 min prior to seizure induction. Local
seizure induction was achieved via bath-application of 100 μL of 4-amino pyridine (4-AP) in
ACSF (30 mM) on the exposed cortical surface adjacent to the graphene electrode array.
SNR calculations
To compute SNR on each electrode, the mean amplitude of 8 ictal spikes that occurred during
a 4-second window during seizure onset was divided by the RMS of the signal during a 3second window of pre-seizure baseline activity.
Dynamic feature extraction
Quantitative analysis was performed on custom scripts on MATLAB R2019a; all scripts to
reproduce analysis figures are available online on https://github.com/BassettLab/GrapheneElectrode-Seizures.

Features from µECoG
For this analysis, we extracted quantitative features that dynamically evolve at a time scale
similar to that evident in the features of calcium imaging. Specifically, we estimated timevarying phase locked high gamma amplitude, frequency-band specific power in two
frequency bands, and sliding-window dynamic functional connectivity.
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Phase-locked high gamma: We estimated phase-locked high gamma amplitude 𝑎

ɸ

following

prior work[152]. Briefly, we applied the Hilbert transform separately to the data recorded at
each microelectrode contact, after filtering each into two distinct frequency bands: a low
frequency band (1-40 Hz) and a high frequency gamma band (80-250 Hz). From the Hilbert
transform we were then able to calculate low frequency instantaneous phase ɸ

, and high

frequency instantaneous amplitude normalized by the average band-passed amplitudes at
baseline a

. From a second Hilbert transform, we derived the instantaneous phase of the

slowly time-varying instantaneous amplitude of the high frequency content ɸ
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these values, we calculated the phase locked high gamma amplitude as a measure of
normalized high frequency amplitude weighted by the mean cross-frequency band phase
correlation. Specifically, we calculated this variable within the sliding window ranging from
sample 𝑛 = 1 to sample 𝑛 = 𝑁:
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We calculated this variable through sliding windows of length 3s and then then interpolated
linearly to a full sampling frequency of 10Hz to enable cross modality analysis with the
imaging features.
Frequency band-specific power: We calculated frequency band-specific power using the
Hilbert transform on time series filtered into low (1-40 Hz), and high (80-250 Hz) frequency
components, tracking evolution of most of the classically visible frequency ranges, and of high
frequency oscillations separately. We estimated band-specific power in 3 second nonoverlapping sliding windows, before interpolating to the 10 Hz sampling frequency of the
calcium imaging in order to track slow modulations of frequency power.
Functional connectivity: To estimate functional networks, we calculated pair-wise
correlations between individual microelectrode contacts. Full correlation matrices were
estimated for sliding 3 second windows, edges with correlation values of < 0 were reset to 0,
and edge-wise temporal evolution was interpolated to the sampling frequency of the calcium
imaging at 10 Hz.
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Features from calcium imaging
For our analysis we derived normalized measures of fluorescence intensity during the
seizure, as well as a measure of each pixel’s proximity to a putative ictal wave front. Imaging
yielded raw epifluorescence image sequences for the baseline period, and from the period
following the application of the chemoconvulsant 4-AP. We used the baseline period to
quantify pixel-wise mean fluorescence, and fluorescence intensity variability (estimated as
the standard error of the mean). From the baseline mean and standard error maps, we then
calculated a t-statistic map for each image in the sequence following chemoconvulsant
exposure, where 𝑡 = (𝑥 − 𝜇 )/𝜎
and 𝜎
̅

̅

, with 𝑥 being the sample value, 𝜇

the baseline mean,

the baseline standard error of the mean.

In order to coarse-grain the data, we applied a 2-dimensional gaussian filter with a width of
15 pixels to each t-map in the sequence, and binarized the resultant images at a manually
selected threshold that would first be crossed at the time of visually apparent electrographic
seizure onset. We detected the edge of these binarized maps at each time point and convolved
the edges with a two-dimensional Gaussian kernel with a width of 15 pixels, which yielded a
measure of proximity of each imaging pixel to the putative ictal wave front.
Finally, we sampled both raw fluorescence, and proximity to the putative wavefront from the
imaging pixels underlying each of the 16 microarray contacts, generating 16 time series for
both measure, which were then used in the subsequent analysis.
Non-negative matrix factorization
We used non-negative matrix factorization on a multimodal feature matrix containing the
time varying features estimated above in order to identify a subset of composite factors,
whose time-varying expression could recapitulate the multi-modal feature evolution
observed in the data. NMF will decompose any 𝑛 ∗ 𝑡 feature matrix 𝑉 (where 𝑛 is the number
of features, and 𝑡 is the number of temporal samples) into a set of 𝑘 factors (i.e., sets of
features encoded in the 𝑊 matrix) and their temporal evolution (encoded in the 𝐻 matrix),
so that the full matrix 𝑉 can be approximately reconstructed from these factors (i.e. 𝑉 ≃
𝑊𝐻 ).
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In terms of network analysis, these approaches have been previously used to decompose
dynamic functional connectivity into sets of variably expressed subnetworks and track their
temporal evolution in human neuroimaging [168]–[170]. Here, we extend the application of
the approach to integrate data features across modalities and feature types. In contrast to the
original formulation of the method, the algorithm applied here uses additional sparsity
constraints and has been previously described elsewhere [187], [188]. The full feature matrix
𝑉 was concatenated from channel-specific time series of broadband LFP (1-40 Hz), and high
gamma (80-250 Hz) band power, normalized fluorescence amplitude, and wave front
proximity estimates, as well as the 𝑛 (𝑛 − 1)/2 unique edge-weights unfolded from the
symmetrical correlation-based 𝑛 functional connectivity matrix, where 𝑛 is the number of
channels.
Ictal discharge analysis
We quantified between-state differences in features of ictal discharge. For this we divided the
whole seizure recording included in the NMF analysis into 3s long non-overlapping time
windows, labelled according to the factor that was maximally expressed during each window.
We z-transformed data for each time window using baseline data to calculate normalizing
mean and standard deviations individually for each channel. In the resultant z-normalized
time series, we identified putative ictal discharges as negative deviations of an amplitude of
z > 3.9 and a width of at least ~30ms. These parameters were identified by a clinician with
training in epilepsy (RER) visually confirming that the detected events were ictal in nature,
and no baseline events were detected (for visualization purposes in Fig 6a, the thresholds
were slightly relaxed in order to allow inclusion of some baseline detections – but those were
not included in subsequent statistical analysis).
We calculated the average inter-discharge interval for each time window as an inverse
measure of spike frequency. We also estimated the correlation of all ictal discharges within a
time window. For this we segmented out ictal discharges from 50ms prior to the peak
amplitude to 150ms after peak amplitude, and calculated Pearson’s correlation coefficient
between each pair of these segments within time windows and channels. We then averaged
all correlation coefficients to estimate a single mean correlation value per 3s window,
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representing ictal discharge stereotypy. We compared each pair of sequential states (defined
by their factor expression) by Wilcoxon ranksum comparison of discharge frequency and
stereotypy for each group of time window associated with either state.
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High-resolution neural interfaces are essential tools for studying and modulating
neural circuits underlying brain function and disease. As we saw in the previous chapter, they
can enable new insights into brain dynamics at the microscale that underly phenomena such
as epileptic seizures. To achieve high spatial resolution and channel count, however,
electrodes must be miniaturized, even down to the scale of individual neuronal processes
(~10s of µm). At these scales, maintaining low electrode impedance and high signal quality
becomes a significant challenge. Nanostructured materials can address this challenge, as they
can combine high electrical conductivity with mechanical flexibility and can interact with
biological systems on a molecular scale. Unfortunately, fabricating high-resolution neural
interfaces from nanostructured materials is typically expensive, time consuming, and does
not scale, which precludes translation beyond the benchtop. Two-dimensional (2D) Ti 3C2
MXene possesses a combination of remarkably high volumetric capacitance, electrical
conductivity, surface functionality, and processability in aqueous dispersions distinct among
carbon-based nanomaterials. In this chapter, I develop a high-throughput microfabrication
process for constructing Ti3C2 microelectrodes and I demonstrate their superior impedance
and in vivo neural recording performance in comparison to standard metal microelectrodes.
Specifically, when compared to gold microelectrodes of the same size, Ti 3C2 electrodes exhibit
a 4-fold reduction in interface impedance. Furthermore, intraoperative in vivo recordings
from the brains of anesthetized rats at multiple spatial and temporal scales demonstrate that
Ti3C2 electrodes exhibit lower baseline noise, higher signal to noise ratio (SNR), and reduced
susceptibility to 60 Hz interference than gold electrodes. Finally, I present a neuronal
biocompatibility study showing that neurons cultured on Ti 3C2 are as viable as those in
control cultures, and they proliferate, grow axonal process, and form functional networks.
Overall, these results indicate that Ti3C2 MXene microelectrodes have the potential to become
a powerful platform technology for high-resolution bioelectronic interfaces.
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4.1 Introduction
Understanding the fundamental mechanisms governing the structure and function of
neural circuits is critical for treating neurological disorders like epilepsy, depression, and
Parkinson’s disease. Microelectrode technologies are widely used to elucidate neural
dynamics on fine spatial and temporal scales (~10-100 µm, 1 ms). However, recording stable
neural signals with high signal-to-noise ratio (SNR) from micro-scale electrodes remains a
significant challenge. Current microelectrode arrays are stiff, invasive, and limited in their
ability to provide high fidelity long-term recordings because conventional electrode
materials, including metals and silicon, are inadequate for interfacing with biological tissues.
The significant mechanical mismatch between conventional electrode materials and the soft
brain tissue elicits an inflammatory response that eventually results in the formation of an
insulating glial scar around the implant [213]. Additionally, as the geometric area of an
electrode is decreased to approximate the size of individual neuronal processes, a
corresponding rise in the electrochemical interface impedance leads to an increased
susceptibility to noise sources, including thermal noise, mains interference, and signal loss to
shunt pathways, which ultimately degrade signal quality [10]. Solving these issues to achieve
seamless, stable, long-term integration between man-made devices and neuronal structures
requires innovation in bioelectronic materials.
One strategy commonly adopted to overcome the trade-off between electrode
footprint and interface impedance is to increase the effective surface area over which ionic
species in the extracellular space can interact with the electrode. This is achieved through
nanopatterning [11], surface roughening [12], or electroplating with porous additives[10],
[13]. Nanomaterials such as graphene [16], carbon nanotubes [126], [133], and nanowires
[214] show great promise for high-resolution neural interfaces because they offer high
specific surface areas, and desirable thermal, electronic and mechanical properties, including
flexibility and high conductivity [215]. However, the lack of scalable assembly methods is a
key barrier to their widespread adoption for neural interfaces. For example, carbon-based
nanomaterials are typically hydrophobic and require the use of surfactants [216], superacids
[217], or surface functionalization [218] to allow fluid-phase assembly from aqueous
dispersions. Residues from surfactants or superacids used in assembly are difficult to remove
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completely and can be detrimental to electrode performance [219] or toxic to biological
tissues [220], respectively. Surface functionalization induces defects and reduces the
conductivity and strength of the resulting structures [218]. Besides solution processing
methods, chemical vapor deposition (CVD) can also be used to assemble carbon-based
nanomaterials into thin films for neural electrodes. However these processes are conducted
at high temperatures that are incompatible with many flexible, biocompatible polymeric
substrates [221], and thus require tedious subsequent steps to align and transfer the films
from the catalyst layer to the polymeric substrate [222].
MXenes are a large class of 2D nanomaterials, composed of early transition metal
carbides, nitrides, and carbonitrides that present an exceptional combination of high
electrical conductivity, strength, flexibility and volumetric capacitance [18]. MXenes contain
abundant surface terminating functional groups, such as hydroxyl (–OH), oxygen (–O) or
fluorine (–F), which make them hydrophilic and also allow for flexible surface modification
or functionalization. MXenes’ hydrophilicity enables the use of high-throughput solution
processing

methods without the need for surfactants,

superacids, or surface

functionalization, and may also provide opportunity for creating functionalized platforms for
drug delivery or electrochemical sensing. While much of the early research on MXenes
focused on applications in energy storage [18], [22], more recent work has shown that
MXenes hold great promise for biomedical applications as well. In the following section, 4.2,
I will expand upon the synthesis, properties, and biomedical applications of MXenes to
provide additional context for this chapter.
Of the dozens of MXenes that have been discovered, the first MXene, Ti 3C2, has been
the most extensively studied, characterized, and optimized [223]–[225]. Ti 3C2 demonstrates
remarkably high volumetric capacitance (1,500 F/cm3) [22] and electronic conductivity
(~20,000 S/cm) [226]. The volumetric capacitance of Ti3C2 exceeds that of activated
graphene (~60–100 F/cm3) [227], carbide-derived carbons (180 F/cm3) [228], and graphene
gel films (~260 F/cm3) [229]. The outstanding electrical properties of Ti3C2, coupled with its
processability and high specific surface area make it an extremely promising material for
neural interfaces, particularly for overcoming the trade-off between geometric surface area
and electrochemical interface impedance, which is a primary limitation to achieving high78
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fidelity recording from micro-scale electrodes. The high capacitance of Ti 3C2 films is also a
significant advantage for biosensing and stimulation applications, where capacitive electrode
interfaces are preferable as they avoid harmful Faradaic reactions. Finally, the hydrophilic
nature of Ti3C2, an uncommon attribute among carbon-based nanomaterials, allows the use
of simple, scalable, high-throughput solution processing methods.
Prompted by its outstanding properties, in this study we investigate the suitability of
Ti3C2 MXene for high-resolution, implantable electrodes for neural signal sensing. First, we
describe a high-throughput fabrication process which combines standard photolithographic
patterning with an ad-hoc method for forming precise, micropatterned MXene films from a
colloidal solution on flexible polymeric substrates. Using this custom approach, we
demonstrate the feasibility of producing implantable, multichannel neural electrode arrays
comprised of Ti3C2, developing different geometries for recording both from the cortical
surface and from deeper brain regions. We show that Ti 3C2 electrodes exhibit markedly
reduced impedance compared to gold (Au) electrodes of the same size, and that this
impedance reduction is accompanied by significant improvement in neural recording signal
quality in vivo. In particular, when used in vivo for high-fidelity recording of neural spiking
activity, Ti3C2 electrodes show significantly improved sensitivity, reduced noise, and the
ability to detect a larger number of spikes compared to Au electrodes. Finally, we
demonstrate that Ti3C2 MXene is biocompatible with neuronal cultures and does not affect
cell viability, proliferation or synapse formation, though neurons are known to be highly
sensitive to their local environment and surface interactions.

4.2 MXenes: background and prior work
4.2.1 Synthesis and properties
MXenes, which are a large family of early transition metal carbides, nitrides, and
carbonitrides, were first discovered in 2011 by Drexel University scientists [223]. They are
produced by selectively etching out the A layers from MAX phases, which are so-called
because of their composition: Mn+1AXn, where M is an early transition metal, A is a group 13
or 14 element of the periodic table, X is carbon and/or nitrogen, and n = 1, 2, or 3. Single-layer
MXene flakes are generally produced by first etching the A element from the MAX phase using
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acid and salt mixtures, such as pure hydrofluoric acid (HF), HCl + LiF (forming HF in situ), or
HF + HCl, and subsequently delaminating the sheets from each other through intercalation
with organic molecules, such as dimethyl sulfoxide (DMSO), or with solvated Li + ions [230]
(Figure 4.1). This top-down selective etching procedure is far more scalable than bottom-up
approaches, such as chemical vapor deposition (CVD) or physical vapor deposition (PVD),
which are required for producing many other 2D materials [231].

Figure 4.1 Schematic for the exfoliation process of MAX phases and formation of MXenes. Note
that there are now many variations on this method, not all using HF and not all requiring sonication to
separate the 2D MXene sheets. From [373].

Methods for synthesizing single-layer MXene flakes are still evolving and undergoing
optimization, and the synthesis conditions have a large effect on the properties of the
resulting MXene material [231]–[233]. For example, early methods of producing single-layer
Ti3C2 required sonication to complete the delamination, however more recently a method
called the minimally intensive layer delamination (MILD) method was developed which made
it possible to isolate single flakes of MXene using manual shaking rather than sonication. This
resulted in larger single flakes, which could produce films with higher conductivity [233].
Another very recent advance has been the development of methods for synthesizing fluorine80
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free MXenes without using HF-containing or HF-forming chemicals, offering improved safety
[234].
MXenes have a number of interesting physical, chemical, and electrical properties
which make them attractive for a wide range of applications. The presence of surface
terminating functional groups, such as hydroxyl (–OH), oxygen (–O) or fluorine (–F) (the
composition of the surface terminations can be tuned by varying the processing conditions
[235]), renders MXenes hydrophilic, which is unusual among 2D materials. This means that
MXenes are stable in surfactant-free water-based colloidal solutions and can be processed
using highly scalable solution processing methods. The surface terminations, along with the
high specific surface area of the 2D sheets, also provide opportunity for flexible
functionalization of the surfaces of MXene flakes, such as with antibodies or drugs [236]–
[238]. Furthermore, the ultrathin layered structure gives MXenes interesting physiochemical
properties (e.g. photothermal conversion [239], [240], X-ray attenuation [241], [242], and
localized surface plasmon resonance [243], [244]) and biological behaviors (e.g.
biodegradation [239], [245] and cellular endocytosis [241]). Regarding their electrical
properties, MXenes show metallic electronic conductivity of up to 15,000 – 20,000 S/cm,
which is higher than all other solution-processed 2D materials [226], [246]. In fact, the unique
combination of hydrophilicity and metallic conductivity is a key advantage for MXenes over
graphene and its derivatives. MXenes also have extremely high volumetric capacitance
(~1,500 F/cm3) [22], which led early research efforts to predominantly focus on energy
storage [18].
Since their initial discovery, more than 30 MXene compositions have been
synthesized and dozens more have been theoretically predicted. Each composition offers a
unique combination of properties, and potentially even a way to tune the properties by
varying ratios of M or X elements. To date, the first MXene, Ti 3C2, has been the most
extensively studied and optimized, with more than 70% of all MXene research focusing on
this single composition [247]. In this thesis, Ti3C2 is the MXene composition of choice because
at the time of these studies it was the most well-optimized, well-studied, and considered to
be the most electrically conductive. It is quite possible that other compositions of MXene may
in time prove even more optimal for biomedical applications such as the ones presented in
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this thesis work, and even open the doors to new areas of research which have not yet been
explored.
4.2.2 Biomedical applications
As noted above, much of the early research on MXenes focused on energy storage, and
it is still the dominant area of MXene research. In just the past few years, however, the number
of applications which have been explored using MXenes has rapidly expanded (Figure 4.2).
The use of MXenes in the biomedical field first gained traction in 2017, and since then there

Figure 4.2 Explored applications of MXenes to date. The center pie chart shows the ratio of
publications in each explored application/property of MXenes with respect to the total number of
publications on MXenes. The middle pie chart ring, with the same colors, shows the starting year for
exploration of each application/property of MXenes. NB: although there may be one or two papers
published prior to the mentioned year, we considered a year with several significant publications as
the starting (breakthrough) year for each slice. The outer ring shows the ratio of publications on
Ti3C2Tx MXene versus all other MXene compositions (M2XTx, M3X2Tx, and M4X3Tx). From [374].
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has been an explosion of interest. The earliest biomedical-related research using MXenes
focused on biosensors for small molecule detection, using the nanolayered structure and
surface functional groups of Ti3C2 to immobilize enzymes for electrochemical detection of
small molecules such as H2O2 [248] and glucose [249]. Next, MXene was demonstrated for
cancer theranostics, both as a photothermal conversion agent for in photothermal therapy
[240], and as a contrast agent for diagnostic imaging techniques such as computed
tomography (CT), photoacoustic (PA), and magnetic resonance imaging (MRI) (when Ti 3C2 is
decorated with magnetic nanoparticles) [250]. In photothermal therapy, the characteristic
800 nm absorption peak of Ti3C2 enables efficient conversion of near infrared (NIR) radiation
to heat in order to ablate tumor cells [240]. The nanosheets preferentially accumulate in
tumor tissue due to the characteristic high permeability of tumor blood vessels, which allows
targeted ablation, diagnostic imaging, and also chemotherapeutic drug delivery [251]. Of the
biomedical applications of MXenes shown to date, cancer theranostics has emerged as one of
the most promising and well-studied [242], [252]–[254].
Another interesting application of MXenes in biomedicine has been in dialysis. It has
been shown that Ti3C2 can selectively adsorb urea from dialysate through binding at the
surface terminations on the MXene flakes, offering great potential for the realization of a
wearable artificial kidney [255]. Yet another promising area of research has been in wearable
mechanical sensors based on MXene. These have predominantly been strain gauge or
pressure sensors which can be used for tracking limb movement [256] or even decoding
facial expressions [257] or speech [258]. Beyond these applications, MXenes have been
explored for pH sensing [259], detection of metabolites in sweat [260], and as antimicrobial
agents [261], [262].
Given the high electrical conductivity of MXenes, it seemed natural that they might
perform well as electrodes for electrophysiological recording from excitable tissues such as
the brain, muscles, and heart. When I began working on developing MXene electrodes for
electrophysiology in 2017, however, no other group had yet reported this. The closest
predicate was a single report from 2016 describing a Ti3C2-based field-effect transistor (FET)
that could detect the spiking activity of neurons in culture, though it did so by electrochemical
detection of dopamine rather than by directly recording the extracellular voltage fluctuations
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[263]. In this chapter and the next, I detail how our group pioneered the use of MXenes for
recording and stimulating electrodes that directly interface with excitable tissues, thus
opening a new field of MXene bioelectronics.
As interest in using MXenes for biomedical applications has grown, so too has
evidence showing their excellent biocompatibility, which is always an important concern
whenever nanomaterials are used to interface with biology. One study showed that
intravenous injection of Ti3C2 into healthy mice at doses up to 20 mg kg-1 did not produce any
measurable behavioral change, weight loss, change in blood indexes, change in liver or kidney
function, or toxicology in any major organ [250]. A similar study evaluating the
biocompatibility of intravenously administered Nb2C MXene also found no measurable
toxicity in mice [239]. One factor contributing to the lack of toxicity when MXenes are
administered intravenously is the fact that MXenes have been shown to be biodegradable
[239], [245], [264]. Thus, they do not accumulate in tissues as micron-sized particles, but
rather break down into small molecules such as TiO2 (from Ti3C2 MXene) which can be
cleared from the body. In addition to the intravenous studies, a series of acute toxicity,
locomotion, and neurotoxicity assays performed in a zebrafish embryo model indicated that
Ti3C2 could be classified within the “practically nontoxic” group according to the Acute
Toxicity Rating Scale by the Fish and Wildlife Service [265]. Several studies have also found
little evidence of cytotoxicity for cells cultured with MXenes [251], [263], [266]. While more
systematic evaluations are needed, these and other studies indicate that MXenes are safe and
biocompatible.
Finally, it is important to note here that MXenes suffer from limited stability in
physiologic conditions, where oxidation causes degradation of the MXene flakes [267], [268].
This is advantageous in applications where biodegradation is desired, but it becomes a
challenge when the MXene is instead part of a system or device where long-term function
inside the body is preferable, such as for chronically implanted neural electrodes. In just the
past few years, however, significant progress has been made toward improving the oxidation
stability of MXenes [226], [269]–[271]. Thus, it is possible that MXenes may be viable for use
in long-term implantable devices in the near future.
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4.2.3 Patterning methods
Interest in using MXenes in electronic devices has exploded in the past few years. One
of the primary challenges of incorporating MXene into devices has been achieving reliable
patterning of the material with high resolution. This challenge is mainly relevant when
devices require sub-millimeter spatial resolution. For example, in this thesis chapter I sought
to develop microscale neural electrodes using MXene, which required patterning the material
with spatial precision of ~5 µm. At the time, no method had yet been developed to allow
precise patterning of MXene at these resolutions. Thus, in this chapter I describe a method I
developed, which uses a selective lift-off process combining photolithography and reactive
ion etching (RIE) to form a polymeric shadow mask. In the years since, many advances have
been made and new methods for patterning MXene have been described, however the
method described in this thesis chapter still appears to offer the highest spatial resolution to
date.
One of the most common methods of patterning MXene is ink-jet printing. Several
studies have focused on tuning the rheological properties of MXene-based ink to push the
limits of ink-jet printing resolution [272]–[274]. Of these, the highest resolution reported is
~40 µm [272]. Another interesting patterning method demonstrated by B. Lyu et al. is the use
of UV/ozone treatment of a substrate with an overlaid shadow mask to render the substrate
selectively hydrophilic [275]. Subsequent dip-coating in MXene ink resulted in selective
wetting in the patterns exposed through the shadow mask in order to form organic fieldeffect transistors (OFETs) with MXene source and drain electrodes sized 1000 x 200 µm.
Another high-resolution patterning method which has been described is micro-contact
printing using PDMS stamps with 20 µm-wide alternating grooves and ridges [263].
A few other interesting approaches which have been demonstrated for patterning
MXene include automated scalpel patterning, which can engrave thin MXene films with an
interspace resolution of 0.1-0.2 mm [276], laser cutting [277], and direct writing [278]. These
approaches give somewhat lower spatial resolution than those listed above, however they
represent highly scalable methods suitable for producing devices where micron-scale
resolution is not needed.
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4.3 Preparation and characterization of Ti3C2 MXene for neural
electrodes
We synthesized Ti3C2 MXene by selectively etching the aluminum atomic layers from
its ternary carbide MAX phase precursor (Ti3AlC2) in aqueous hydrofluoric (−HF)/
hydrochloric (HCl) solution for 24 hours. After washing, intercalation and delamination was
performed using LiCl and several steps of centrifugation and re-suspension. After collecting
the supernatant containing well-dispersed single-layer Ti3C2 flakes, the solution was Argon
bubbled, and packaged in an Argon-sealed headspace vial to ensure longevity. This process
is outlined in Figure 4.3. This Ti3C2 solution could be used to spin-coat Si wafers on which
devices are fabricated. An overview of the process flow from Ti 3C2 synthesis, through device
fabrication, to final application in neural signal recording is shown in Figure 4.4a, along with
the atomic structure of Ti3C2. The atomic model shows the –OH termination for simplicity,
however the MXenes produced for this study have a distribution of –F, –OH, and –O
terminations. We characterized the Ti3C2 MXene by scanning electron microscopy (SEM),
dynamic light scattering, and UV-vis spectroscopy. SEM of Ti3C2 flakes deposited on a porous

Figure 4.3 Schematic depicting MXene synthesis procedure. (a) Ti3AlC2 MAX is added to a
selective etchant solution (HF, HCl, and DI H2O), resulting in the removal of aluminum (Al). (b) After
washing the etching solution to neutral pH using DI H2O, multilayered Ti3C2 is obtained. Multilayered
Ti3C2 is intercalated with Li+ from an aqueous solution of lithium chloride (LiCl). (c) After washing
the intercalation reaction, sediment swelling is observed representing the exchange of Li+ with H2O.
Agitation of the swollen sediment results in exfoliated (or delaminated) single- to few-layer flakes of
Ti3C2 MXene in H2O. Size selection and separation of delaminated Ti3C2 MXene from multilayered
Ti3C2 and Ti3AlC2 MAX phase occurs at this stage. (d) Ti3C2 MXene ink is transferred via syringe to
an Argon sealed headspace vial for long-term storage.
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alumina membrane from the MXene colloidal solution reveals flake-like morphology and µmscale lateral size (Figure 4.4b). Single-layer MXene flakes have a thickness of ~ 1 nm and
lateral sizes in the range of a few hundred nm to few microns, depending on the synthesis

Figure 4.4 Synthesis, characterization, and application of Ti3C2 for neural recording. (a)
Schematics illustrating synthesis and atomic structure of Ti3C2, fabrication of Ti3C2 neural
microelectrode arrays, and application of Ti3C2 arrays for recording brain activity at different
locations in the rat brain. (b) SEM image of Ti3C2 flakes deposited onto an alumina membrane. The
arrows point to Ti3C2 flakes on the membrane. (c) Dynamic light scattering particle size intensity
distribution (percent) of the Ti3C2 solution in terms of hydrodynamic size (d, nanometer) (d) UV−vis
absorption spectra of the Ti3C2 aqueous solution diluted 1000×. (e, f) Schematics and bright-field
microscopy image of (e) Ti3C2 micro-ECoG array and (f) Ti3C2/Au intracortical electrode array.
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process [224]. For application to neural electrodes, flakes with large lateral size are
preferable because they produce films with higher conductivity [224]. Thus, we disperse the
Ti3C2 flakes in solution by manual agitation rather than sonication, as it is gentler and
produces samples with larger flakes. To determine the distribution of flake sizes in our
sample, we performed dynamic light scattering on a dilute Ti3C2 solution. The intensity
distribution reveals a Z-average of 1406 ± 77 nm, a polydispersity index of 0.390, with three
noticeable peaks located at 1.6 μm (81.1%), 6.8 μm (16.8%) and 164 nm (2.1%), indicating
the percent intensity of different sized flakes (Figure 4.4c). Finally, to confirm the
composition of the Ti3C2 aqueous dispersion, we performed UV-vis spectroscopy from 2001000 nm. The material in solution absorbed light at the characteristic UV-vis-NIR
wavelengths for Ti3C2, showing high UV absorption and a broad peak from 760-800 nm
(Figure 4.4d).

4.4 Development of Ti3C2 MXene neural electrode arrays
4.4.1 Fabrication optimization
To evaluate the performance of Ti3C2 as a bioelectronic material for recording neural
activity at different spatiotemporal scales, we designed two different electrode array
geometries. The first electrode array is a 3x3 micro-electrocorticography (micro-ECoG) array
consisting of 50 µm x 50 µm square electrode contacts with 300 µm pitch, covering a total
recording area of 750 µm x 750 µm, for recording field potentials from the cortical surface
(Figure 4.4e). We fabricated micro-ECoG arrays of both gold and Ti3C2 contacts for
comparison. The second electrode array is a 10-channel laminar array with pairs of 25 µmdiameter Ti3C2 and Au contacts arranged in a side-by-side “stereotrode” configuration (i.e.
close enough that each electrode in a pair could plausibly record from the same neurons)
(Figure 4.4f) [279]. This configuration enables recording the spiking activity of individual
neurons within deeper brain structures and allows direct comparison of the signals recorded
by the two types of electrode materials.
Unlike most carbon-based nanomaterials, the surface of Ti 3C2 is inherently
hydrophilic due to the surface terminations present, thus enabling dispersion in aqueous
solution without the need for surfactants or strong acids. This property is particularly
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favorable for developing high-throughput microfabrication processes and patterning highquality Ti3C2 films onto flexible, biocompatible polymeric substrates. To precisely and
reliably micropattern Ti3C2 recording contacts and interconnects on flexible parylene-C
substrates, we developed and optimized an ad-hoc spin-coat and dry lift-off technique, similar
to previously-reported techniques for micropatterning thin films of organic polymers such as
PEDOT:PSS [280]. Briefly, we applied an antiadhesive layer to the wafer, followed by a
sacrificial parylene-C layer. Patterns in this sacrificial layer were defined by photolithography
and etched by oxygen plasma reactive ion etching (RIE). Then, we spin-coated the Ti 3C2
colloidal solution onto the wafer, thoroughly dried it, and peeled up the sacrificial parylene
layer to leave Ti3C2 films behind only in the patterns that had been etched through the
sacrificial layer. Using this technique, we were able to pattern Ti 3C2 features with high fidelity
and reproducibility. A detailed description of the fabrication procedure outlined in the
Methods section of this chapter (Section 4.8), and a schematic of the procedure is shown in
Figure 4.5.
It is worth noting that we designed the devices such that Ti3C2 contacts and traces
overlapped with gold traces outside of the electrode array, so that Ti 3C2 was the sole material
comprising the electrode contact and exclusively responsible for the device’s impedance and

Figure 4.5 Fabrication of multi-channel Ti3C2 neural electrodes. Fabrication process: pattern
metal traces and connection pads on bottom parylene-C layer; deposit an anti-adhesive layer (1%
Micro 90) and a sacrificial parylene-C layer; use photolithography and oxygen plasma RIE to pattern
the sacrificial parylene-C layer; spin coat Ti3C2 and thoroughly dry the film; peel up the sacrificial layer,
leaving Ti3C2 patterns behind; deposit top parylene-C layer; use photolithography and oxygen plasma
RIE to pattern and etch open electrode and Au bonding pad contacts; release completed device from
wafer.
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recording performance. To provide adequate mechanical strength for precise insertion of the
intracortical arrays into the brain along a straight trajectory, we manually aligned and affixed
micromachined steel backings to the parylene substrate with a thin layer of
polydimethylsiloxane (PDMS). Finally, for interfacing the devices with the data acquisition
systems, we connected the assembled devices to custom printed circuit boards (PCBs) via
zero insertion force (ZIF) connectors.
4.4.2 Characterization of Ti3C2 neural electrodes
We used electrochemical impedance spectroscopy (EIS) in a three-electrode
configuration to characterize the electrochemical behavior of the electrode-electrolyte
interface (Figure 4.6a). At the 1 kHz reference frequency, the 50 µm x 50 µm Ti3C2 and Au
micro-ECoG electrodes show impedance values of 52 ± 25 kΩ and 206 ± 31 kΩ, respectively,
while the impedance of 25 µm diameter Ti3C2 and Au intracortical electrodes is 219 ± 60 kΩ
and 865 ± 125 kΩ, respectively (Figure 4.6b) (Student’s t-test, p < .001). In both cases, Ti3C2
electrodes exhibit roughly 4-fold lower impedance than comparable Au contacts, showing an
advantage in utilizing Ti3C2 as the active material. The Ti3C2 electrodes exhibit a more
complex phase behavior than the Au electrodes, which display predominantly capacitive
behavior (Figure 4.6a). It has been well established that Ti3C2 exhibits mainly capacitive
charge transfer mechanisms [281], [282], and the roughness and porosity of the film
contributes to its behavior as a non-ideal capacitor, as shown by the higher values of the
impedance phase. Furthermore, the functional groups on the surface of the Ti 3C2 flakes can
interact with the ionic species in the electrolyte, possibly leading to mixed charge-transfer
mechanisms.
One attribute that can reduce electrode impedance is the overall surface roughness
or porosity, which produces an increase in the effective surface area without impacting the
device footprint. We evaluated the surface morphology of the Ti 3C2 electrodes with SEM and
atomic force microscopy (AFM) and found that the electrode surface is comprised of a dense
network of overlapping Ti3C2 flakes (Figure 4.6c) of nanoscale thickness and several µm in
lateral size. AFM mapping of the surface further elucidates the rough and wrinkled
morphology and reveals an average surface roughness of 32 nm (Figure 4.6d). The thickness
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of the Ti3C2 films forming the electrodes, as measured by a profilometer following lift-off
patterning, is 200 ± 30 nm. The rough surface morphology we observe suggests that ions can
interact with the Ti3C2 electrodes over a large effective surface area, likely contributing to
their remarkably low impedance compared to metal electrodes.

Figure 4.6 Characterization of Ti3C2 neural electrodes. (a) Bode plots of impedance magnitude and
phase for comparable Ti3C2 and Au micro-ECoG electrodes. Points represent means, and bars show
standard deviations; Ti3C2 n = 10 and Au n = 10. (b) Scatter plots of 1 kHz impedance values for Ti3C2
and Au electrodes in micro-ECoG and intracortical electrode arrays. Micro-ECoG electrodes are 50 μm
× 50 μm, and intracortical electrodes are 25 μm in diameter. For both types of electrode arrays, Ti3C2
shows a ∼4× reduction in impedance compared to Au. Black bars indicate means. Micro-ECoG: Ti3C2 n
= 18 and Au n = 18. Intracortical: Ti3C2 n = 19 and Au n = 19. Single asterisks indicate p < 0.001 (c) SEM
images of Ti3C2 electrodes. Individual Ti3C2 flakes are visible on the electrode surface. (d) AFM surface
mapping showing the rough surface morphology of a Ti3C2 electrode.

4.5 In vivo neural recording with Ti3C2 MXene neural electrode
arrays
4.5.1 Cortical surface recording
To assess the functionality of Ti3C2 neural electrodes in vivo, we performed acute
recording experiments in rats under ketamine-dexmedetomidine anesthesia. Schematic of
the recording setup for both the brain surface (micro-ECoG) and the brain-penetrating
(intracortical) arrays are shown in Figure 4.7a. First, we tested Ti3C2 and Au micro-ECoG
devices placed over sensorimotor cortex (Figure 4.7a, left). On both electrodes, we detected
91

Chapter 4: High-resolution neural interfaces using Ti 3C2 MXene

Figure 4.7 In vivo neural recordings with Ti3C2 MXene electrodes. (a) Schematic of in vivo neural
recording with Ti3C2 electrode arrays. (b) Raw signals obtained from a Ti3C2 micro-ECoG device. (c)
Power spectral density of micro-ECoG signals showing physiologic peaks for 1−2Hz slow oscillations
and 40−70 Hz γ oscillations. (d) γ-triggered average showing γ oscillations coupled to the up phase of
the slow oscillation. (e) Action potentials (spikes) recorded extracellularly in rat hippocampus. Noise
in the spike frequency band (500−5000 Hz) was 4.67 μVrms. (f) Overlaid spike waveforms (N = 580)
from a 200 s recording. (g) Interspike intervals had a bimodal distribution. The neuron tended to fire
rhythmically at 1 to 2 Hz with bursts of 2 spikes separated by about 10 ms. (h) The full bandwidth
(0.5−5000 Hz) recording revealed that the rhythmic spiking was related to a slow oscillation in the
field potential. Red lines indicate spike times corresponding to E. (i) Spike-triggered average showing
that the spikes were locked to the rising phase of the slow oscillation. (j) Power spectrum of the full
bandwidth recording with a physiological peak at 1.5 Hz.
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clear physiological signals (Figure 4.7b). However, the background noise level in the spike
band (500 – 5000 Hz) was lower in the Ti3C2 recordings than in the Au recordings: 3.7 ± 0.3
µVrms vs. 6.6 ± 2.0 µVrms, respectively. The power spectral density (PSD) of the recorded
signals confirmed the presence of two brain rhythms commonly observed in rats under this
type of anesthesia: slow oscillations at 1-2 Hz and gamma oscillations at 40-70 Hz (Figure
4.7c). These two rhythms were, in fact, coupled, as revealed by computing the signal average
in a window centered on gamma oscillation events (Figure 4.7d). Gamma bursts occurred on
average at a specific phase, namely the peak, of the slow oscillation as reported previously
with traditional metal electrode recordings [283], [284]. Thus, the Ti3C2 electrode surface
recordings reproduced known physiology in this brain state and with lower noise than Au
electrodes.
4.5.1 Intracortical recording
Next, we inserted electrode arrays intracortically to record neuronal action potentials
(spikes). The 10-channel intracortical arrays were composed of both Ti3C2 and Au electrodes
(Figure 4.7a, right). Examples of the neural activity recorded from a Ti3C2 contact are shown
in Figure 4.7e,f. The neuron recorded on this Ti3C2 electrode tended to fire rhythmically at a
low frequency (<5 Hz), but with bursts of spikes in each cycle (Figure 4.7e,g). The full
bandwidth recording revealed that the rhythmic spiking of this cell was related to the slow
oscillation in the field potential (Figure 4.7h). As with gamma oscillations recorded at the
brain surface, spikes from this neuron were biased to occur at a particular phase of the
rhythm (Figure 4.7i), which again had a frequency of 1-2 Hz (Figure 4.7j). Although these
results demonstrate the functionality of intracortical Ti 3C2 electrodes, we next pursued the
more critical question of how they perform relative to the Au electrodes.
The intracortical array was designed such that each pair of Ti3C2 and Au electrodes
was arranged as a stereotrode, with contacts separated by 35 µm. This configuration allows
the direct comparison of the signal recorded with the two types of electrodes at different
depths in the sensorimotor cortex (Figure 4.8a). Spiking activity was observed
predominantly on the distal three pairs of electrodes (Figure 4.8b). Spikes that occurred
simultaneously on adjacent Ti3C2 and Au electrodes in a pair were considered to be generated
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Figure 4.8 Comparison of in vivo signal recorded on Ti3C2 and Au electrodes intracortically. (a)
Schematics of an intracortical electrode array with five Ti3C2/Au stereotrode pairs. The array was
inserted into the cortex and advanced in approximately 500 µm steps to a depth of 2 mm while
recording. (b) Multiunit spiking activity observed on the distal three pairs of electrodes in the array at
three different recording depths. Spikes that were observed simultaneously on adjacent Ti3C2 and Au
contacts are indicated by blue dots. Spikes unique to a given electrode are indicated by orange dots.
(c) Histogram of SNRMXene – SNRAu for the common spikes on the adjacent electrodes outlined in blue
boxes in (b). In all cases the distribution mean was significantly greater than zero (permutation tests,
p < 0.001), indicating higher SNR on Ti3C2 contacts compared to Au. (d) Number of unique spikes seen
on adjacent Ti3C2 and Au electrodes. In all cases, more unique spikes were observed on Ti3C2 contacts,
indicating these electrodes were more sensitive for recording unit activity than Au electrodes.

by the same neuron. For each of these “common spikes,” we computed the SNR from each
electrode. The mean of the distribution of SNRMXene – SNRAu was, at all three depths, greater
than zero (permutation test, p < .001), indicating that spikes recorded on the Ti 3C2 electrodes
had higher SNR than those on the Au electrodes (Figure 4.8c). Additionally, Ti3C2 electrodes
recorded more “unique spikes”, or spikes that occurred only on one electrode in the pair
(Figure 4.8d). These unique spikes had lower amplitudes than the common spikes and
therefore may have arisen from neurons located further from the electrode sites. This result
suggests that, due to their lower impedance, the Ti3C2 electrodes have a larger “seeing
distance”, allowing them to resolve spiking activity from a larger volume of tissue.
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Finally, we quantified the power spectrum of the wideband neural signal recorded on
representative Ti3C2 and Au electrodes in the array (Figure 4.9). The Ti3C2 electrode
recorded higher overall power across a wide range of frequencies. Additionally, a significant
peak at 60 Hz was observed on the Au electrode, while this peak is completely absent on the
adjacent Ti3C2 contact, which indicates that the higher impedance Au electrodes are more
susceptible to mains interference.

Figure 4.9 In vivo noise characteristics. (a) Wide band power spectral density from representative
Ti3C2 and Au electrodes from the intracortical array. (b) A significant peak in power at 60 Hz,
attributed to mains noise, was seen on Au electrodes but was not observed on Ti3C2 electrodes. (c,d)
Ti3C2 electrodes recorded higher power across a broadf range of frequencies, including 1-10 Hz delta
and theta rhythms (c) and 35-45 Hz gamma rhythms (d).
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4.6 Neuronal biocompatibility of Ti3C2 MXene
MXenes have shown great promise in a number of biomedical applications including
cancer theranostics [242], diagnostic imaging [285], and biosensing [249]. Recent studies
report that MXenes are biocompatible to immortalized tumor cell lines in vitro and at the
systemic level when injected intravenously in vivo [236], [250]. However, very little is known
about the safety and compatibility of MXenes to neuronal cells. Thus, we performed

Figure 4.10 Biocompatibility of Ti3C2 MXene films. Representative phase images of primary cortical
neurons cultured on (a) polystyrene and (b) 200 nm-thick Ti3C2 films at 7 DIV. (c) Quantitative
comparison shows no significant difference in neuronal survival on Ti3C2 or polystyrene (p>0.6). (d-i)
Representative multiphoton images of neurons cultured on Ti3C2 at 7 DIV stained for nuclei (blue),
axons (red), and synapses (green). Outlined region in (d) is shown in (e-g); outlined region in (g) is
shown in (h-i), highlighting network formation as confirmed by the presence of synapsin-positive
puncta along axons and cell bodies (arrows). Scale bars: 100 µm (a, b, d), 50 µm (g), 25 µm (i).
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cytotoxicity studies in vitro on primary cortical neurons grown on Ti3C2 films. At 7 days in
vitro (DIV), quantification of the percent viable neurons showed no significant difference in
cell survival between Ti3C2 and control polystyrene cultures (Ti3C2: 84.4 ± 4.40%,
polystyrene: 87.3 ± 2.05%; p > 0.64) (Figure 4.10a-c). Cell densities on Ti3C2 at 7 DIV were
significantly sparser than those on polystyrene (Ti3C2: 650 ± 155 neurons/mm2, polystyrene:
1132 ± 132 neurons/mm2; p < 0.05), suggesting additional surface treatments may be
required to promote neuronal adhesion. Although there was also a reduction in overall
neurite density on the Ti3C2 cultures, there were no significant differences in neurite
outgrowth per neuron (Ti3C2: 5.73 ± 1.05 neurites per neuron, polystyrene: 6.00 ± 0.737
neurites per neuron; p > 0.8). Immunocytochemistry revealed widespread network
formation on both substrates (Figure 4.10d-i), with neurons extending branching neurites
(Figure 4.10e,h) and synapsin-positive puncta present surrounding cell bodies and at axonsoma junctions (Figure 4.10f,i).
Overall, neurons reproducibly adhered, grew, and formed neuronal networks on both
Ti3C2 and polystyrene, with both substrates yielding equivalent neuronal viability and neurite
outgrowth per neuron out to at least 7 DIV. These results indicate that Ti 3C2 is capable of
supporting neuronal growth and network formation with negligible cytotoxicity relative to
established cell culture substrates. While both cultures exhibited similar neurite counts per
neuron and axonal/synaptic presence at 7 DIV, Ti3C2 cultures had a reduction in both neuron
density and a commensurate reduction in neurite outgrowth compared to polystyrene. These
results suggest decreased neuronal adhesion on Ti3C2 compared to polystyrene, which
indicates further optimization of the pre-treatment protocol used to culture neurons and
promote neuronal adhesion and neurite growth on Ti 3C2 films is necessary.

4.7 Discussion
In this study, we developed a protocol for fabricating high-resolution Ti 3C2 MXene
neural electrode arrays using simple, scalable solution processing methods. The methodology
described here can easily be extended to create other types of MXene sensors, and the
extraordinary processability of MXenes highlights the potential for cost-effective production
of MXene biosensors at industrial scales, which is not currently possible for devices based on
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other carbon nanomaterials. The high conductivity of Ti 3C2, coupled with the high effective
surface area of MXene films, endows Ti3C2 neural electrodes with remarkably low impedance,
which improves their sensitivity for recording neural activity at fine spatial scales.
Recordings from Ti3C2 micro-ECoG devices showed known physiologic signatures with lower
baseline noise than control Au electrodes. Using high-resolution intracortical arrays, we
demonstrated that Ti3C2 electrodes record multiunit neuronal spiking activity with improved
SNR compared to gold electrodes. Additionally, our observation that Ti3C2 electrodes
recorded overall a larger number of spikes, many of which were low-amplitude, suggests that
these electrodes are capable of recording from a larger volume of brain tissue. Thus, Ti 3C2
micro-electrodes may represent a significant advance for the sensitive detection of neuronal
spiking activity compared to conventional silicon or metal-based micro-electrodes.
Furthermore, our observations suggest that Ti3C2 could be useful for a range of implantable
sensors beyond neural recording applications, such as cardiac monitoring, and it may be a
candidate to replace expensive electrode materials, such as platinum, currently used in many
implantable devices. Finally, though the biocompatibility of Ti3C2 has been demonstrated
following systemic injection for cancer theranostic applications, the compatibility of this
material to neurons and brain cells has so far remained largely untested. Our work shows
that not only do neurons remain viable in contact with Ti 3C2, but that they also extend
neurites and form functional networks when cultured on Ti 3C2 films. While more work needs
to be done, our experiments indicate that Ti3C2, and possibly other MXenes, have significant
potential to transform the field of implantable sensors in both research and clinical
applications. The promising bioelectronic properties and versatility in fabrication of Ti 3C2
MXene may both reduce cost and improve performance in current and future medical
devices.

4.8 Materials and methods
Preparation of Ti3C2 colloidal solution
Ti3AlC2 MAX phase carbide powder synthesis has been explained elsewhere [232]. 5 g of
Ti3AlC2 was added slowly to a chemical etchant (50 mL, 12 M HCl (Alfa Aesar), deionized (DI)
water, 49 % HF (Sigma-Aldrich), 6:3:1 ratio) while it was in an ice bath and was agitated on
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a stir plate (24 h, 500 rpm, 25 °C, Teflon stir bar) in an unsealed container to make multilayer Ti3C2 MXene (ML-MXene). The solution was then centrifuged (2 minutes, 3500 rpm, ~6
cycles) in 2 large tubes (175 mL) to reach ~6 pH. An intercalant was used to delaminate Ti 3C2
into single flakes by mixing 10 grams lithium chloride (LiCl, Alfa Aesar) and 100 mL DI water
in an ice bath 30 minutes prior to adding the ML-MXene. After adding Ti 3C2, the solution was
manually shaken until small bubbles appeared on the side of the container (~15 min) and the
solution was stirred on a stir plate (at least 4 h at 300 rpm). The solution was then centrifuged
(3500 rpm, 2 cycles, 2 min) in 2 large tubes to cause the sediment to swell. Next, the sediment
was evenly dispersed and centrifuged (3500 rpm, 1 hr, 2 cycles) in 4 150-mL tubes, Finally,
to remove insoluble contaminates from the single flake and ML-MXene, the sediment was
dispersed (10 minutes manual hand shaking) in 300 mL DI water in 2 150-mL tubes and
centrifuged (500 rpm, 2 minutes). The resulting supernatant was centrifuged at 10000 rpm
for 15 minutes in 6 small tubes (50 mL) and the sediment (with concentration of 10 mg/mL)
was collected. Prior to spin coating, the Ti3C2 solution was dispersed for centrifugation (3500
rpm, 2 minutes) in 2 small tubes and the supernatant was collected to be used for spin
coating. The concentration of Ti3C2 in the supernatant was measured (~10 mg/mL) by
vacuum filtration of the solution (1 mL) on a hydrophobic Celgard membrane.
Characterization of Ti3C2 flakes
As-prepared Ti3C2 was characterized by SEM, dynamic light scattering, and UV-vis
spectroscopy. Scanning electron microscopy was performed using a Zeiss Supra 50 VP (Zeiss,
Germany) at an accelerating voltage of 5 kV by vacuum filtering a dilute (~0.01 mg/mL)
solution over a porous alumina membrane (Anodisc, 0.1 μm pore size, Whatman). Dynamic
light scattering was performed using a dilute Ti3C2 solution (<0.1 mg/mL) in a polystyrene
disposable cuvette (Malvern Instruments, Zetasizer, NanoZS). The measurement was
repeated 5 times and an average was reported (Figure 1C). UV-vis spectroscopy was
conducted from 200-1000 nm on a Ti3C2 solution diluted 1000x (ThermoScientific Evolution
201).
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Device Fabrication and Assembly
A silicon wafer was coated with a 4 µm-thick layer of parylene-C. Metal traces and pads
(Ti/Au = 10/100 nm) were patterned using standard photolithography and lift-off processes.
The wafer was coated with an anti-adhesive layer (1% Micro-90), then a second, 3 µm thick
sacrificial layer of parylene-C was deposited. Patterns for MXene traces and electrode
contacts were defined by photolithography with the negative resist NR71-3000p and
subsequent oxygen plasma reactive-ion etching (RIE) to etch through the sacrificial paryleneC layer. A Ti3C2 colloidal solution was spin-coated on the wafer and the wafer was
subsequently baked at 130 °C for 3 hrs to ensure that the resulting Ti 3C2 film was fully dried.
A 50 nm-thick layer of SiO2 was deposited by e-beam evaporation to serve as a protective
mask on the Ti3C2 patterns during subsequent fabrication steps. The sacrificial parylene-C
layer was then manually peeled up with tweezers, leaving behind Ti 3C2/SiO2 only on the Ti3C2
contacts and traces previously defined. After deposition of a top 4 µm-thick parylene-C
encapsulation layer, an etch mask was defined through photolithography, e-beam deposition
of aluminum (100 nm), and lift-off to define the outline of the devices, and openings over Au
bonding pads and electrode contacts. The exposed parylene-C was etched with oxygen RIE,
and the Al etch mask was subsequently removed via wet etching. The SiO2 protective layer
covering the Ti3C2 contacts was etched with 1:6 buffered oxide etchant (BOE: 6 parts 40%
NH4F, 1 part 49% HF, Sigma-Aldrich) to expose the Ti3C2 electrode sites. Finally, the
completed devices were released from the silicon wafer. Both micro-ECoG and intracortical
electrode arrays were fabricated using this procedure, with different photomasks to define
the geometries. Steel backings (2.5 µm thick) were laser-micromachined (IPG IX280-DXF
Green Laser Micromachining, 532 nm) to provide mechanical support for insertion of the
intracortical arrays. Devices were carefully aligned and manually fixed to these steel backings
using polydimethylsiloxane (PDMS) as an adhesive. Both micro-ECoG devices and steelbacked intracortical array devices were inserted into zero-insertion force (ZIF) connectors
on custom printed circuit boards for connection to the data acquisition systems for in vitro
characterization or in vivo neural recording.

100

Chapter 4: High-resolution neural interfaces using Ti 3C2 MXene

Electrochemical Impedance Spectroscopy
EIS of Ti3C2 and Au microelectrodes was performed with a Gamry Reference 600 potentiostat
(Gamry Instruments) in a phosphate buffered saline (PBS) bath pH 7.4 at room temperature.
EIS measurements were collected using a three-electrode configuration with Ti 3C2 or Au
microelectrodes as the working electrode, a graphite rod (Bio-Rad Laboratories, Inc.) as the
counter electrode, and a Ag/AgCl (Sigma Aldrich) electrode as the reference electrode.
Measurements were acquired by applying a 20 mV rms sinusoidal voltage input in the 1 Hz –
1 MHz range.
Electrode Surface Morphology Characterization
SEM images (Zeiss Supra 50VP) were taken with an accelerating voltage of 5 kV. AFM surface
mapping (Bruker Dimension Icon AFM) was performed in tapping mode in air and data were
analyzed in NanoScope Analysis software (Bruker).
Animal Surgery and In Vivo Recording
In vivo neural recordings were collected from n = 3 Sprague-Dawley rats during acute, sterile
procedures. Rats were anesthetized with a solution of ketamine (60 mg/kg) and
dexmedetomidine (0.25 mg/kg) and placed in a stereotaxic frame. The right somatosensory
cortex was exposed with a craniectomy and durotomy. Skull screws were placed in the left
parietal and frontal bones around which Ag wires were wrapped to serve as the reference
and ground for the recordings. The electrode arrays were mounted on a stereotaxic
manipulator, positioned over the exposed cortex, and lowered. Ti3C2 and Au micro-ECoG
arrays were placed over barrel cortex successively and recordings from each were collected
in 5-minute segments. For intracortical Ti3C2 /Au arrays, recordings were made at a number
of depths throughout the cortex to sample neural activity. The wideband neural signals (1 Hz
to 7.5 kHz) were acquired at 30,000 sample/s by an electrophysiology system (Intan
RHS2000 Stimulation/Recording System, Intan Technologies). All procedures were approved
by the Institutional Animal Care and Use Committees at the University of Pennsylvania and
adhered to the guidelines set forth in the NIH Public Health Service Policy on Humane Care
and Use of Laboratory Animals (2015).
101

Chapter 4: High-resolution neural interfaces using Ti 3C2 MXene

In Vivo Data Analysis and Statistical Methods
For multiunit analysis, signals were band-pass filtered from 300-6000 Hz (2nd order
Butterworth). The standard deviation of the background noise for each channel was
estimated as
𝜎 = 𝑚𝑒𝑑𝑖𝑎𝑛

|𝑥|
0.6745

and spikes were detected by setting a threshold of 5𝜎 [286]. Spikes observed on both the
Ti3C2 and Au electrode in a stereotrode pair were assumed to have been generated by the
same neuron, and classified as “common spikes”, if they occurred within 0.1 ms of each other.
All remaining spikes were classified as “unique spikes”. To compare signal quality, the SNRs
for each common spike were computed from the signals observed on the Ti3C2 and Au
electrodes in the stereotrode pair and subtracted. A permutation test was then performed to
test if the mean of the resulting distribution was centered around zero.
Cell Culture Substrate Preparation
Glass slides coated with Ti3C2 were soaked in 70% ethanol for 20 minutes. Slides were then
rinsed in sterile cell culture water before exposing each side to UV light for 30 minutes (1 hr
total exposure). Post-UV, slides were immersed in Poly-L-lysine (PLL) (0.05 mg/mL in sterile
cell culture water) overnight. Slides were then rinsed in sterile cell culture water before being
immersed in laminin (20 µg/mL in sterile cell culture water) overnight prior to neuronal
plating. For control cultures, polystyrene petri dishes were coated in PLL and laminin using
the same protocol.
Cortical Neuron Isolation and Culture
All procedures were approved by the Institutional Animal Care and Use Committees at the
University of Pennsylvania and the Michael J. Crescenz Veterans Affairs Medical Center and
adhered to the guidelines set forth in the NIH Public Health Service Policy on Humane Care
and Use of Laboratory Animals (2015). Neural cell isolation and culture were performed
following protocols previously published [287]. Briefly, timed-pregnant rats were
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euthanized, and embryonic day 18 fetuses were removed from the uterus and transferred to
cold Hank’s balanced salt solution (HBSS). Post-removal, the fetus brains were extracted and
the cerebral cortical hemispheres isolated under a stereoscope via microdissection. Cortical
tissue was dissociated in 0.25% trypsin + 1mM Ethylenediaminetetraacetic acid (EDTA) at
37˚C, after which the trypsin/EDTA was removed and replaced with 0.15 mg/ml DNase in
HBSS. Dissociated tissue + DNase was centrifuged for 3 min at 3000 RPM before the DNase
was removed and the cells re-suspended in neuronal culture media, composed of
Neurobasal® + B27® + Glutamax™ (ThermoFisher) and 1% penicillin-streptomycin. Neurons
were diluted to ~1.5 x 106 neurons/ml. 200 µL from the primary cortical neuronal
suspensions were plated on each of the Ti3C2 slides and control dishes within 2 mL of
neuronal culture media and grown under standard cell culture conditions (37˚C, 5% CO 2).
Half-media changes were performed every 2 days, with phase images taken using a Nikon
Eclipse Ti-S microscope paired with a QIClick camera and NIS Elements BR 4.13.00.
Neuronal Viability Assessment
To assess culture viability, phase images of Ti3C2 slides (n = 6) and control cultures (n = 6)
were taken at 7 days in vitro (DIV). Neurons within a randomly identified 0.5 mm2 area were
manually scored as either live or dead, depending on their morphology (i.e. presence and
integrity of neurites; cell body). Neuronal survival was quantified as the proportion of live
neurons to total (live + dead) neurons, while cell density was calculated as the total number
of neurons per mm2. Each metric was averaged across Ti3C2 and polystyrene controls and
compared via unpaired t-test, with statistical significance identified as a p-value less than
0.05. All data presented as mean ± s.e.m.
Immunocytochemistry
At 7 DIV, Ti3C2 slides (n = 6) and control cultures (n = 6) were fixed in 4% formaldehyde for
35 min. Fixed cultures were rinsed in 1x PBS and permeabilized with 0.3% Triton X100 + 4%
horse serum in PBS for 60 min before being incubated with primary antibodies overnight at
4˚C. Primary antibodies were Tuj-1/beta-III tubulin (T8578, 1:500, Sigma-Aldrich) to label
axons and synapsin-1 (A6442, 1:500, Invitrogen) to label pre-synaptic specializations. Post103

Chapter 4: High-resolution neural interfaces using Ti 3C2 MXene

incubation, cultures were rinsed in PBS before being incubated with fluorescently-labeled
secondary antibodies (1:500; sourced from Life Technologies & Invitrogen) for 2h at 18˚24˚C. Finally, Hoechst (33342, 1:10,000, ThermoFisher) was added for 10 min at 18˚-24˚C
before rinsing in PBS. Cultures were imaged on a Nikon A1RMP+ multiphoton confocal
microscope paired with NIS Elements AR 4.60.00 and a 16x immersion objective. Sequential
slices of 1-1.2 µm in the z-plane (nslices = 20) were acquired for each fluorescent channel. All
confocal images presented are maximum intensity projections of the confocal z-slices.
Neurite Measurement & Data Analysis
Multiphoton images from the immunocytochemistry performed above were imported into
ImageJ and processed using the open-source NeuriteQuant plugin. NeuriteQuant provided
quantitative estimates of neurites per cell from the multiphoton images. Neurites per cell
were averaged for both polystyrene and Ti 3C2 cultures, with unpaired t-tests used to compare
measurements. All data is presented as mean ± s.e.m.
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Technologies enabling the seamless integration of electronics with soft biological
tissues for mapping and modulating excitable networks at high resolution and at large scale
can enable paradigm-shifting diagnostics, monitoring, and treatment strategies. Realizing
such technologies has required significant innovation in both materials and fabrication
strategies to develop bioelectronic interfaces which are soft, biocompatible, and highly
conformable to the tissue of interest. Many of the most successful advances in this realm so
far have leveraged traditional metal and silicon materials along with thin-film
microfabrication strategies to create highly flexible and conformable bioelectronic interfaces.
While these thin-film technologies can achieve exquisite tissue conformability, they have
largely failed to translate into clinical and consumer markets because the materials and
fabrication schemes are expensive, do not scale, and they critically limit the maximum
attainable resolution and coverage. Solution processing is a cost-effective manufacturing
alternative, however biocompatible conductive inks matching the performance of
conventional metals have been lacking. In the previous chapter, I introduced Ti 3C2 MXene as
a solution-processable 2D material that showed excellent performance for neural recording
when incorporated into microelectrodes. Driven by the success of those MXene
microelectrodes, I next sought to expand Ti3C2 to human-scale translational neurodevices. In
this chapter, I introduce MXtrodes, a novel class of soft, high-resolution, large-scale
bioelectronic interfaces enabled by Ti3C2 MXene and scalable solution processing. I show that
the electrochemical properties of MXtrodes exceed those of conventional materials in both
epidermal and implantable use cases. In fact, MXtrodes do not require conductive gels for
epidermal sensing due to their exceptionally low interface impedance. I then validate
MXtrodes in a number of applications ranging from mapping large scale neuromuscular
networks in humans to delivering cortical microstimulation in small animal models. Finally,
I demonstrate that MXtrodes are compatible with standard clinical neuroimaging modalities.
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5.1 Introduction
Recent advances in soft materials and electronics have fueled a new generation of
bioelectronic technologies for medical diagnostics and therapeutics, healthcare monitoring,
and wearable devices [29], [112], [288], [289]. Soft and flexible bioelectronic devices
designed to safely and intimately interface with multiscale networks in the human body offer
paradigm-shifting opportunities for monitoring brain activity, cardiac health, and muscle
function, as well as for facilitating human-machine interactions, such as myoelectric control
of advanced prostheses [290]–[292] or non-invasive brain-computer interfaces [293]. Active
bioelectronic devices can also implement intelligent control strategies based on electrical
stimulation of excitable circuits for treating neurological diseases [23], [24], heart
arrhythmias [25], [26], and inflammatory disorders [27], [28], as well as for rehabilitation
therapies [294]–[296].
Despite significant progress in the field of soft, ultra-thin, and conformable
bioelectronics [54], [108], [120], [297], [298], conventional materials and fabrication
processes remain largely inadequate for producing large-scale, high-density multielectrode
arrays that can map and modulate activity in excitable tissues with high spatiotemporal
resolution over broad areas. For example, thin-film processing has enabled advances in ultrathin and flexible electronics; however, such processes rely on wafer-scale microfabrication
conducted in a cleanroom facility, which is time consuming, expensive, and typically limits
the maximum attainable area coverage to a few square centimeters [112]. Recent work has
demonstrated the possibility to overcome this size limit by implementing the fabrication
process on large-diameter wafers [120], but microfabrication techniques remain difficult to
scale and are still not cost-effective. Contributing to the manufacturing challenges is the fact
that flexible polymeric encapsulation materials require low-temperature processing below
their glass transition points and can also be incompatible with certain chemicals and solvents
commonly used in microfabrication. In addition to the processing constraints, conventional
bioelectronic materials – such as gold (Au), platinum (Pt), iridium (Ir), and silver/silverchloride (Ag/AgCl) – are both costly and intrinsically limited in their electronic, mechanical,
and chemical compatibility with biological tissues. For example, they present challenges in
achieving low electrode-tissue interface impedance, which is essential for high-fidelity
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recording and for safe, effective delivery of electrical stimulation. As a result, in applications
such as epidermal electronics, conventional Ag/AgCl electrodes typically require a
conductive gel at the skin interface to lower the impedance enough to acquire good quality
signal. The conductive gels pose a host of issues including skin irritation and impedance
instability as they dry out [115], [299]. Metal-based devices are also inadequate for coupling
with clinical imaging modalities such as magnetic resonance imaging (MRI), often causing
artifacts in the images even if they are considered MR safe. To realize the next generation of
soft, large-scale, high-density bioelectronic interfaces for human applications, innovation in
both materials and fabrication is needed.
Solution processing techniques, such as inkjet or screen printing, offer a scalable and
low-cost route for fabricating large-area multielectrode arrays unencumbered by the size
constraints of wafer-level methods. Despite these advantages, widespread adoption of such
techniques has so far been limited by the lack of conductive inks that can produce electrodes
with biocompatibility, flexibility, electronic conductivity, and electrochemical properties
comparable to those made with conventional materials. High conductivity can be achieved by
printing ink formulations based on metal nanoparticles, however, they typically require high
annealing temperatures which are not compatible with soft polymeric substrates [300],
[301]. Furthermore, metal inks raise concerns about potential toxicity [302]. Conducting
polymer-based inks, notably those using poly(3,4-ethylenedioxythiophene) doped with
poly(styrene sulfonate) (PEDOT:PSS), can be processed at ambient temperatures to generate
flexible, biocompatible films, but their conductivity is generally significantly lower than metal
films [303], [304]. Finally, graphene oxide (GO) inks require an additional reduction step to
be converted to the conductive reduced graphene oxide (rGO) form, which poses materials
and safety issues due to the high temperatures and toxic chemicals employed in the reduction
process [305]. Furthermore, the conductivity of rGO is still far inferior to that of pristine
graphene [306] and PEDOT:PSS films.
Transition metal carbides, nitrides, and carbonitrides (MXenes) have emerged as a
new class of two-dimensional (2D) nanomaterials that enable low-cost, additive-free,
solution processing and can produce biocompatible films with metallic conductivity. MXenes
are 2D flakes ~1 nm in thickness and up to 10s of µm in lateral size which contain abundant
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surface-terminating functional groups, including hydroxyl (-OH), oxygen (-O), or fluorine (F), which make them hydrophilic and also allow for versatile surface modification and
functionalization. The unique hydrophilic nature of MXenes enables a wide range of safe,
high-throughput, and scalable processing methods using simple water-based inks, including
spray [307], spin [308], and dip coating [309], direct writing [278], and inkjet printing [274],
[278]. Of the large variety of MXenes that have been synthesized to date, Ti 3C2 (the chemical
formula is often written as Ti3C2Tx to account for the surface terminations, Tx) has been the
most widely studied and optimized MXene. It is made of Earth-abundant elements and no
cytotoxicity has been observed in previous studies [250]. In the past few years, Ti 3C2 has
attracted great attention for a number of biomedical applications [310], including cancer
theranostics [236], hemodialysis [255], and wearable mechanical sensors [256], [311]. Our
group has pioneered the use of Ti3C2 for implantable neural microelectrodes [312], [313] and
skin-conformable, thin-film wearable sensors [314]. Ti3C2 has metallic behavior exhibiting
electronic conductivity of up to 15,000 – 20,000 S/cm, higher than all other solutionprocessed 2D materials [226], [246]. Additionally, MXenes are produced using a top-down
selective etching procedure which is highly scalable compared to the bottom-up techniques
such as physical and chemical vapor deposition required to synthesize many other
nanomaterials [231]. Additional background on MXenes can be found in Section 4.2 of this
thesis.
In this work, we demonstrate a new class of flexible, multichannel, high-density
bioelectronic interfaces – which we have named “MXtrodes” – that are capable of both highfidelity recording and effective stimulation of neural and neuromuscular circuits at multiple
scales. The key value of the work presented here rests on a series of advances: first, we
leverage the excellent processability of Ti3C2 MXene to develop a rapid, low-cost, and highly
scalable method for fabricating multichannel electrode arrays of arbitrary size and geometry.
This process is conducive to industrial manufacturing, and paves the way for translating
MXene bioelectronics into clinical and consumer markets. Second, we report the first
comprehensive study of the electrochemical properties of Ti 3C2 relevant for recording and
stimulation of bioelectric circuits. We show that the electrochemical behavior of Ti 3C2 is
comparable, and in many aspects superior to, conventional bioelectronic materials, especially
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in the context of delivering charge for safe and effective electrical stimulation. Third, we
demonstrate the utility of MXtrodes for mapping and modulating excitable networks at scales
ranging from large neural and muscular circuits in humans to small animal models. In
particular, we show gel-free multichannel arrays for large-scale human epidermal recording
with electrode-skin interface impedance and recording quality comparable to larger,
commercially available pre-gelled Ag/AgCl single contact electrodes. Furthermore, we
demonstrate the ability of MXtrodes to finely map clinically relevant neural and
neuromuscular activation patterns at high spatial and temporal resolution – which is elusive
for conventional epidermal sensors – and to deliver effective electrical stimulation. Fourth,
we experimentally characterize the compatibility of Ti 3C2 with clinical imaging modalities
and we demonstrate that MXtrodes minimally interact with magnetic fields and X-rays,
resulting in artifact-free high-field MRI and computed tomography (CT) imaging. This finding
opens up new and exciting opportunities for future research and clinical paradigms
combining high temporal resolution electrophysiology with advanced functional imaging.
Propelled by the unique properties of Ti3C2 and the high-throughput, scalable, and costeffective fabrication process developed here, MXtrodes show great promise for numerous
applications in healthcare, research, and wearable electronics.

5.2 Rapid, low-cost manufacturing of MXtrodes
We developed a simple method for producing the MXtrode arrays involving 1) laserpatterning a porous absorbent substrate, 2) infusing it with a water-based Ti 3C2 MXene ink,
and 3) encapsulating the resulting conductive composite in flexible elastomeric films. For the
various applications demonstrated in this work, we fabricated two types of electrodes by
slightly varying the same basic process: 1) flat or planar electrodes for gel-free epidermal
sensing and for epicortical brain recording and stimulation, and 2) 3D “mini-pillar” electrodes
for gel-free electroencephalography (EEG). The versatility of our fabrication process allows
addressing application-specific requirements and customizing the electrodes to the
structures of interest: while for epidermal and cortical recording flat planar electrodes
achieve adequate tissue coupling, gel-free EEG requires 3D components to overcome the hair
barrier and make contact with the scalp. The fabrication process, with both variations, is
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Figure 5.1 Rapid, high-throughput manufacturing of MXene ink-infused bioelectronics:
MXtrodes. (a) Schematic of the fabrication method for laser-patterned planar and 3D mini-pillar
MXene electrode arrays. (b)-(e) Photographs of different electrode array geometries (top) with their
intended bioelectronic applications (bottom): (b) EMG, (c) ECG, (d) EEG, and (e) ECoG monitoring.
Scale bars: (b)-(d) 5 mm; inset in (d) and (e) 2 mm.

depicted in Figure 5.1a. Briefly, we used a CO2 laser to pattern a nonwoven, hydroentangled
cellulose-polyester blend substrate into the desired electrode array geometry. This served as
a scaffold for the MXene flakes, with the laser patterning process allowing for rapid
prototyping and customization of the array geometry. Next, we infused the cellulose110
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Figure 5.2 Optical and SEM images of MXtrode composites. Optical microscopy images (top panel)
and corresponding SEM images (bottom panel) for: (a) pristine cellulose/polyester blend substrate,
(b) the same substrate after infusing with MXene ink, (c) cross-section of MXene composite trace
embedded in PDMS, (d) edge of planar electrode contact, (e) side of MXene-infused cellulose foam in
3D mini-pillar MXtrode.

polyester substrate with MXene ink, which was prepared by a minimally intensive layer
delamination (MILD) method[232] to produce a water-based MXene ink with a concentration
of 30 mg/mL. The ink quickly wicked into the absorbent substrate, coating all the fibers. The
ink-infused substrates were then thoroughly dried in a vacuum oven for 1 h at 70°C and 60
mmHg. The resulting structure was a rough, macro-porous conductive composite, with
MXene flakes coating the individual fibers in the textile matrix (Figure 5.2a,b). For the planar
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MXtrode arrays, the MXene conductive composite was then encapsulated in ~1 mm-thick
layers of polydimethylsiloxane (PDMS), with a thorough degassing step prior to curing that
allows the PDMS to infiltrate into the conductive matrix (Figure 5.2c). Electrode contacts
were defined by cutting through the top encapsulation layer with a biopsy punch of the
desired electrode diameter and peeling up the resulting PDMS disk to expose the conductive
MXene composite beneath (Figure 5.2d). In the planar MXtrode arrays for cortical recording
and stimulation, an additional 1 µm-thick layer of parylene-C was deposited prior to opening

Figure 5.3 Scalable fabrication of MXtrode arrays. (a) Photo of laser-patterned array substrates
for various device and array geometries. (b) The same batch of devices shown in a after infiltrating
with MXene ink. In the top left are shown the EEG ring MXtrode arrays after addition of the 3D minipillars. (c) Photographs of completed devices (from left to right) designed for ECG, ECoG, EMG, and
EEG sensing.
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the electrode contacts to serve as an additional barrier to moisture. To fabricate 3D MXtrode
arrays for gel-free EEG recording, “mini-pillars” of MXene-infused cellulose foam were
deposited onto the electrode locations prior to PDMS encapsulation. Similar to the absorbent
cellulose-polyester substrate, the cellulose foam readily absorbed the MXene ink, which
thoroughly coated all surfaces to form a porous conductive composite after vacuum drying
(Figure 5.2e). It is worth noting that no adhesive was required to affix the 3D mini-pillars to
the underlying laser-patterned substrate: inking the two structures simultaneously with
MXene and vacuum drying them while in contact resulted in the formation of a continuous
conductive network fusing the laser-patterned substrate and the cellulose foam together. The
final steps of the 3D MXtrode array fabrication involved PDMS encapsulation and manual
trimming of the mini-pillars to expose the conductive MXene-cellulose foam composite. The
versatility, simplicity, scalability, and low cost of this process enabled parallel fabrication of
MXtrodes in a variety of geometries for diverse bioelectronic applications, even within the
same batch (Figure 5.1b-e, Figure 5.3).
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5.2 Electrical and electrochemical properties of MXtrodes
5.2.1 DC conductivity
In the MXtrode arrays, the MXene-cellulose-polyester conductive composite forms
the wires which carry the signal out to the recording amplifier. Thus, it is important that this
composite is highly conductive in order to reduce Ohmic losses, minimize noise, and acquire
high-quality signals. We measured the bulk conductivity of the MXene composites and
determined it to be 3015 ± 333 S/m (Figure 5.4) which is in agreement with previously
reported values for MXene-coated cellulose fibers [315]. To highlight the conductivity
advantage of Ti3C2 MXene compared to other conductive inks – which could in principle be
used in our fabrication process – we also fabricated conductive composites using PEDOT:PSS
and rGO inks with the same cellulose-polyester absorbent substrate. The bulk conductivity of

Figure 5.4 DC conductivity of ink-infused composites. (a) Plot of length vs. DC resistance for
composites made using MXene, PEDOT:PSS, and rGO as the conductive ink. Test structures were 20 cm
x 3 mm x 285 µm (L x W x H) strips. (b)-(d) Individual plots of DC resistance vs. length for (b) MXene,
(c) PEDOT:PSS, and (d) rGO, with linear fitting curves shown as dashed lines. The linear relation of
resistance vs. length, along with the cross-sectional area of the test structure, is used to compute the
bulk conductivity, σ, of the composites. DC resistance of the rGO composite could only be measured
out to 8 cm due to high resistance. (e) Demonstration of exceptional conductivity of the MXene
composite here used as conductive trace to power an LED.
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PEDOT:PSS and rGO composites was 7.6 ± 0.4 S/m and 0.005 ± 0.002 S/m, respectively, both
significantly lower than MXene.
5.2.2 Electrochemical properties in saline and their scaling relations
To evaluate the impedance and charge transfer properties of MXene electrodes and
compare them with other common bioelectronic materials, we conducted electrochemical
measurements on MXtrodes with diameters ranging from 500 µm to 3 mm and compared
them to 2.3 mm-diameter clinical Pt electrodes. Specifically, we performed electrochemical
impedance

spectroscopy

(EIS),

cyclic

voltammetry

(CV)

and

voltage

transient

(chronopotentiometry) experiments to measure the impedance magnitude, charge storage
capacity (CSC), safe voltage window, and charge injection capacity (CIC) of each electrode,
and to determine how these properties scale with electrode diameter.
Data are shown in Table 5.1, along with additional comparisons to other common
electrode materials from literature. EIS revealed that the MXtrodes of all diameters tested
showed significantly reduced impedance compared to the Pt electrodes at frequencies below
500 Hz – where impedance is dominated by the electrochemical properties of the electrode
interface [321] and where most physiologic signals of interest lie (Figure 5.5a). At 10 Hz, the
impedance of the MXtrodes ranging from 500 µm to 3 mm was 1343.3 ± 81.6 Ω (500 µm),
644.2 ± 97.3 Ω (1 mm), 451.2 ± 35.4 Ω (2 mm), and 241.4 ± 14.7 Ω (3 mm), while the
impedance of the Pt electrodes was 8838.3 ± 1154.2 Ω (2.3 mm). At the reference frequency
of 1 kHz – where the interface impedance is controlled by the solution resistance and
electrode size [321] – the impedance of similar-sized MXtrodes is comparable to, and in some
cases lower than, Pt and other bioelectronic materials like PEDOT:PSS (Figure 5.5a and
Table 5.1). The 1 kHz impedance values can be found in Table 5.1. We attribute the
exceptionally low impedance of the MXtrodes to the highly porous and rough morphology of
the electrodes, which endows the interface with a high effective surface area.
The safe voltage window for MXtrodes determined from wide-scan CVs is −1.8 – +0.6
V (Figure 5.6a,b), showing that MXene is exceptionally stable in the cathodic region, with
hydrolysis beginning at −1.9 V. This wide safe potential range is advantageous for therapeutic
electrical stimulation applications, and while the safe anodic potential limit (+0.6 V) is slightly
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Table 5.1 Electrochemical properties in saline. Summary of electrochemical properties of
MXtrode planar electrodes of varying diameters, compared to a 2.3 mm-diameter Pt electrode and
to literature values for other electrode materials.
Material

Geometric
Surface Area
(mm2)

1 kHz |Z|
(Ω)

Potential Limits
vs. Ag/AgCl
(V)

CSCC
(mC cm-2)

CICC
(mC cm-2)

Source

7.069

205.6 ± 11.1

-1.8 – 0.6

233.1 ± 19.6

0.55 ± 0.10

This work

3.142

369.2 ± 40.2

-1.8 – 0.6

392.3 ± 9.8

0.69 ± 0.03

This work

0.7854

430.2 ± 86.1

-1.8 – 0.6

604.8 ± 61.4

1.07 ± 0.07

This work

0.1963

729.2 ± 71.2

-1.8 – 0.6

1024.1 ± 3.0

2.12 ± 0.48

This work

Pt

4.155

287.3 ± 7.8

-0.6 – 0.8

4.3 ± 0.2

0.07 ± 0.003

This work

Pt

3.142

1910

-0.6 – 0.8

3.6

0.17

a

[316], [317]

Au
PEDOT:PSS
on Pt
PEDOT: PSS
on Au
Pt

3.142

470 a

-0.9 – 0.6

0.3 a

0.21 a

[316], [317]

3.142

1690 a

-0.9 – 0.6

2.3 a

0.18 a

[316], [317]

3.142

430 a

-0.9 – 0.6

1.0 a

0.86 a

[316], [317]

0.1963

7790 a

-0.6 – 0.8

5.1 a

0.50 a

[316], [317]

0.1963

4430

a

-0.9 – 0.6

0.3

0.21

a

[316], [317]

0.1963

2110 a

-0.9 – 0.6

3.7 a

0.66 a

[316], [317]

0.1963

990 a

-0.9 – 0.6

1.5 a

1.35 a

[316], [317]

0.7854

760 a

-0.6 – 0.8

2.1 ± 0.1

0.026 a

[123]

0.0314

2100 a

-0.6 – 0.7

70

2.5 ± 0.1 a

[318]

0.09

519

-1.3 – 0.8

50

3.1

[16]

-1.5 – 1.5

372 ± 56 b

6.52

[133]

MXtrode
(Ti3C2
composite)

Au
PEDOT:PSS
on Pt
PEDOT:PSS
on Au
laserroughened Pt
PEDOT/CNT
coating on Pt
Porous
graphene
(doped)

TiN

0.004

11.2 ± 7.6
x103
11.5 x103 a

IrOx

0.004

7.1 x103

PtIr

5.985

CNT fiber

a
b

a

0.00145

125

a

a

a

-0.9 – 0.9

2.47

0.55

[319]

-0.6 – 0.8

11

4

[319]

-0.7 – 0.7

5.0

–

[320]

Represents values extracted from plots from the respective references.
CSC calculated from CV in Pt window, -0.6 – 0.8 V at 100 mV/s.

lower than that of Pt, PtIr, or IrOx (+0.8 V), stimulation waveforms can be engineered to
minimize voltage excursions in the anodic range while taking advantage of the large cathodic
limit [60], [322], [323]. While previous studies have reported anodic oxidation of Ti 3C2 films
at +430 mV [324], we observed no oxidation peak and negligible current loss when MXtrodes
were cycled within the range of −1.8 – +0.6 V. We attribute the improved anodic stability to
the rough surface morphology of the MXtrodes, resulting in decreased current density. In the
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Figure 5.5 Electrochemical properties of MXtrodes. (a) EIS spectra measured in 1X PBS for 3 mm,
2 mm, 1 mm, and 500 µm planar MXene electrodes compared to 2.3 mm Pt electrodes. (b) CVs for 3
mm planar MXtrode and 2.3 mm Pt electrodes scanned from −0.6 – +0.6 V at 50 mV/s. (c) Voltage
transients in response to biphasic current pulses, with tc = ta = 500 µs and tip = 250 µs, current
amplitudes ranging from 1 to 5 mA for 3 mm planar MXtrode and 2.3 mm Pt electrodes. Anodic and
cathodic voltage limits for MXene and Pt are displayed on their respective plots as dashed red lines.
(d) EIS spectra measured on skin for 3 mm MXtrode 3D pillar and planar electrodes.

cathodic region, the 1 mm, 2 mm, and 3 mm MXtrodes showed stable capacitive behavior
down to −1.8 V, however the 500 µm-diameter MXtrode showed initial evidence of faradaic
current near this negative limit (Figure 5.6c) likely due to size effects. Still, the 500 µmdiameter MXtrode showed stable behavior through repeated CV cycles and no evidence of
hydrolysis, confirming −1.8 V as a reasonable cathodic limit.
Analysis of cathodal CSC (CSCC) for MXtrodes and Pt electrodes from CVs at 50 mV/s
within their respective water windows reveals enhanced capacitive charging and charge
delivery properties for MXtrodes with ~100 times larger CSCC than Pt electrodes and other
common materials such as PtIr and PEDOT:PSS (Figure 5.6c,d, Table 5.1). To enable a more
direct comparison of CSCC values between MXtrodes and Pt electrodes, we also ran CV scans
in the intersection of the MXene and Pt voltage windows, –0.6 – +0.6 V (Figure 5.5b, Figure
5.6d, and Table 5.2). Even in this more constrained voltage range, the MXtrodes showed
more than 20 times enhanced CSCC compared to Pt, which we attribute both to the
exceptionally high intrinsic capacitance of Ti3C2 MXene [18], [21], [325] and to the high
effective surface area of the MXtrode surface. The scaling dependency of CSC C on the electrode
diameter for the MXtrodes is shown in Figure 5.6e. The non-linear relationship between CSCC
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Figure 5.6 Scaling of electrochemical properties in saline. (a) CVs probing the negative voltage
limit for MXene at 50 mV/s. Hydrolysis of water begins at −1.9 V. (b) CVs probing the positive voltage
limit for MXene. Current loss and evidence of faradaic current begins at +0.7 V. Test electrode for (a)
and (b) was 3 mm-diameter planar MXene. (c) CVs in MXene safe voltage window, −1.8– +0.6 V, for 3
mm, 2 mm, 1 mm, and 500 µm-diameter MXtrodes. (d) CVs in MXene-Pt intersection window, −0.6 to
+0.6 V, for 3 mm, 2 mm, 1 mm, and 500 µm-diameter planar MXtrodes and 2.3 mm-diameter Pt
electrode. (e) Charge storage capacity of scaled planar MXtrodes as a function of diameter, highlighting
the CSC scaling dependence on the electrode diameter, due to edge effects. CSC values were calculated
for CVs in MXene water window. (f)-(i) Voltage transients for biphasic current pulses, with tc = ta = 500
µs and tip = 250 µs, for currents ranging from 1 to 5 mA for (f) 3 mm, (g) 2 mm, (h) 1 mm, and (i) 500
µm-diameter planar MXene electrodes. (j) Charge injection capacity of scaled planar MXtrodes as a
function of diameter, highlighting the CIC scaling dependence on the electrode diameter, due to edge
effects. (k) Schematic demonstrating the relative electrode sizes used in the study.
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Table 5.2 CSCc values in different voltage windows. CSCC values for planar MXtrodes of varying
diameters and the comparison clinical Pt ECoG electrode. CV scans were performed at 50 mV/s for
each electrode in both its safe voltage window and the intersection of the MXene and Pt voltage
windows.
Material

MXtrode
(Ti3C2
composite)
Pt

Electrode
diameter

CSCC (mC cm-2)
MXene window: -1.8 – 0.6 V

CSCC (mC cm-2)
Intersection: -0.6 – 0.6 V

CSCC (mC cm-2)
Pt window: -0.6 – 0.8 V

3 mm

233.1 ± 19.6

80.9 ± 8.9

N/A

2 mm

392.3 ± 9.8

118.6 ± 10.1

N/A

1 mm

604.8 ± 61.4

188.5 ± 28.4

N/A

500 μm

1024.1 ± 3.0

288.7 ± 1.7

N/A

N/A

4.0 ± 0.2

4.3 ± 0.2

2.3 mm

and electrode diameter is expected, and reflects the known phenomenon of electrochemical
charge exchange happening predominantly at the edge of the electrode [60], [317].
Finally, we measured the voltage transients evolved on each electrode when used to
deliver charge-balanced, cathodal-first biphasic current pulses ranging from 1 to 5 mA with
a duration of 500 µs in both phases (tc, ta) and an interpulse interval (tip) of 250 µs (Figure
5.5c and Figure 5.6f-i). For the 500 µm-diameter MXtrode, the current amplitude range was
restricted to 600 µA – 2 mA. The maximum cathodal excursion potential, Emc, was taken 10 µs
after the cathodal pulse end and CICC was defined as the injected charge at which Emc would
reach the water reduction potential. The resulting CICC values, shown in Table 5.1, reveal
that the MXtrodes significantly outperform Pt electrodes, with MXtrodes showing ~10 times
larger CICC than the Pt electrodes. Furthermore, we found a similar ~10 times improvement
in CICC when we compared MXtrodes to other common electrode materials (Table 5.1). This
result has significant implications for stimulation applications, and suggests that MXtrodes
may offer more efficient charge transfer than current state-of-the-art Pt electrodes. This
could potentially prolong battery life for implantable simulation systems such as deep brain
stimulation (DBS), vagal nerve stimulation (VNS), and cardiac pacemakers. The scaling
dependency of CICC on electrode diameter for the MXtrodes is shown in Figure 5.6j, again
revealing the expected non-linear scaling dependency resulting from edge effects. A
schematic depicting the relative sizes of the MXtrodes included in the analysis is shown in
Figure 5.6k.
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5.2.3 Electrode-skin interface impedance
While measurements in saline allow comparing the properties of MXtrodes to current
standard electrode materials such as Pt, for epidermal sensing applications it is also essential
to evaluate the impedance at the interface with human skin. Specifically, achieving low
electrode-skin impedance is key for recording high-fidelity signals [326], [327] and becomes
particularly challenging in gel-free structures like MXtrodes. Thus, we measured EIS for 3
mm-diameter MXtrodes, both in planar and 3D configurations, on clean human skin following
standard preparation with an alcohol swab and light abrasion with 3M Trace Prep tape. At 1
kHz, the planar and 3D MXtrodes showed impedances of 6.6 ± 2.9 kΩ and 4.9 ± 2.6 kΩ,
respectively, with the lower impedance of the 3D electrodes attributable to the improved
contact from the protruding mini-pillars pressing into the skin (Figure 5.5d). When
normalized by their geometric surface area (GSA) of 0.071 cm 2, the impedance is 0.47 ± 0.20
kΩ·cm2 for planar and 0.35 ± 0.12 kΩ·cm2 for 3D MXtrodes, which are among the best values
reported so far for dry, gel-free epidermal electrodes [111], [112], [328] and ~100 times
lower than those of commercially available gelled Ag/AgCl electrodes commonly used for
electrodiagnostics and monitoring [314].

5.3 Gel-free epidermal sensing in humans
5.3.1 Scalp electroencephalography (EEG)
Motivated by the exceptionally low electrode-skin interface impedance of the dry
MXtrodes, we investigated their use in a variety of human epidermal sensing applications,
with custom geometries specifically designed for each application. First, we acquired scalp
EEG on a healthy human subject using high resolution gel-free MXtrodes and standard gelled
Ag/AgCl EEG electrodes for comparison. We designed an 8-channel MXtrode, with 3 mmdiameter 3D mini-pillar electrodes arranged in a ring around a central opening, where we
placed a standard 1 cm-diameter gelled Ag/AgCl EEG electrode for side-by-side comparison
of simultaneously acquired EEG (Figure 5.7a). In the first EEG task, we placed the MXtrode
array over the parietal region near EEG site P1 (as defined in the EEG 10-20 system, located
over inferior parietal cortex to the immediate left of the midline). The gelled Ag/AgCl EEG
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Figure 5.7 Dry EEG recording enabled by 3D pillar MXtrodes. (a) Images of a MXtrode 3D EEG
array with eight 3 mm-diameter MXene electrodes in a circular arrangement around a central opening.
(b) Image of MXtrode electrode array and standard gelled Ag/AgCl cup electrode placed on head of
human subject. (c) Map of 1 kHz impedance values for all electrodes on the subject’s head. (d)
Segments of recorded EEG signal from all electrodes during the eyes open (left) and eyes closed (right)
tasks at resting state. (e) Spectrograms of the EEG signal recorded on MXene electrode b in the eyes
open (top) and eyes closed (bottom) conditions. Alpha frequency band is enclosed in dashed box to
highlight differences between eyes open and eyes closed states. (f) Power spectral density during eyes
open and eyes closed EEG recordings. The 8-12 Hz alpha band is highlighted.
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electrode was placed in the center of the MXtrode ring (Figure 5.7b). Ground and reference
for all EEG recordings were gelled Ag/AgCl electrodes placed at the center forehead and left
mastoid, respectively. The slightly lateralized recording position was chosen because the
subject had the shortest hair at that location (~5 mm). Before placing the electrodes on the
skin, the entire recording area was cleaned with an alcohol swab and lightly abraded with 3M
Trace Prep tape. Notably, we found that the electrode-skin interface impedance at 1 kHz for
the dry MXtrodes was 2.8 ± 0.9 kΩ, while the impedance of the larger gelled Ag/AgCl electrode
during the same experiment was 1.2 kΩ at 1 kHz (Figure 5.7c). Given the critical role of the
electrode-skin interface impedance in determining the quality of scalp EEG signals [329],
most standard EEG electrodes require conductive gels at this interface, as well as a large
contact area of at least ~1 cm2 to achieve suitably low impedance (e.g., less than 5 kΩ) [330].
Due to their enhanced material and surface area properties, our mm-scale, gel-free MXtrodes
can achieve strikingly low impedance, which enables high-resolution EEG recording. We
recorded EEG in 2 min sessions, with the subject alternating between a resting state with the
eyes closed and a resting state with the eyes open and fixating on a target. In both tasks, the
EEG signal recorded on the dry MXtrodes was indistinguishable from the signal recorded on
the gelled Ag/AgCl electrode (Figure 5.7d). Additionally, a clear 10 Hz alpha rhythm emerged
in the eyes closed state with a significantly higher amplitude than in the eyes open condition
(Figure 5.7e-f). This alpha signature is one of the most reliable and widely studied
behaviorally-linked EEG signatures in human subjects research [331], and arises from
endogenous thalamic input to the visual cortex in the absence of visual input (i.e. when the
eyes are closed) [332]. During the recording session, there was no significant difference
between the alpha bandpower on the gelled Ag/AgCl electrode and any individual dry
MXtrode, confirming that the signals were comparable between the electrode types (Figure
5.8). Interestingly, when alpha bandpower values were calculated in 1 s windows with 0.5 s
of overlap and observed sequentially, distinct spatiotemporal patterns of alpha activation
emerged even across the small sampled scalp area. MXtrodes could be spaced much closer
than they were in the ring configuration we used in this experiment, however the density we
tested already approximates or exceeds the densest configurations of traditional Ag/AgCl
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Figure 5.8 EEG alpha bandpower mapping. (a) 8-12 Hz alpha bandpower across the 2 min recording
in the eyes open state. Color plot (top) shows average alpha power for each electrode, mapped to its
corresponding location on the scalp. Bar plot (bottom) shows average alpha power, with error bars
corresponding to standard error of the mean across all time windows. No significant difference was
detected between the gelled Ag/AgCl electrode (labelled i) and the dry MXtrode electrodes (labelled
a-h). (b) The same alpha bandpower analysis shown in (a), for the eyes closed task.

electrodes in common use today (the 10-5 system). This highlights the potential of mm-scale,
gel-free MXtrodes to enable ultra high-density EEG mapping.
For the second EEG task, the electrodes were removed and replaced at site C3 near
the hand motor area. The precise location of the hand motor area was determined using
single pulses of transcranial magnetic stimulation (TMS) to evoke lateral finger movements,
and the electrodes were centered over this location (Figure 5.9a). The subject performed 2
min periods of imagined and actual hand flexion while the EEG was recorded simultaneously
with the co-located MXtrodes and gelled Ag/AgCl electrode. During this motor task, we also
found that the EEG signal was indistinguishable between the two electrode types.
Furthermore, we observed a suppression of the 8–12 Hz motor mu rhythm during the actual
hand flexion relative to the imagined hand flexion (Figure 5.9b). The mu suppression
signature during imagined hand movement is an important EEG feature which has been
successfully used as a control signal for EEG-based brain-computer interfaces (BCIs) [333],
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[334]. Together, the results of these EEG experiments confirm that mm-scale, gel-free
MXtrodes can record EEG signal at least as well as standard gelled Ag/AgCl EEG electrodes,
while also improving spatiotemporal resolution for high-density EEG applications.
Furthermore, the application of MXtrodes to the scalp is faster and easier than standard
Ag/AgCl electrodes and leaves no residue on the head. This positions MXtrodes to
dramatically lower the effort of conducting EEG experiments, and to expand the use of highfidelity EEG to environments outside the laboratory.

Figure 5.9 Motor EEG recording. (a) Photograph of the EEG recording setup with electrodes centered
over the hand motor region, as localized with single TMS pulses. (b) PSDs of the recorded EEG signal
reveal a suppression of the 8-12 Hz motor mu rhythm during actual hand flexion as compared to
imagined hand flexion.

5.3.2 High-density surface electromyography (HDsEMG)
Next, we evaluated MXtrodes for high-density surface electromyography (HDsEMG)
recording, muscle activation mapping and localization of the of innervation zones (IZs).
HDsEMG is attracting growing interest for a number of applications in neuromuscular
diagnostics and rehabilitation, including control of multifunctional prostheses [120], studies
of muscle activation and coordination [335], peripheral nerve/muscle fiber conduction
velocity measurements [336], and for accurate localization of neuromuscular junctions
(NMJs) to target chemodenervation therapies for muscle spasticity [337], [338]. HDsEMG
recordings require flexible, large-area, and high-density electrode arrays capable of covering
the wide range of muscle sizes. To demonstrate the versatility of the MXtrode fabrication
process, we created custom HDsEMG arrays to map muscle activation and localize IZs in two
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Figure 5.10 High density surface EMG mapping with MXtrode arrays. (a)-(b) EMG recordings from
the APB muscle. (a) Average evoked response following N=10 median nerve stimulation epochs
recorded on 20-ch MXtrode array placed over APB. Blue ticks indicate time of nerve stimulation, and
purple dots indicate time of peak evoked response. (b) Latency map of peak response overlaid on
photo of the MXtrode array on the APB. White “x” indicates the channel with shortest latency,
corresponding to the IZ. c-d EMG recordings from the biceps muscle. (c) Average evoked response
following N=10 supraclavicular nerve stimulation epochs recorded on 40-ch MXtrode array placed
over the biceps. Blue ticks indicate time of nerve stimulation, and purple dots indicate time of peak
evoked response. (d) Latency map of peak response overlaid on photo of the MXtrode array on the
subject’s biceps. Distributed IZ running perpendicular to the muscle is apparent as the band with the
shortest latency.
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muscle groups of different sizes (Figure 5.10). First, we used a 20-ch planar MXtrode array
placed over the abductor pollicis brevis (APB) at the base of the thumb. In this experiment, the
3 mm-diameter dry MXtrodes had an average electrode-skin interface impedance of 54.6 ±
28.4 kΩ at 1 kHz (Figure 5.11a). We then stimulated the median nerve with a handheld
bipolar stimulator to evoke APB contractions and recorded the EMG on the MXtrode array.
We calculated the mean evoked muscle response across stimulation trials (Figure 5.10a) and
constructed a latency map of the peak of the evoked response. The location with the shortest
latency indicates the location of the IZ, which can be seen overlaid on the subject’s hand in

Figure 5.11 Impedance and bipolar subtraction EMG experiment. (a), (b) 1 kHz impedance
magnitude maps for the (a) 20-ch planar MXtrode array used to map the APB muscle and the (b) 40ch planar MXtrode array used to map the biceps, overlaid on images of the arrays on the subject during
the experiment. (c) Schematic showing the arrangement for bipolar signal subtraction shown in (d)
for resisted flexion EMG recordings on the biceps. The latency map obtained from the supraclavicular
stimulation experiment is shown overlaid on the bottom image. (d) Bipolar EMG signals recorded
during resisted flexion on the biceps. The location of the innervation zone is indicated by the arrows,
and is clear from the propagation of the EMG signal outward from this region with some delay, as well
as the inversion of the spikes on either side. The innervation zone determined from this analysis is in
agreement with the region identified by the electrical stimulation-derived latency map shown in (c).
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Figure 5.10b, and it is in good agreement with expectations based on anatomical landmarks
[339].
Following the APB mapping experiment, we mapped the activation of the larger
biceps brachii with a 40-ch planar MXtrode array. Here, the 3 mm-diameter dry MXtrodes had
an average electrode-skin interface impedance of 22.0 ± 14.3 kΩ at 1 kHz (Figure 5.11b).
Unlike the smaller APB muscle, which has a small and spatially confined IZ corresponding to
a single NMJ, the larger biceps brachii has distributed NMJs in IZ regions that run
perpendicular to the muscle and are typically located near the center [340]. To further
confirm the validity of our approach, we used two different methods to localize these IZs in
the biceps: first we stimulated the supraclavicular nerve and constructed a latency map of the
peak evoked response, similar to the methods described for the APB (Figure 5.10c,d). This
produced a clear mapping of the IZ location as the region with the shortest latency, running
across the short head of the biceps brachii. Second, we recorded motor unit action potentials
(MUAPs) as the subject performed isometric contractions of the biceps (Figure 5.11c,d). In
these recordings, bipolar subtraction of the raw EMG signal along the length of the biceps
muscle revealed MUAPs that propagated outward in both directions from the IZ, with signal
inversion and a clear latency as the MUAP traveled away from the IZ (Figure 5.11d).
Localization of the biceps IZ obtained from both methods were in excellent agreement with
each other, and with previous reports [340]. These results demonstrate that dry, highresolution MXtrode arrays are capable of mapping muscle activation with high accuracy in
order to precisely localize IZs in both small and large muscle groups.
5.3.3 Electrocardiography (ECG)
To demonstrate the applicability of MXtrodes to electrocardiogram (ECG), we
acquired ECG recordings on a healthy human subject with 1.3 cm-diameter MXtrodes in a
simplified 3-electrode montage as shown in Figure 5.12a. For validation and signal
comparison, we recorded sequentially from the MXtrodes and from 1 cm-diameter pre-gelled
Ag/AgCl electrodes, placed in the same locations. The dry MXtrodes and pre-gelled electrodes
had average 1 kHz skin-electrode impedances of 1.29 kΩ and 1.38 kΩ, respectively. On both
types of electrodes, characteristic ECG features were clearly visible, with the P wave followed
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by the QRS complex and the T wave (Figure 5.12b,c). Mean R peak amplitude, however, was
slightly higher on the MXtrodes compared to the commercial electrodes: 2.55 ± 0.06 mV vs.
2.47 ± 0.30 mV. Thus, we confirmed that dry MXtrodes can record the ECG with comparable
signal quality compared to standard clinical gelled electrodes.

Figure 5.12 Electrocardiography with MXtrodes. (a) Photo of ECG recording setup on human
subject. Electrodes were interchanged in the same locations to obtain sequential recordings from
either dry MXene or pre-gelled commercial electrodes. (b) Ten seconds of ECG recordings on the dry
MXtrodes (top) and the pre-gelled commercial electrodes (bottom). (c) Average ECG waveforms
recorded on the two electrode types, marked with salient ECG features.

5.3.4 Electrooculography (EOG)
As a final demonstration of MXtrodes for human epidermal sensing, we acquired
electrooculography (EOG), which has applications in ophthalmological diagnosis, BCIs, and
for monitoring attention and fatigue [341], [342]. The EOG signal arises from the standing
dipole potential between the positively charged cornea and the negatively charged retina,
which enables tracking eye movements as this dipole is rotated. With the same 1.3 cmdiameter dry MXtrode geometry used in ECGs, we recorded the EOG in two configurations to
track up-down and left-right eye movements (Figure 5.13). By placing MXtrodes above and
below the eye, recorded voltage fluctuations could be decoded to track the up and down
movements of the eye (Figure 5.13a,b). Similarly, placing MXtrodes on both sides of the eyes
enabled decoding the left-right movements (Figure 5.13c,d).
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Figure 5.13 Electrooculography with MXtrodes. (a) Schematic of EOG recording for monitoring updown eye movements. (b) EOG data recorded on MXtrodes, showing distinct up and down eye
movements. (c) Schematic of EOG recording for monitoring left-right eye movements. (d) EOG data
recorded on MXtrodes, showing distinct left and right eye movements.

5.4 Cortical neural recording and microstimulation in animal
models
5.4.1 Intraoperative electrocorticography (ECoG)
Beyond epidermal sensing modalities, the favorable electrochemical interface of the
MXtrodes also supports their use for implantable sensing and stimulation applications. One
such application is intraoperative electrocorticography (ECoG), a common mapping
technique used in resective brain surgery for epilepsy or tumors. We acquired ECoG
recordings in an anesthetized swine, a relevant animal model in neuroscience given the
gyrencephalic structure and neuro-anatomical similarity of the swine brain to the human
brain. In this experiment we inserted a 6-ch array of 500 µm-diameter planar MXtrodes
through an 8 mm craniotomy/durotomy and placed MXtrodes in direct contact with the
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Figure 5.14 ECoG recording with MXtrode arrays in swine brain. (a) Schematic depicting ECoG
recording setup with the 6-ch array of 500 µm-diameter MXtrodes placed subdurally on
somatosensory cortex. (b) A few seconds of representative ECoG data recorded on the MXtrode array.
(c) Power spectral density of the ECoG recording, illustrating the low-noise quality of the ECoG signals
obtained, evidenced by the lack of a 60 Hz noise peak. (d) Segment of ECoG data, displayed according
to the spatial arrangement of the 6 MXtrodes. (e) Instantaneous snapshots of the voltage mapping
recorded across the 6 MXtrodes reveals stereotyped patterns during down states (panels 1 and 4) and
up states (panels 2 and 3). The timing of these voltage snapshots is indicated in (e) by the vertical lines.
Voltage was interpolated across the array and normalized, with black dots indicating location of the 6
MXtrode contacts.

cortical surface (Figure 5.14a). The array configuration consisted of 3 rows of electrode pairs
with 5 mm inter-row spacing and 4.5 mm pitch, so that the rows of electrodes spanned
several cortical gyri. A few seconds of representative raw ECoG signal are shown in Figure
5.14b. The signals were large in amplitude with negligible 60 Hz noise interference, as
evidenced by the power spectra (Figure 5.14c). Furthermore, maps of interpolated voltage
across the MXtrode array revealed stereotyped spatial patterns emerging during the “up” and
“down” states in the ECoG signal (Figure 5.14d,e), highlighting the advantages and
opportunities offered by high-density cortical brain mapping with MXtrodes.
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5.4.2 Cortical microstimulation
In addition to ECoG recording, direct stimulation of the cortical surface is used
clinically for intraoperative cortical mapping [343] and neuromodulation therapies [344], as
well as for closed-loop BCIs [345]. Given that the MXtrodes showed superior CSC and CIC
compared to Pt, a material commonly used in stimulating electrodes, we sought to
demonstrate the effectiveness of MXtrodes for electrical stimulation by evoking motor
responses via intraoperative stimulation in rat brain. Specifically, we placed a 500 µmdiameter planar MXtrode subdurally onto the whisker motor cortex of an anesthetized rat.
Contralateral to the MXtrode, an optical micrometer was positioned to track whisker
displacement, with one whisker placed into a plastic tube to maximize detection sensitivity

Figure 5.15 Cortical stimulation with MXtrode arrays in rat brain. (a) Schematic of the cortical
stimulation setup, with the 4-ch array of 500 µm-diameter MXtrodes placed over barrel cortex, and the
optical micrometer used to detect and amplify the whisker deflection signal. (b) Whisker deflection
data recorded by the optical micrometer during a series of stimulation pulse trains delivered at 1.4
mA. (c) Average first whisker deflection for each stimulation pulse amplitude, time-aligned by the
stimulation onset. (d) Whisker deflection amplitude scales with stimulation amplitude, with
stimulation at 1.0 mA falling below the threshold required to evoke whisker movement.
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(Figure 5.15a). Trains of charge-balanced, cathodal-first stimulation pulses with amplitudes
ranging from 1.0 to 1.4 mA were delivered through the MXtrode. We observed stimulationevoked whisker movements for amplitudes greater than 1.0 mA, with the whisker deflection
amplitude scaling with the stimulation intensity (Figure 5.15b-d). Whisker movements
registered as oscillatory deflections on the micrometer, with the first deflection peak always
being the largest in amplitude. To compare whisker deflection across stimulation current
amplitudes, we computed the mean amplitude of the first whisker deflection peak for each
stimulation trial at each current level. These results confirm that MXtrodes are capable of
delivering electrical stimulation to effectively modulate neural activity.

5.5 Compatibility of MXtrodes with clinical imaging
With the widespread adoption of bioelectronic technologies, compatibility with
clinical imaging has become increasingly important. MRI and CT are the two most common
imaging techniques used in the diagnosis of injury and disease, as well as in image-guided
interventions. However, many of the conductive materials traditionally used in bioelectronic
devices are incompatible with the challenging MRI environment and can produce heating or
exert forces on the tissues. Even devices considered MR-safe often produce imaging artifacts
that shadow the surrounding anatomical structures because of the mismatch in magnetic
susceptibility between the device materials and the tissue [346]. These challenges are
compounded at high field strengths, which are increasingly being used for high resolution
imaging, as well as for novel functional and metabolic imaging techniques [347], [348]. While
the magnetic susceptibility of Ti3C2 MXene had not been previously characterized, we
hypothesized from the weak dia- and paramagnetic properties of C and Ti, respectively, that
Ti3C2 may have a low magnetic susceptibility and thus prove compatible with the MR
environment. To verify our hypotheses, we performed MRI scans of MXtrodes and measured
the magnetic properties of Ti3C2 at body temperature. First, we imaged cross-sections of 3
mm-diameter planar MXtrodes and 2.3 mm-diameter commercial Pt electrodes embedded in
conductive agarose phantoms in a 9.4T high-field research MRI system (Figure 5.16a,b). In
the MR images, we found significant shadowing around the Pt electrodes, while no artifact
was visible around the MXtrode (Figure 5.16b). In fact, the MXene composite forming the
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conductive electrode was almost completely indistinguishable from the surrounding PDMS
encapsulation. To further explore the MRI compatibility of the MXtrodes, we next imaged an
array of 3 mm-diameter 3D mini-pillar MXtrodes – the same array used for EEG recording in
this work – in a 3T clinical MRI scanner. The MXtrodes were placed atop a tissue phantom
and imaged using a battery of scan sequences typical of structural and functional MRI.
Regardless of the scan sequence, the MXtrodes showed no artifact and were nearly invisible
in the images (Figure 5.17a). Thermal IR images of the MXtrode array immediately following
a 10 min scan sequence also showed no evidence of RF heating (Figure 5.17b). Finally, we
measured the magnetic susceptibility of a Ti3C2 free-standing film at 310 K, and found it to be
2.08 x 10−7 (Figure 5.17c), indicating that Ti3C2 is weakly paramagnetic with magnetic
susceptibility very close to that of human tissues (−11.0 to −7.0 x 10 −6). This innate property

Figure 5.16 MRI and CT compatibility of MXtrodes. (a) Schematic of the phantom imaging setup for
MRI and CT imaging. Strips of disk electrodes (3 mm-diameter MXtrodes or 2.3 mm-diameter clinical
Pt ECoG strip electrodes) were embedded in a conductive agarose phantom and imaged in the
transverse plane. (b) A high-field 9.4T MRI scan showing significant shadow artifact and image
distortion around the Pt electrode (top), but no visible artifact from MXtrodes (bottom). The MXene
contact is indistinguishable from the PDMS encapsulation in the device. (c) High-resolution CT scans
with Pt electrodes (top) showing significant x-ray scattering artifacts, while no artifact is visible from
the MXtrodes (bottom).
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of Ti3C2, which has not been reported previously, leads directly to the excellent compatibility
of the MXtrodes with MRI imaging. For comparison, the magnetic susceptibility of Pt is 2.79
x 10−4, several orders of magnitude larger than the susceptibility of human tissues [346]. In
situations where it might be important for implanted electrodes to be visible in MRI images,
such as in epilepsy seizure foci localization relative to electrode locations, a marker such as
iron oxide nanoparticles could in principle be incorporated into the electrode contacts to aid
in their visualization [349].

Figure 5.17 3T MRI compatibility and magnetic susceptibility of MXene. (a) MXtrode EEG array,
imaged in a 3T clinical MRI with a T2 weighted sequence. The array was placed atop an MRI phantom
and a Vitamin E marker was placed on top of the MXtrode array. The Vitamin E marker is visible, while
the MXtrode array is not. (b) Thermal IR image of MXtrode EEG array captured immediately after a 10
min MRI sequence, showing no sign of heating. Left image shows MXtrode array atop the MRI phantom,
and right image shows the thermal image overlay. (c) Magnetic susceptibility of Ti3C2 MXene
measured at body temperature (i.e., 310 K) for applied magnetic field up to 9T. For calculation of the
magnetic susceptibility value, Χ, magnetization and field strength were both converted to units of A/m
such that Χ is unitless.
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As for CT compatibility, the X-ray attenuation characteristics resulting from the high
density and large atomic mass of metals in conventional electrodes poses challenges for CT
imaging with bioelectronic devices [350]. Multilayer Ti3C2 MXene has a density of about 4
g/cm3, which is ~5 times lower than Pt. Thus, we hypothesized that Ti3C2 could minimize
attenuation and scattering artifacts in CT [351]. To test our hypothesis, we imaged 3 mmdiameter planar MXtrodes and 2.3 mm-diameter commercial Pt electrodes embedded in
conductive agarose phantoms in a microCT scanner. As expected from the density matching
considerations, we observed significant X-ray scattering artifacts around the Pt electrodes,
but not around the MXtrodes (Figure 5.16c).

5.6 Discussion
In this work we developed a new class of MXene-based bioelectronic interfaces and
demonstrated their use for high-fidelity recording and effective stimulation of neural and
neuromuscular circuits across multiple scales. The simple fabrication method reported here
offers a scalable and low-cost means of producing large-area, multichannel electrode arrays
from high performance, solution processable 2D materials. The method is conducive to largescale manufacturing, a key aspect for translation beyond the lab and into clinical and
consumer markets. It also enables rapid customization of array geometries for various
applications as well as for patient- or subject-specific fit where desired. The exceptional
properties of Ti3C2 endow MXtrodes with impedance and charge delivery properties that
meet and even exceed current state-of-the-art noble metal electrode materials in both
epidermal and implantable use cases. In epidermal sensing applications, the remarkably low
electrode-skin interface impedance of gel-free MXtrodes opens exciting new possibilities for
high-resolution EMG and EEG, while eliminating the challenges associated with wet
conductive gels. In HDsEMG mapping, MXtrode arrays hold promise for accurately localizing
NMJs for use with neurolytic procedures for the treatment of spasticity and excessive muscle
tone. In the future, this may eliminate the need for intramuscular needle EMG stimulation in
search of the NMJ – the optimal place for injecting medications (e.g. botulinum toxin and
phenol) for denervation. Furthermore, such HDsEMG arrays can also be integrated within an
active prosthesis system where EMG from the residual limb serves as input signal for the
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prosthesis control [352], [353]. In EEG applications, a dry electrode system enabled by
MXtrodes may offer a route toward minimizing skin breakdown and alleviating many of the
key logistical challenges associated with current gelled EEG systems, such as the time
required to apply each electrode and impedance fluctuations over time as the gels dry out.
These advantages, coupled with the possibility for obtaining high density EEG recording with
mm-scaled MXtrodes, also make this technology attractive for neuroscience research [354],
[355], non-invasive BCI systems [356], [357], neuro-rehabilitation [358], and braincontrolled videogaming [41]. The compatibility of MXtrodes with both CT and MRI imaging
enables accurate, artifact-free imaging without the need for removing electrodes from the
subject before the scan, thus opening exciting possibilities for multimodal studies in both
clinical diagnostics and neuroscience research, such as those combining simultaneous EEG
with functional MRI or GluCEST imaging [348], [359]. In addition to the low interface
impedance, the extensive characterization of the electrochemical behavior of MXtrodes
presented in this work demonstrates for the first time the advantages of Ti 3C2 for electrical
stimulation, as highlighted by remarkably high CSC and CIC compared to many commonly
adopted bioelectronic materials. This finding suggests that MXtrodes may represent a
suitable alternative for stimulation electrodes with enhanced safety, charge transfer
efficiency, and reduced power consumption. While the technology presented here already
shows great potential for translation, ongoing efforts include evaluating and improving the
stability of Ti3C2 for long-term use [226], [269], [360], optimizing the MXene infusion process
to maximize the MXene loading and conductivity of the resulting composite [315], and
exploring alternative encapsulation materials to further improve the flexibility and
breathability of the electrode arrays [120]. Overall, our results indicate that MXene-based
bioelectronics have tremendous potential for enabling the next generation of soft interfaces
for advanced healthcare diagnostics, monitoring and therapy, as well as for research and
consumer electronics.
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5.7 Materials and methods
Synthesis of Ti3C2 MXene
Ti3C2 MXene was provided by Murata Manufacturing Co., Ltd. It was produced using the MILD
synthesis method [232] to create an ink of 30 mg/mL Ti3C2 in deionized water, which was
placed in a vial and sealed under Argon atmosphere for long term storage.
Fabrication of MXtrode devices
Devices were fabricated by first laser-patterning absorbent nonwoven textile substrates
comprised of hydroentangled 55% cellulose / 45% polyester blend (Texwipe TechniCloth)
using a CO2 laser (Universal Laser Systems PLS 4.75) such that electrode array patterns were
easily separable from the surrounding textile, but could still be lifted and handled as one
sheet. These were transferred to a thin and slightly tacky bottom layer of 1:10 PDMS (Sylgard
184) on a flat acrylic sheet, and the excess textile surrounding the array patterns was then
peeled up. The textile patterns were then inked with 30 mg/mL Ti 3C2 MXene, allowed to air
dry for 15 min, then placed in a vacuum oven (Across International) at 70 °C and 60 mmHg
for 1 h to remove all remaining water. For devices incorporating 3D mini-pillar electrodes, 3
mm circles were cut from absorbent cellulose sponges (EyeTec Cellulose Eye Spears) using a
3 mm biopsy punch and these circular sponges were inked with MXene and placed onto the
electrode locations of the MXene-textile constructs at the same time that the laser-patterned
textile was inked. The subsequent drying steps were identical. No adhesive was necessary at
this interface, as the dried MXene and the subsequent PDMS encapsulation was sufficient to
hold the 3D mini-pillars firmly in place. For multichannel arrays, connectors (FCI/Amphenol
FFC&FPC clincher connectors) were then attached by screen printing silver conductive epoxy
(CircuitWorks CW2400) onto the ends of the dried MXene constructs, inserting these into the
connectors, and clinching shut. The devices were baked at 70 °C for 30 min to cure the silver
epoxy. Next, 1:10 PDMS was layered over the devices to form the top insulation layer,
thoroughly degassed at 60 mmHg for 15 min – which forced PDMS to infiltrate into the MXene
composite matrix – and subsequently cured at 70 °C for 1 h. Finally, devices were cut out with
a razor blade, and peeled up from the acrylic substrate. For planar electrodes, electrode
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contacts were exposed by cutting circular holes though the top PDMS layer using a biopsy
punch (diameters ranging from 500 µm – 3 mm) and carefully peeling up the disk of PDMS to
expose the MXene composite electrode below. For 3D mini-pillar electrodes, contacts were
exposed by trimming the tops of the mini-pillars with a flat razor blade, exposing the MXenesponge composite electrode. Slight variations on this method were utilized for MXtrode
arrays designed for different applications: for EMG arrays, a thin layer of silicone medical
adhesive spray (Hollister Adapt 7730) was applied to the skin-facing side of the array prior
to opening the electrode contacts to enhance skin adhesion; for single-channel ECG and EOG
MXtrodes, EcoFlex (Smooth-on Ecoflex 00-30) in a 1:2 ratio (part A:part B) was used as the
encapsulation rather than PDMS to offer enhanced skin adhesion and comfort; for the ECoG
electrodes, arrays were fabricated in PDMS as described above, but were additionally coated
in a 1 µm-thick layer of Parylene-C prior to opening electrode contacts to enhance the
moisture barrier properties of the encapsulation.
Imaging of MXtrode devices
Optical images of MXtrodes and their constituent parts were taken with a Keyence VHX6000
digital microscope. Scanning electron microscopy (SEM) images were captured using a Zeiss
Supra 50VP scanning electron microscope with an accelerating voltage of 5 kV.
DC conductivity of ink-infused composites
DC conductivity measurements were made on laser-cut test structures 20 cm long x 3 mm
wide x 285 µm thick comprising 55% cellulose / 45% polyester blend (Texwipe TechniCloth)
infused with either: (1) 30 mg/mL Ti3C2 MXene in DI, (2) 1.1% high conductivity grade
PEDOT:PSS in H2O (Sigma Aldrich), or (3) 18 mg/mL highly concentrated single-layer
graphene oxide (Graphene Supermarket) which was subsequently reduced using a vitaminC reduction method[361]. Measurements were taken with a handheld multimeter with flat
alligator clip terminations, where the negative lead was fixed at the end of the construct and
the positive lead was moved in 2 cm increments for each measurement.
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Electrochemical characterization
For cutaneous EIS measurements, the skin of the inner forearm was prepared with an alcohol
swab followed by light abrasion (3M TracePrep abrasive tape) before placing 3 mm planar
and 3D mini-pillar MXtrodes and measuring EIS from 1 – 105 Hz with a 10 mVpp driving
voltage using a Gamry Reference 600 potentiostat. Reference was placed on the inner wrist
and ground was placed on the elbow (Natus disposable disk electrodes). Electrochemical
measurements in saline, including EIS, CV, and current pulsing, were performed for planar
MXtrodes with diameters of 3 mm, 2 mm, 1 mm, and 500 µm, and Pt electrodes with a
diameter of 2.3 mm (Adtec epilepsy subdural grid TG48G-SP10X-000) in 10 mM phosphate
buffered saline (Quality Biological, pH 7.4) using a Gamry Reference 600 potentiostat. All
electrochemical measurements were done in a 3 electrode configuration with a graphite rod
counter electrode (Bio-Rad Laboratories, Inc.) and a Ag/AgCl reference electrode (SigmaAldrich). EIS was measured from 1 – 105 Hz with 10 mVpp driving voltage. Cyclic voltammetry
was performed at a sweep rate of 50 mV/s. Safe voltage limits for MXtrodes were determined
by incrementally increasing the negative limit of the CV scan until water reduction was
observed (beginning at −1.9 V), then the positive limit of the CV scan until a linear, resistive
behavior was observed (beginning at +0.7 V) beyond which the MXtrode showed current loss
with subsequent scans. CSCc was determined from the CV scans by taking the time integral of
the cathodal current. Current pulsing was performed using chronopotentiometry with
biphasic, charge-balanced current pulses with tc = ta = 500 µs and tip = 250 µs for currents
ranging from 600 µA to 5 mA for N=3 electrodes of each size. For CICc calculations, Emc was
determined as the instantaneous voltage 10 µs after the end of the cathodal current pulse. Emc
values were plotted as a function of injected current amplitude, and the linear relation was
determined to estimate the current limit at which the electrode would reach its cathodal limit
(−1.8 V for MXtrodes, −0.6 V for Pt). Any series of measurements in which current amplitude
vs. Emc was not linear with R2 < 0.95 were excluded. CICc was defined as: 𝐶𝐼𝐶 =

×

, where

Ilim is the cathodal current limit, tc is the cathodal pulse width, and GSA is the electrode
geometric surface area. CSC and CIC scaling relations were determined by fitting power
functions to the data, similar to work by M. Ganji et al [317].
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EEG experiments
EEG experiments were conducted under a protocol approved by the Institutional Review
Board of Drexel University (Protocol # 1904007140). One healthy human subject was seated
in a comfortable chair with a head rest. Prior to placing electrodes, the subject’s scalp was
prepared with an alcohol swab and light abrasion (3M TracePrep abrasive tape), though the
presence of hair may have limited the efficacy of the skin abrasion. Recordings were made
using an 8-electrode MXtrode device with dry 3 mm-diameter 3D mini-pillar electrodes and
1 standard gelled Ag/AgCl EEG cup electrode (Technomed Disposable EEG cup) placed in the
center of the MXtrode array. Recordings were obtained using a NeuroNexus SmartBox
amplifier system with a sampling rate of 20 kHz. Standard gelled Ag/AgCl EEG cup electrodes
were used for reference (placed on left mastoid) and ground (placed on forehead center). In
the first set of recordings, electrodes were positioned on the parietal region, centered over
10-20 site P1. Pre-wrap (Mueller) was used to hold the electrodes in place, and a small hole
was made in this wrapping to allow application of conductive gel (SuperVisc, EASYCAP
GmbH) beneath the standard EEG cup electrode. To evoke identifiable changes in the alpha
band[362], six 2-minute-long recordings were obtained, alternating between eyes open and
eyes closed states. During resting state, the subject was instructed to remain relaxed but alert.
For the eyes open state, the subject was asked to fixate on a cross on a computer monitor to
reduce oculomotor saccades and maintain a consistent level of external vigilance. In the
second set of recordings, the hand motor region was localized using single TMS pulses to
isolate a location that evoked lateral finger movements [363] via induced contractions of the
first dorsal interosseus, and the electrodes were positioned centered over this location,
approximately at site C3. Six 2-minute-long recordings were obtained, cycling through a
resting state, imagined hand flexion, and actual hand flexion. Signals were notch filtered at 60
Hz and bandpass filtered from 0.1 – 100 Hz. Bridging analysis was performed to ensure that
gel did not leak from the cup electrode to contact any recording surface on the MXtrode array.
EMG experiments
EMG, ECG, and EOG human epidermal recordings were conducted under an experimental
protocol approved by the Institutional Review Board of the University of Pennsylvania
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(Protocol # 831802). For all EMG experiments, skin preparation prior to placing MXtrode
arrays included an alcohol swab followed by light abrasion (3M TracePrep abrasive tape),
and signals were recorded at a sampling rate of 20 kHz on an Intan RHS2000
Stimulation/Recording Controller (Intan Technologies). For recordings from abductor
pollicis brevis (APB), a 5x4 grid of 3 mm planar MXtrodes with center-to-center spacing of
7.5 mm horizontal, 6.5 mm vertical, was placed over the APB at the base of the thumb.
Reference was placed over the bony interphalangeal thumb joint and ground was placed on
the back of the hand (Natus disposable adhesive electrodes). The median nerve was
stimulated at the wrist using a VikingQuest handheld bipolar stimulator (Nicolet), starting at
10 mA and gradually increasing until supramaximal activation of the APB was achieved in the
form of a thumb twitch (amplitude 38.8 mA for the subject shown). For localization of the
NMJ of the APB, evoked responses recorded on each electrode in the array (no signal filtering
was used) were averaged across all stim trials (N=10), the peak of the average evoked
response was determined, and a map of the latency of this peak from the onset of the
stimulation was created. The location of the NMJ was approximated as the location with the
shortest latency in the peak evoked response. For recordings of the biceps, a 10x4 grid of 3
mm planar MXtrodes with center-to-center spacing of 8.5 mm horizontal, 8.5 mm vertical,
was placed over the center of the biceps muscle. Reference was placed distal to the array just
above the inner elbow and ground was placed proximal to the array on the deltoid (Natus
disposable adhesive electrodes). The supraclavicular nerve was stimulated using the same
VikingQuest handheld bipolar stimulator (Nicolet), starting at 30 mA and gradually
increasing until clear submaximal activation of biceps was observed (amplitude 49.0 mA for
the subject shown). As for the APB recordings, evoked responses recorded on each electrode
were averaged across all stim trials (N=11), the peak of the average evoked response was
determined, and a map of the latency of this peak from the onset of the stimulation was
created. The IZ was determined as the area with the shortest latency in the peak evoked
response. To further validate the IZ localization in the biceps, additional EMG recordings
were made with the subject performing periods of isometric voluntary contractions. Signals
were subtracted in bipolar configuration down the length of the MXtrode array, and MUAPs

141

Chapter 5: Human-scale, translational neurodevices using Ti3C2 MXene

were identified in the raw EMG signal. The IZ was determined as the region where the MUAP
appears earliest and where the signal polarity inverts.
ECG recording
For ECG recording experiments, skin preparation prior to placing electrodes included an
alcohol swab followed by light abrasion (3M TracePrep abrasive tape), and signals were
recorded at a 20 kHz sampling rate on an Intan RHS2000 Stimulation/Recording Controller
(Intan Technologies). Recordings were made in a 3-electrode configuration with reference
placed just below the subject’s right clavicle, ground placed just below the subject’s left
clavicle, and the working electrode placed on the lower left ribs. For comparison, recordings
were made sequentially using either all 2 cm gelled Natus electrodes (Natus disposable
adhesive electrodes) or all 1.3 cm dry MXtrodes, with electrodes placed in the same locations.
EOG recording
EOG recording experiments followed a similar protocol to ECG recording. Skin preparation
prior to placing the electrodes included an alcohol swab followed by light abrasion (3M
TracePrep abrasive tape), and signals were recorded at a 20 kHz sampling rate on an Intan
RHS2000 Stimulation/Recording Controller (Intan Technologies). 1.3 cm-diameter dry
MXtrodes were used for ground, (+) and (-) contacts. For tracking up-down eye movements,
the (+) and (-) electrodes were placed below and above the right eye, respectively. The
subject moved their eyes in a center-down-center-up-center pattern for 2 minutes. For
tracking left-right eye movements, the (+) and (-) electrodes were placed just lateral to the
left and right eyes, respectively. The subject moved their eyes in a center-left-center-rightcenter pattern for 2 minutes. The ground electrode was centered on the forehead for both
EOG recording paradigms.
ECoG recording
Pigs were pair housed when possible and were always in a shared room with other pigs in a
research facility certified by the Association for Assessment and Accreditation of Laboratory
Animal Care International (AAALAC facility). All experiments were conducted according to
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the ethical guidelines set by the Institutional Animal Care and Use Committee of the
University of Pennsylvania and adhered to the guidelines set forth in the NIH Public Health
Service Policy on Humane Care and Use of Laboratory Animals (2015). Prior to the
procedures, animals were fasted for 16 hours with water remaining ad libitum. After
induction with 20 mg/kg of ketamine (Hospira, 0409-2051-05) and 0.5 mg/kg of midazolam
(Hospira, 0409–2596-05), anesthesia was provided with using 2−2.5% isoflurane (Piramal,
66794-013-25) via a snout mask and glycopyrrolate was given subcutaneously to curb
secretions (0.01 mg/kg; West-Ward Pharmaceutical Corp., 0143-9682-25). The animals were
intubated with a size 6.0 mm endotracheal tube and anesthesia was maintained with 2−2.5%
isoflurane per 2 liters O2. Animals were then moved to an operating room, where they were
transferred onto a ventilator. The ventilator provided the same rate of isoflurane and O 2 for
anesthesia maintenance at a rate of 20-25 breaths per minute. Heart rate, respiratory rate,
arterial oxygen saturation, end tidal CO2, blood pressure and rectal temperature were
continuously monitored, while pain response to pinch was periodically assessed. All of these
measures were used to maintain an adequate level of anesthesia. A forced air warming
system was used to maintain normothermia. Prior to electrode insertion, the pig was placed
in a stereotaxic frame described previously [364], and the surgical site was prepared and
draped in the standard sterile fashion. After the skull was exposed, an 11 mm craniectomy
was performed at the recording site, 7 mm lateral to midline and 4.5 mm posterior to bregma
in order to expose the frontoparietal cortex. The dura was opened to expose the cortical
surface and the MXtrode array was then placed in the subdural space for recording.
Recordings were obtained using an HS-36 amplifier and collected continuously at 32 kHz
using a Neuralynx Digital Lynx SX recording system. Raw data was collected and stored using
Neuralynx’s Cheetah recording software.
Cortical stimulation
An adult male Sprague Dawley rat (Crl:SD, 300 g) was used for the stimulation experiment.
Anesthesia was induced with 5% isoflurane and the rat was placed in a stereotaxic frame.
Depth of anesthesia was monitored by respiratory rate and pedal reflex and maintained at a
surgical plane with 1.5−2.5% isoflurane. Whisker motor cortex (wM1) was exposed
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bilaterally with a craniotomy centered on the midline. A durotomy was performed over right
wM1. A stimulation return skull screw was placed in the left frontal bone. Trains of biphasic
current pulses (300 µs/phase, 3 µs interpulse interval, 100 pulses, variable pulse amplitude
from 1.0 to 1.4 mA) were delivered through a single electrode in the MXtrode array using the
Intan RHS System (Intan Technologies). Stimulus-evoked contralateral whisker movement
was quantified with a laser micrometer (IG-028, Keyence Corp.), which had a measurement
range of 28 mm, a spatial resolution of 5 µm, and a temporal resolution of 490 µs. A 360 µm
diameter polyimide tube was placed over a whisker with visually apparent stimulus evoked
movement. Spatial sensitivity of the micrometer was adjusted to detect only the motion of
the whisker in the tube [365]. At the conclusion of the experiment, the rat was killed with an
intraperitoneal injection of sodium pentobarbital. These procedures were approved by the
Institutional Animal Care and Use Committee of the University of Pennsylvania.
Evaluation of MRI and CT compatibility
A strip of six 3 mm-diameter MXtrodes were prepared with PDMS encapsulation to match the
geometry of the comparison Pt clinical ECoG electrode strips (Adtec epilepsy subdural grid
TG48G-SP10X-000). Both types of electrode arrays were placed in 0.6% agarose (IBI
Scientific) prepared with 10 mM PBS (Quality Biological, pH 7.4) in a 15 mm inner-diameter
glass test tube, with degassing to remove air bubbles. A 9.4 T Horizontal bore MRI scanner
(Bruker, Erlangen) and 35 mm diameter volume coil (m2m Imaging, USA) were used to
acquire T1-weighted gradient echo MR images of cross-sections of both electrode types. The
acquisition parameters for T1-W MRI were: TE/TR = 7/150 ms, FOV = 30x30 mm 2, Matrix
size = 256x256, Averages = 4, Flip angle = 30°, slice thickness = 0.7 mm. For CT imaging, a
µCT50 specimen scanner (Scanco Medical, Bruttisellen, Switzerland) was used to scan the
electrodes at 70 kV, 115 µA, and 10 µm isotropic resolution. 2D images in the axial plane of
each electrode type were acquired for comparison.
Magnetic susceptibility measurements
Magnetic properties of Ti3C2 were measured with Quantum Design EverCool II physical
property measurement system. A free-standing film of Ti 3C2 with a mass of 4.820 mg was
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packed in a plastic sample container. The sample was heated to 310 K and was allowed to
reach thermal equilibrium for about 10 min. Magnetization was recorded with respect to the
applied magnetic field up to 9 T. The measured data was subtracted from that of the plastic
sample holder and normalized by sample mass.
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5.8 Supplementary material: MXtrode stability
Given the promise of MXtrodes for numerous applications, there has already been
considerable interest in commercializing the technology. One important factor to consider is
the usable “shelf life” of MXtrodes stored in ambient conditions, given prior knowledge that
Ti3C2 MXene is prone to oxidation. To assess the stability of MXtrodes in ambient conditions,
I performed periodic EIS testing of two 10 channel MXtrode arrays stored in air over a period
of 6 months.
Methods
Two, 10 channel planar MXtrode arrays with 3 mm-diameter contacts were
fabricated for the evaluation. For device 1, EIS was performed in PBS for all 10 channels every
two weeks. Following EIS, the device was rinsed with DI water, gently dried with a Kim Wipe,
then baked at 70°C for 1 h. For device 2, EIS was performed in PBS for channels 1-6 every two
weeks and for channels 7 and 8 at fewer selected time points. Channels 9 and 10 were not
tested until the final time point. Care was taken not to expose the un-tested channels to PBS
or to DI water. Following EIS, the channels which were tested were rinsed with DI water and
gently dried with a Kim Wipe. Device 2 was not baked. Between tests, both devices were
stored in a foil pouch in ambient conditions.
Results
Bode plots of the impedance magnitude and phase at a few selected time points are
shown in Figure 5.18 for Device 1 (all channels) and Device 2 (channels 1-6) and plots
showing the progression of impedance values at 1 kHz and at 10 Hz are shown in Figure 5.19.
Throughout the course of the study the impedance gradually increased, however the changes
were most pronounced in the first 6 weeks. The changes were also more pronounced at low
frequencies. By week 16, the MXtrodes stabilized, and they showed little change in the last 10
weeks of the study. Accompanying the rise in impedance magnitude, the phase behavior
dramatically shifted, consistent with the formation of a porous oxide layer on the surface of
the electrodes. Comparing between the two devices, Device 1 showed faster oxidation and
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stabilized to a higher overall impedance value compared to Device 2, indicating that the
baking step following the EIS testing likely contributed to oxidation, as expected.

Figure 5.18 EIS spectra for two MXtrode devices over 26 weeks. (a-b) Impedance modulus (a) and
phase (b) shown at selected time points for Device 1. All 10 channels were tested every 2 weeks and
Device 1 was baked following each test. (c-d) Impedance modulus (c) and phase (d) shown at selected
time points for Device 2. Only channels 1-6 were tested every 2 weeks, and no baking was performed
following EIS testing.

An important concern in the test design is how much the periodic EIS testing
contributed to accelerating the oxidation and degradation of the devices. Because the
electrodes are exposed to PBS and DI water during each test, and because moisture is known
to accelerate Ti3C2 oxidation, the results may not accurately represent the aging conditions of
a device left in ambient air for a prolonged period, and thus may not give an accurate measure
of the stable “shelf life” of the devices. To assess the contribution of the periodic EIS testing
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Figure 5.19 1 kHz and 10 Hz impedance values monitored over 26 weeks. (a) 1 kHz impedance
values over time for Devices 1 and 2. Device 1 was baked following each test, while Device 2 was not.
(b) 10 Hz impedance over time for Devices 1 and 2. (c-d) Normalized impedance change from initial
value at (c) 1 kHz and (d) 10 Hz for each device.

to the rate of oxidation, 4 channels on Device 2 were held aside and tested at fewer time
points: channels 7 and 8 were tested at four time points throughout the study, and channels
9 and 10 were only tested at the final time point. The results, shown in Figure 5.20, indicate
that channels 7 and 8 had undergone significantly less oxidation by the final time point than
the channels which were tested more frequently, suggesting that the EIS testing does
accelerate the degradation. The behavior of channels 9 and 10, however, do not match
expectations. These two channels were never exposed to PBS prior to testing at the final time
point, thus we expected to see significantly less oxidation than any of the other channels, and
phase behavior similar to that of un-aged MXtrodes at the initial time point. While the
impedance at 1 kHz was lower than the other channels, the impedance in the low frequency
regime was higher than expected. Furthermore, the phase behavior of these channels was
unlike that of the other MXtrodes channels at any time point in the study.
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Despite the formation of the oxide layer over the course of the study, even the aged
MXtrodes that appear to have reached a stable state of oxidation still have low enough
impedance that they may be able to record biosignals, though likely with reduced signal
fidelity. Further evaluation will be needed to fully assess the useable shelf life of MXtrodes,
and to determine an acceptable level of oxidation for functional devices.

Figure 5.20 Effect of repeated impedance testing on device aging. (a-b) Impedance modulus (a)
and phase (b) at the final 26 week time point for subsets of channels on Device 2, which were tested
with varying frequencies. Channels 1-6 were tested every 2 weeks for a total of 13 tests by the final
time point. Channels 7 and 8 were tested 4 times throughout the study. Channels 9 and 10 were tested
only at the final time point. (c-d) 1 kHz (c) and 10 Hz (d) impedance values over time for each subset
of channels.
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In this thesis, I have developed neurotechnologies that leverage unique properties of
carbon nanomaterials to enable recording and modulating neural and neuromuscular activity
across spatial scales. Starting at the microscale, I showed how transparent graphene
microelectrodes could be used with simultaneous optical imaging to enable new insights into
microscale brain dynamics. By optimizing the fabrication and processing of transparent
graphene electronics, I improved the impedance and optical transparency properties of the
electrodes beyond what had previously been reported. Still, such graphene-based
transparent electrodes reach a fundamental limit in how far impedance can be reduced due
to the quantum capacitance of graphene [144]. Thus, it remains challenging to scale
transparent graphene electrodes down to the dimensions required for resolving neuronal
spiking activity (~10s of µm) because their high impedance at these scales significantly
degrades the recorded signal quality. New materials may soon enable transparent electrodes
at these scales, however, and Ti3C2 MXene is a very promising candidate. A number of recent
studies have shown that thin films of Ti3C2 MXene can achieve an optoelectronic figure of
merit that meets or even exceeds that of CVD-grown graphene [21], [366], [367]. In Chapter
4 of this thesis, I showed that non-transparent Ti3C2 microelectrodes are highly sensitive for
recording neural spiking activity. It would be a fairly simple matter to tune the processing
conditions to fabricate similar Ti3C2 microelectrodes where the MXene films are optically
transparent, and it seems plausible that such electrodes could achieve lower impedance than
their graphene counterparts. In the future, Ti3C2 could push the bounds of transparent
microelectrode density and spatial resolution beyond what is possible with graphene.
In Chapter 3, I also presented a new approach for combining multimodal data to
harness the key advantages of electrophysiology and optical imaging, while accounting for
their differences in temporal and spatial sampling. Such an approach can help elucidate the
relation between individual cellular activity and network oscillations observed in neurologic
phenomenon such as epileptogenesis. For example, high frequency oscillations (HFOs) have
been proposed as a biomarker for identifying the seizure onset zone in epilepsy and for
predicting epileptogenesis following cerebral insult or prolonged febrile seizures [183]–
[185]. HFOs can also occur in the healthy brain, however, and distinguishing between normal
and pathologic HFOs has been the subject of some debate [368]. It is now believed that
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different cellular mechanisms give rise to normal and pathologic HFOs, however it has been
challenging to study this phenomenon because the oscillations are too fast to be detected
using optical imaging methods alone. The multimodal approach presented in Chapter 3 offers
the necessary spatiotemporal resolution to begin to answer these questions. By using
genetically-targeted optical reporter molecules, it may be possible to discern the individual
contributions of specific neuronal and even glial sub-types to broader network oscillations
such as HFOs.
In Chapter 4, I introduced Ti3C2 MXene as a new material for neural microelectrodes.
I showed that Ti3C2 electrodes offered lower impedance, lower noise, and improved neural
recording performance compared to gold electrodes. This was the first demonstration of any
MXene for in vivo electrophysiology, and it identified the tremendous potential of MXenes for
bioelectronics. Motivated by this success, I then developed a new class of MXene
bioelectronics suitable for human-scale electrophysiology, with a focus on clinical
translation. These MXtrodes, which are fast, simple, and low-cost to produce, have excellent
electrochemical properties, outperforming current state-of-the-art electrode materials. In
particular, their low electrode-skin interface impedance enables gel-free epidermal
recording with high spatial resolution, which has been challenging for epidermal electronics.
Of the epidermal applications shown in Chapter 4, gel-free, high-density EEG with
MXtrodes is one that has generated significant interest. In current clinical practice, recording
an EEG requires a certified EEG technician to measure and individually place each gelled EEG
electrode on the subject’s scalp. This process is time-consuming, thus limiting the ability to
rapidly obtain EEG in emergency situations, and it is costly to health systems to staff certified
EEG technicians around-the-clock. The conductive gels used with current EEG electrodes
leave unwanted residues in the hair, and in patients who require long-term EEG monitoring
they can cause skin irritation and breakdown as well as impedance fluctuations over time as
the gels dry out. This often necessitates periodic replacement of the gels, which is again a
time-consuming process requiring an EEG technician. Given the success of MXtrodes in
recording high-quality EEG signals without any conductive gel, it’s possible that MXtrodes
could be incorporated into an EEG cap or headband system that could be deployed rapidly
without the need for a certified EEG technician. This could significantly improve access to
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rapid EEG diagnostics in emergency and trauma situations. It could also enable simpler athome monitoring for epilepsy patients, if they could put on the cap or headband system
themselves at home and stream the data to a secure cloud-based platform where a clinician
could monitor the EEG. More work is certainly needed to develop such a system, particularly
in ensuring that the gel-free MXtrodes can achieve good scalp contact in subjects with long or
thick hair, but initial results are promising.
In addition to clinical EEG applications, high-density EEG enabled by the mm-scale
dry MXtrodes has also generated significant interest in the research community. High-density
EEG can be used to study important phenomena in cognitive neuroscience and in sleep
research, and can also be used as a non-invasive tool for epilepsy source localization [369]. It
is also of great interest to the BCI community, where enhanced spatial resolution can improve
decoding accuracy for non-invasive EEG-based BCIs [370]. So far, the spatial resolution of
EEG has been limited because gelled electrodes can experience bridging when placed too
close together, and because dry electrodes have so far required scalp contact areas >1 cm 2 in
order to achieve sufficiently low interface impedance. Thus, it is not yet clear what the limit
of scalp EEG resolution is, in part because there have not been electrodes capable of pushing
the spatial sampling down to sub-cm scales. MXtrodes could enable studies to begin to
answer this question. Spatial smearing from the skull and scalp as well as volume conduction
surely limit the unique information content that can be obtained from closely adjacent scalp
electrodes. However, techniques such as independent component analysis can help to detect
subtle differences to leverage high spatial sampling [371].
Another key advantage of the MXtrodes is their compatibility with clinical imaging
techniques. In clinical practice, inpatients requiring long-term EEG monitoring are often set
up with MRI-compatible EEG leads so that they can be disconnected and taken for diagnostic
imaging without requiring the EEG electrodes to be removed and replaced. Current MRIcompatible leads are very expensive, however, and MXtrodes may offer a significantly lowercost solution. In research, the compatibility of MXtrodes with clinical imaging techniques
opens new possibilities for multimodal studies combining EEG with imaging. Concurrent
collection of EEG with fMRI or metabolic imaging such as GluCEST can yield complementary
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information to enable new insights into brain activity, similar to the advantages of
multimodal recording described in Chapter 3, albeit on a different scale.
Beyond epidermal recording applications, the MXtrodes were also found to possess
exceptional electrochemical properties in saline, suggesting that they could outperform Pt
and other noble metals in implantable electrodes. This observation matched the results
shown for the Ti3C2 microelectrodes, which had ~4x lower impedance compared to sizematched Au electrodes. The MXtrodes have a slightly different morphology than the
microelectrodes shown in Chapter 4, because the electrode contact is comprised of a MXenecoated textile composite rather than a pure thin film of Ti3C2. This is strong evidence that the
unique properties of Ti3C2 are largely responsible for the exceptional electrochemical
performance of MXene-based electrodes, though the electrode surface morphology and
roughness certainly play a role.
One striking finding is that MXtrodes have significantly enhanced CSC c and CICc
compared to Pt and other common materials used for stimulation electrodes. The use of
implantable neuromodulation systems to treat neurological conditions is rapidly expanding,
with deep brain stimulation used to treat the motor symptoms of Parkinson’s disease, vagus
nerve stimulation used to treat depression and other conditions, and newer responsive
neuromodulation systems developed for epilepsy seizure control such as the NeuroPace and
Medtronic RC+S. These systems rely on safe, efficient charge transfer through their
stimulation electrodes, and the efficiency of charge delivery has a significant effect on the
battery life of the implanted system. While more work is needed to fully characterize the
stimulation efficiency and safety of MXene-based electrodes, the results shown in this thesis
suggest that they could offer more efficient stimulation performance, potentially prolonging
the battery life of such implanted systems.
A notable caveat to any notion of using MXene for implantable electrodes is their poor
oxidation stability in physiologic environments. Further optimization of the synthesis and
processing conditions will be needed to realize stable MXene compositions for chronic
bioelectronic applications. Significant progress toward oxidation-resistant MXene
compositions has been made just in the past two years, however, so there is hope that this
challenge can be overcome in the future.
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The ultimate goal of this thesis was to develop new neurotechnologies that could
expand our capabilities for recording and modulating neural and neuromuscular activity.
Interfacing manmade electronics with biological tissues presents numerous challenges, and
it is clear that new materials and fabrication methods can offer solutions to some of these
challenges. In this work, I’ve shown that the unique properties of graphene and MXene can
be harnessed to offer new capabilities for high-resolution neural recording and stimulation
electrodes. Additionally, the fabrication methods developed here represent a significant step
toward translating nanomaterial-based technologies beyond academic research by
improving scalability. It is my hope that these technologies will enable future research studies
aimed at unraveling complex neural dynamics, as well as advances in clinical monitoring and
diagnostics to improve patient care.
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arrays for in vivo neural recording
Abstract
Implantable microelectrode technologies have been widely used to elucidate neural
dynamics at the microscale to gain a deeper understanding of the neural underpinnings of
brain disease and injury. As electrodes are miniaturized to the scale of individual cells, a
corresponding rise in the interface impedance limits the quality of recorded signals.
Additionally, conventional electrode materials are stiff, resulting in a significant mechanical
mismatch between the electrode and the surrounding brain tissue, which elicits an
inflammatory response that eventually leads to a degradation of the device performance. To
address these challenges, we have developed a process to fabricate flexible microelectrodes
based on Ti3C2 MXene, a recently discovered nanomaterial that possesses remarkably high
volumetric capacitance, electrical conductivity, surface functionality, and processability in
aqueous dispersions. Flexible arrays of Ti 3C2 MXene microelectrodes have remarkably low
impedance due to the high conductivity and high specific surface area of the Ti 3C2 MXene
films, and they have proven to be exquisitely sensitive for recording neuronal activity. In this
protocol, we describe a novel method for micropatterning Ti 3C2 MXene into microelectrode
arrays on flexible polymeric substrates and outline their use for in vivo microelectrocorticography recording. This method can easily be extended to create MXene
electrode arrays of arbitrary size or geometry for a range of other applications in
bioelectronics and it can also be adapted for use with other conductive inks besides Ti 3C2
MXene. This protocol enables simple and scalable fabrication of microelectrodes from
solution-based conductive inks, and specifically allows harnessing the unique properties of
hydrophilic Ti3C2 MXene to overcome many of the barriers that have long hindered the
widespread

adoption

of

carbon-based

nanomaterials

microelectrodes.
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1. Synthesis of Ti3C2 MXene
NOTE: The reaction procedures described in this section are intended for use inside a
chemical fume hood. Washing steps included in this procedure are intended to be used with
balanced centrifuge tubes. All waste produced is considered hazardous waste and should be
discarded appropriately following University guidelines.
CAUTION: Hydrofluoric acid (HF) is an extremely dangerous, highly corrosive acid. Consult
the materials safety data sheets (MSDS) for the chemicals used to synthesize MXenes before
use and implement and follow appropriate safety measures. Appropriate personal protective
equipment (PPE) for handling HF includes a laboratory coat, acid resistant apron, close-toed
shoes, long pants, goggles, full face shield, nitrile gloves, and HF resistant gloves made of butyl
rubber or neoprene rubber.
1.1. MAX phase synthesis: The Ti3AlC2 MAX phase precursor used to synthesize MXenes has
been shown to have direct implications on the resulting Ti3C2 MXene properties[372].
The Ti3C2 used to fabricate neural electrodes was selectively etched from MAX prepared
following a previous procedure.[224] Ti3AlC2 was synthesized by ball milling TiC (2 µm),
Ti (44 µm), and Al (44 µm) powders at a molar ratio (TiC:Ti:Al) of 2:1:1 for 18 h using
zirconia balls. Then, the powders were placed in an alumina crucible and heated to 1380
°C (5 °C heating rate) and held for 2 h under argon. After the powders have been cooled,
the MAX block was milled and sieved through a 200 mesh sieve (< 74 µm particle size).
1.2. Etching: Removal of the Al layer in Ti3AlC2 in an acidic etchant solution. Prepare the
selective etching solution in a 125 mL plastic container by first adding 12 mL deionized
water (DI H2O) followed by the addition of 24 mL hydrochloric acid (HCl). Wearing all
appropriate HF etching PPE, add 4 mL of hydrofluoric acid (HF) to the etchant container.
Perform selective etching by slowly adding 2 g Ti 3AlC2 MAX phase to the reaction
container and stirring with a Teflon magnetic bar for 24 h at 35 °C at 400 rpm.
1.3. Washing: Bringing the material to neutral pH. Fill (2) 175 mL centrifuge tubes with
100 mL of deionized water. Split the etching reaction mixture into 175 mL centrifuge
tubes and wash the material by repeated centrifugation at 3500 rpm (2550 rcf) for 5
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min. Decant the acidic supernatant into a plastic hazardous waste container. Repeat until
the pH reaches 6.
1.4. Intercalation: Insertion of molecules between multilayer MXene particle to waken
out-of-plane interactions. Add 2 g lithium chloride (LiCl) to 100 mL of DI H2O and stir
at 200 rpm until dissolved. Mix 100 mL of LiCl/H2O with the Ti3C2/Ti3AlC2 sediment and
stir the reaction for 12 h at 25 °C.
1.5. Delamination: Exfoliation from bulk multilayer particle into single- to few- layer
Ti3C2 MXene. Wash the intercalation reaction in 175 mL centrifuge tubes by
centrifugation at 3500 rpm for 5 min. Decant the clear supernatant. Repeat until a dark
supernatant is found. Continue to centrifuge for 1 h at 3500 rpm (2550 rcf). Decant the
dilute-green supernatant. Re-disperse the swollen sediment with 150 mL of DI H 2O (redispersion will become difficult and will require agitation or manual shaking). Transfer
supernatant to 50 mL centrifuge tubes and centrifuge at 3500 rpm for 10 min to separate
remaining MAX (sediment) from MXene (supernatant). Collect supernatant as Ti 3C2
MXene. Further size selection and optimization of the solution should be performed to
isolate single- to few-layer flakes by collecting the supernatant following a
centrifugation step at 3500 rpm for 1 h.
1.6. Solution Storage: Packaging the MXene ink for long-term storage. Solutions are
Argon bubbled for 30 min prior to packaging in an Argon sealed headspace vial (transfer
via a syringe). Solutions are stored at high concentrations (> 5 mg/mL), away from
sunlight, and at low temperatures (≤ 5 °C) to ensure longevity.

2. Fabrication of Ti3C2 MXene Microelectrode Arrays
NOTE: The procedure described in this section is intended for use inside a standard
university clean room facility, such as the Singh Center for Nanotechnology at the University
of Pennsylvania. This facility, as well as similar facilities, are accessible to outside users as
part of the National Nanotechnology Infrastructure Network (NNIN) supported by the
National Science Foundation (NSF). In these facilities, many of the tools, equipment, and
materials described in this section are provided along with access to the clean room facility
and would not require separate purchase.
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CAUTION: Many of the chemicals used in the fabrication of MXene electrodes are hazardous,
including photoresists, RD6 developer, remover PG, aluminum etching solution, and buffered
oxide etchant. Consult the materials safety data sheets (MSDS) for these chemicals before use
and implement and follow appropriate safety measures at all times.
2.1. Deposit a 4 μm-thick bottom layer of parylene-C onto a clean Si wafer. (Figure A1a)
2.2. Use the first photomask (mask-1) to define the metal interconnects of the devices,
as well as a metal ring around the edge of the wafer to aid in later lift-off steps.
(Figure A1b)
2.2.1. Spin coat NR71-3000p onto the wafer at 3000 rpm for 40 s.
2.2.2. Soft bake the wafer on a hot plate for 14.5 min at 95 °C.
2.2.3. Load the wafer and mask-1 into a mask aligner. Position the wafer so that the ring
on the photomask overlaps with all edges of the wafer.
2.2.4. Expose with i-line (365 nm wavelength) at a dose of 90 mJ/cm2.
2.2.5. Hard bake the wafer on a hot plate for 1 min at 115 °C.
2.2.6. Immerse the wafer in RD6 developer for 2 min, continuously agitating the
solution. Rinse thoroughly with DI and blow dry with an N 2 gun.
2.2.7. Use an electron beam evaporator to deposit 10 nm Ti, followed by 100 nm Au
onto the wafer. NOTE: Typical deposition parameters are a base pressure of 5 x 10 7

Torr and a rate of 2 Å/s.

2.2.8. Immerse the wafer in remover PG for approximately 10 min until the photoresist
has dissolved and the excess metal has fully lifted off, leaving Ti/Au only in the
desired interconnect traces and the ring around the edge of the wafer. Once lift-off
appears complete, sonicate for 30s to remove any remaining traces of unwanted
metal. Rinse wafer first in clean remover PG solution, then thoroughly rinse in DI
H2O and dry the wafer with an N2 gun.
2.3. Deposit the sacrificial parylene-C layer. (Figure A1c)
2.3.1. Expose the wafer to O2 plasma for 30 s to render the underlying parylene-C layer
hydrophilic.
2.3.2. Spin coat 2% Micro-90 in DI H2O solution onto the wafer at 1000 rpm for 30 s.
This dilute soap solution acts as an anti-adhesive, allowing the sacrificial parylene158
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C layer to be peeled up later in the process. Allow wafer to air dry for at least 5
mins.
2.3.3. Deposit 3 μm of parylene-C onto the wafer
2.4. Use the second photomask (mask-2) to define the MXene patterns and a ring
around the edge of the wafer. (Figure A1d)
2.4.1. Repeat steps 2.2.1 through 2.2.6, this time using mask-2 and carefully aligning the
alignment marks between the wafer and photomask before exposure.
2.4.2. Use O2 plasma reactive ion etching (RIE) to etch through the sacrificial paryleneC layer in the areas not covered by the photoresist to define the MXene electrodes
and traces, which should partially overlap with the Ti/Au interconnects, as well as
the ring around the edges of the wafer. Confirm complete etching of the sacrificial
parylene-C layer by using a profilometer to measure the profile between the
exposed Ti/Au interconnects and the bottom parylene-C layer. When etching is
complete, the profile across the exposed metal surface will be smooth, while the
bottom parylene-C layer will be rough and partially etched. NOTE: This etch step
should be completed in a planar etch RIE system, not a barrel asher, and etch times
and parameters will be highly dependent on the RIE system.
2.5. Spin-coat the MXene solution onto the wafer. (Figure A1e)
2.5.1. Pipette MXene solution onto each of the desired MXene patterns, then spin the
wafer at 1000 rpm for 40 s.
2.5.2. Dry the wafer on a 120 °C hot plate for 10 mins to remove any residual water from
the MXene film.
2.6. Use an electron beam evaporator to deposit 50 nm SiO2 onto the wafer, to act as a
protective layer over the MXene patterns for subsequent processing steps. NOTE:
Typical deposition parameters are a base pressure of 5 x 10-7 Torr and a rate of 2 Å/s.
2.7. Remove the sacrificial parylene-C layer to pattern the MXene and SiO2 layers.
(Figure A1f).
2.7.1. Apply a small drop of DI H2O to the edge of the wafer and use tweezers to peel up
the sacrificial parylene-C layer, beginning where its edges are defined in the ring

159

Appendix A: Fabrication of Ti3C2 MXene microelectrode arrays for in vivo neural recording

Figure A1. Schematics of the fabrication procedure for MXene microelectrode arrays. (a) Bottom
parylene-C layer is deposited on a clean Si wafer. (b) Ti/Au (10 nm/100 nm) conductive traces are
patterned through photolithography, e-beam deposition, and lift-off. (c) An anti-adhesive layer of 1%
Micro-90 in DI H2O is applied, followed by deposition of a sacrificial parylene-C layer. (d) The
sacrificial parylene-C layer is patterned through photolithography and O2 RIE etching. (e) Ti3C2
MXene is spin-coated onto the wafer, followed by e-beam deposition of 50 nm of SiO2. (f) The sacrificial
parylene-C layer is lifted off, residues of Micro-90 are rinsed off, and the wafer is baked dry. (g) Top
parylene-C layer is deposited. (h) An Al etch mask layer is patterned through photolithography, e-beam
deposition, and lift-off to define VIAs and device outline. (i) Parylene-C over electrode contacts and
surrounding devices is etched away through O2 RIE. (j) Al etch mask and SiO2 protective layer over
MXene are etched away through wet etch processes. (k) Finished device is lifted off wafer.

around the outside of the wafer. The water will combine with the soap residue
beneath the sacrificial parylene-C layer to enable this lift-off.
2.7.2. Rinse the wafer thoroughly in DI H2O to remove any remaining Micro-90 residue.
Dry the wafer with an N2 gun, then place on a 120 °C hot plate for 1 h to remove
any residual water from the patterned MXene films.
2.8. Deposit the 4 μm-thick top layer of parylene-C. (Figure A1g)
2.9. Use the third photomask (mask-3) to define device outline and openings over
electrodes and Au bonding pads (VIAs) (Figure A1h)
2.9.1. Repeat steps 2.2.1 through 2.2.6, this time using mask-3 and carefully aligning the
alignment marks between the wafer and photomask before exposure.
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2.9.2. Use an electron beam evaporator to deposit 100 nm Al onto the wafer. NOTE:
Typical deposition parameters are a base pressure of 5 x 10-7 Torr and a rate of 2
Å/s.
2.9.3. Immerse the wafer in remover PG for approximately 10 min until the metal has
fully lifted off, leaving Al covering the devices with openings for the electrodes and
bonding pads. When lift-off is complete, sonicate for 30s to remove any remaining
traces of unwanted metal. Rinse wafer first in clean remover PG solution, then
thoroughly rinse in DI H2O and dry the wafer with an N2 gun.
2.10. Etch the parylene-C to pattern the device outline and openings over electrodes
and Au bonding pads (VIAs) (Figure A1i)
2.10.1.

Use O2 plasma RIE to etch through the parylene-C layers surrounding the

devices, and through the top parylene-C layer covering both the MXene electrode
contacts and the Au bonding pads. Etching is complete when no parylene-C residue
remains on the wafer between devices. The SiO2 layer covering the MXene will act
as an etch-stop layer, preventing the O2 plasma from etching into or damaging the
MXene electrode contacts.
2.11. Etch the Al layer covering the devices using a wet chemical etch in Al etchant Type
A at 50 °C for 10 min, or for 1 min past when all visual traces of Al have been removed.
2.12. Etch the SiO2 covering the MXene electrodes using a wet chemical etch in 6:1
buffered oxide etchant (BOE) for 30 s. (Figure A1j)
2.13. The MXene microelectrode arrays are now complete. They can be released from
the Si substrate wafer by placing a small drop of DI H2O water at the edge of a device,
and gently peeling up the device as water is wicked underneath it by capillary action.
(Figure A1k and Figure A2)
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Figure A2. Photographs and optical microscopy images of MXene microelectrode arrays. (a)
Photograph of a 3 inch Si wafer containing 14 completed MXene microelectrode arrays. Note the gold
ring around the outer edge of the wafer, which is helpful for performing step 2.7 effectively. (b) Optical
microscope image showing the peeling up of a completed device from the wafer using a small amount
of DI H2O. (c) Optical microscope image showing the array of MXene microelectrodes. (d) Optical
microscope image of an individual MXene electrode. Scale bars, left to right: 1 cm, 3 mm, 500 μm, 20
μm.

3. Adapter Construction and Interfacing
NOTE: At this point, the thin film microelectrode arrays must be interfaced with an adapter
to connect to the electrophysiology recording system. In this protocol, we use the Intan 128ch
Stimulation/Recording Controller with the RHS2000 16-ch stim/record headstage, which
requires input via a connector compatible with the Omnetics 18-pin connector A79039-001.
This section uses a printed circuit board (PCB, Figure A3a) with a zero-insertion force (ZIF)
connector for interfacing with the Au bonding pads on the microelectrode array and
Omnetics connector A79040-001 for interfacing with the head-stage of the recording system.
Depending on the data acquisition system, different connectors can be used on the PCB to
enable interfacing with the electrophysiology headstage.
3.1. Solder the Omnetics and ZIF connectors to the PCB by applying a thin film of solder
paste to each of the contact pads on the PCB, placing the parts in their appropriate
locations, and heating on a hot plate until the solder reflows to form connections (Figure
A3b). NOTE: Reflow soldering can be done very easily on a hot plate or in a toaster oven
and does not require the use of a costly reflow oven.
3.2. Apply two layers of Kapton tape to the back side of the Au bonding pad region of the
MXene microelectrode array to give the device sufficient thickness to be secured in the
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ZIF connector. After applying the tape, trim any excess beyond the edges of the paryleneC device using a razor blade or precision scissors (Figure A3c).
3.3. Either under an inspection scope or using magnifying glasses, align the MXene
microelectrode array in the ZIF connector so that the Au bonding pads align with the
pins inside the ZIF connector, then close the ZIF to form a secure connection (Figure
A3d,e). NOTE: The ZIF connector used here is an 18-channel connector, while our
device has 16 channels. The extra uncontacted channels are easily identified as an open
circuit by means of impedance testing during recording sessions.
3.4. Test the electrochemical impedance of the MXene electrodes using a potentiostat to
ensure successful fabrication and connection to the PCB adapter. Reasonable impedance
values are given in the Discussion section to aid in troubleshooting.

Figure A3. Interfacing the MXene microelectrode array with the adapter board. (a) PCB with pads
for soldering Omnetics and ZIF connectors. (b) PCB after soldering of Omnetics and ZIF connectors. (c)
Addition of Kapton layers to back side of Au bonding pads of device, to give sufficient thickness for the
ZIF connector. Two layers of Kapton are added (top) and then trimmed around the edges (bottom). (d)
MXene microelectrode array inserted into ZIF connector with proper alignment. (e) Top view of MXene
microelectrode array connected to adapter board and ready for a recording experiment. Scale bars are
2 mm.

4. Acute Implantation and Neural Recording
NOTE: All in vivo procedures conformed to the National Institutes of Health (NIH) Guide for
the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care
and Use Committee (IACUC) of the University of Pennsylvania. Rat surgeries were performed
using sterile instruments and with aseptic technique. Respiratory rate, palpebral reflex, and
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pedal pinch reflex were checked every 10 min to monitor depth of anesthesia. Body
temperature was maintained with a heating pad.
4.1. Administer preemptive analgesia (subcutaneous injection of buprenorphine SR, 1.2
mg/kg).
4.2. Administer anesthesia (intraperitoneal injection of a mixture of 60 mg/kg ketamine and
0.25 mg/kg dexdomitor)
4.3. Secure rat in stereotaxic frame, apply ocular lubricant to the eyes, and clean shaved scalp
with 10% povidone-iodine.
4.4. Expose the calvaria with single midline scalp incision and blunt dissection of underlying
tissue.
4.5. Place a 00-90 screw into the skull to serve as the ground for recordings.
4.6. Using a dental drill with a small burr, make a craniotomy at the desired cortical
recording site.
4.7. Secure the array connector to a stereotaxic manipulator and position the device over the
craniotomy. Gently lower until the entire array is in contact with the exposed cortex.
4.8. Wrap the ground wire around the skull screw.
4.9. Connect the recording system headstage to the array and begin recording spontaneous
activity.
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Discussion
The MXene synthesis and delamination procedure described in this protocol
(HF/HCl/LiCl) was built from the MILD etching approach which employed a LiF/HCl (in situ
HF) etchant medium [224]. The MILD approach allows for large Ti3C2 flakes (several µm in
lateral size) to be spontaneously delaminated during washing once pH ~5-6 has been
attained. Compared to etching with HF alone, this results in material with higher quality and
improved material properties, such as electronic conductivity and chemical stability. The
HF/HCl/LiCl method takes advantage of the MILD synthesis improvements, while
additionally separating each step (etching, intercalation, and delamination) allowing for
more user control.
During step 1.1, the ratio of raw materials (TiC, Al, Ti), temperature, temperature
ramp rate, and time are critical to achieving the correct MAX phase. Sieving of the MAX phase
prior to etching will ensure more homogenous etching. Adding the MAX phase to the etchant
media (step 1.2) must be conducted slowly to prevent overheating and a general rule of 5 min
per 1 g of MAX is suggested. If overheating becomes a challenge, an ice bath should be
employed during addition of the Ti3AlC2 MAX phase. When washing the etching reaction to
neutral pH (step 1.3), each acidic supernatant after centrifugation should be transparent. If
the supernatant after centrifugation is dark or dilute green, increase the centrifuge time
and/or speed to sediment material. Because the addition of LiCl to H2O is exothermic, some
heating will occur (step 1.4). In this procedure, the intercalation time (step 1.4) is 12 h,
although it can be modified or shortened to as little as 15 minutes. The quality of delamination
(step 1.5) is specific to the quantity of water used during washing and the degree of agitation.
The supernatants decanted during this step may be dilute instead of transparent. If
sedimentation of material becomes a challenge, increasing the centrifuge speed/rcf should
be used. It is critical to perform separation and size selection by centrifugation (step 1.5) to
avoid polydisperse samples. Failure to perform this step will result in an ink that has both
Ti3AlC2 MAX phase contamination and large multilayer Ti3C2 particles. During step 1.6, it is
important that the headspace volume of the vial is minimized.
During the fabrication of the MXene microelectrode arrays, there are several critical
steps which are essential for producing functioning, high-quality electrodes. It is important
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to design the first photomask such that there is a metal ring patterned around the outer edge
of the wafer (step 2.2) and the second photomask such that there is a corresponding, slightly
larger diameter ring which will be etched through the sacrificial parylene-C (step 2.4) layer
to aid in removing the sacrificial layer. Without this ring, it can be difficult to establish an edge
to begin peeling up the sacrificial parylene-C layer in step 2.7. During step 2.3, it is critical to
expose the wafer to O2 plasma to allow the dilute Micro-90 solution to properly wet and
adhere to the wafer. Failure to perform this step will result in areas of the wafer not
accumulating a Micro-90 anti-adhesive layer, which renders the removal of the sacrificial
parylene-C layer in step 2.7 impossible. During the removal of the sacrificial parylene-C layer
in step 2.7, it is important to be careful to avoid scratching or damaging the bottom paryleneC layer, as this can lead to the formation of bubbles between the bottom parylene-C and the
Si wafer, and subsequent delamination. If the sacrificial parylene-C layer does not peel up
easily, a slightly more concentrated Micro-90 solution (4% in DI) can be used in step 2.3.2, or
the O2 plasma exposure in step 2.3.1 can be prolonged to improve hydrophilicity of the
underlying parylene-C layer.
After the fabrication is completed, properly interfacing the MXene device with the
connector board is essential. The addition of two layers of Kapton tape in step 3.2 is essential
to ensure proper thickness for insertion into the ZIF connector, however care should be taken
to avoid accidental folding or crumpling of the thin parylene-C device while the tape is added,
as it is not possible to remove the tape without damaging the device. Subsequently, proper
alignment of the Au bonding pads on the MXene device with pins inside the ZIF connector
(Figure A3d) is essential for forming a robust connection (step 3.3). At this stage, measuring
the impedance of the MXene electrodes is helpful for troubleshooting. A 50 μm x 50 μm
square MXene electrode should have an impedance magnitude near 50 kΩ at a frequency of
1 kHz in 1x PBS, and a 25 μm diameter circular MXene electrode should have an impedance
magnitude near 200 kΩ under the same parameters [312]. An impedance significantly larger
than this can indicate that the electrode is not properly connected in the ZIF connector, or
that the MXene electrode is not exposed, as may happen if either the top parylene-C layer was
not completely etched in step 2.10.1 or the SiO2 protective layer was not fully etched in step
2.12.
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One limitation of this method is variability in MXene film thickness that is sometimes
observed after spin-casting MXene onto the wafer. This variability can become more
pronounced if electrodes are scaled up to larger areas. This limitation can be readily
overcome by utilizing spray-coating instead of spin-coating to apply MXene to the wafer,
representing another simple, low-cost solution processing method with which MXene, and
this protocol, are compatible [307].
The protocol described here presents exciting new opportunities in neuroscience and
in the larger field of bioelectronics. While there has long been interest in leveraging carbonbased nanomaterials for neural microelectrodes, the incorporation of Ti 3C2 MXene into such
electrodes has enabled significantly simpler and more high-throughput fabrication than has
been possible with other carbon-based nanomaterials. Furthermore, the outstanding
properties of Ti3C2 MXene endow the electrodes with remarkably low impedance for their
size, thus improving sensitivity and signal quality. A growing body of literature also describes
a number of methods for micropatterning MXene, which may be adapted for fabricating
MXene microelectrodes in the future, including micro-contact printing [263], inkjet printing
[274], [278], and automated scalpel engraving [276]. There exists great potential to extend
this protocol to fabricate Ti3C2 MXene electrodes of arbitrary size and geometry for a range
of biosensing applications.
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